include,reason,title,doi,pubmed_id
True, The study meets the inclusion criteria as it is a head-to-head randomized controlled trial comparing the efficacy of olanzapine and haloperidol in patients with treatment-resistant schizophrenia.,Comparative efficacy of olanzapine and haloperidol for patients with treatmentresistant schizophreniaSee accompanying Editorial in this issue,https://doi.org/10.1016/s0006-3223(98)00291-1,10071708
False," The study population does not match the inclusion criteria as it only includes adults and adolescents with schizophrenia treated with clozapine, whereas the review includes a broader range of patient populations and treatment options.",A placebocontrolled crossover trial of dcycloserine added to clozapine in patients with schizophrenia,https://doi.org/10.1016/s0006-3223(98)00367-9,10071726
True," The study meets the inclusion criteria as it involves a randomized double-blind placebo-controlled trial of clozapine in patients with drug-induced psychosis in Parkinson's disease, which is one of the interventions included in the review.",LowDose Clozapine for the Treatment of DrugInduced Psychosis in Parkinsons Disease,https://doi.org/10.1056/nejm199903113401003,10072410
False," The abstract does not mention any of the specified psychiatric conditions (schizophrenia, bipolar disorder, major depressive disorder, pervasive developmental disorders, disruptive behavior disorders, or behavioral and psychological symptoms of dementia) or the specified interventions (aripiprazole, asenapine, clozapine, iloperidone, olanzapine, paliperidone, quetiapine, risperidone, and ziprasidone) that are the focus of the review.",Managing Psychosis in Patients with Parkinsons Disease,https://doi.org/10.1056/nejm199903113401011,10072418
False," The study population does not match the inclusion criteria as it only includes adults and adolescents with chronic schizophrenia, whereas the review includes a broader range of patient populations.",Comparison of Risperidone and Mosapramine Addition to Neuroleptic Treatment in Chronic Schizophrenia,https://doi.org/10.1159/000026565,10072664
True," The study meets the inclusion criteria as it involves adults and adolescents with schizophrenia, a randomized controlled trial, and examines the effectiveness of an intervention (errorless learning approach) on cognitive rehabilitation.",Errorless learning and the cognitive rehabilitation of memoryimpaired schizophrenic patients,https://doi.org/10.1017/s0033291798007673,10077298
True," The study meets the inclusion criteria as it examines predictors of relapse in patients with first-episode schizophrenia or schizoaffective disorder, which falls within the specified diagnostic categories.",Predictors of Relapse Following Response From a First Episode of Schizophrenia or Schizoaffective Disorder,https://doi.org/10.1001/archpsyc.56.3.241,10078501
True," The study meets the inclusion criteria as it involves a randomized controlled trial of risperidone in patients with dementia, which is one of the specified patient populations.",Comparison of Risperidone and Placebo for Psychosis and Behavioral Disturbances Associated With Dementia,https://doi.org/10.4088/jcp.v60n0207,10084637
False," The study population does not match the inclusion criteria as it only includes adults and adolescents with schizophrenia, whereas the review includes a broader range of patient populations such as bipolar disorder, major depressive disorder, and pervasive developmental disorders.",No evidence for association of serotoninA receptor variant TC with schizophrenia or clozapine response in a Chinese population,https://doi.org/10.1097/00001756-199901180-00011,10094133
True," The study meets the inclusion criteria as it involves a randomized controlled trial comparing risperidone to placebo and other antipsychotic agents in patients with chronic schizophrenia, and examines the factors associated with extrapyramidal symptoms.",A combined analysis of doubleblind studies with risperidone vs placebo and other antipsychotic agents factors associated with extrapyramidal symptoms,https://doi.org/10.1111/j.1600-0447.1999.tb00972.x,10100910
False," The title and abstract do not mention any specific interventions (medications) that are included in the review, such as aripiprazole, asenapine, clozapine, iloperidone, olanzapine, paliperidone, quetiapine, risperidone, and ziprasidone.",Measuring the Costs of Schizophrenia,https://doi.org/10.2165/00019053-199508030-00004,10155617
False, The title and abstract do not mention any specific interventions (medications) that are included in the review.,Measuring Quality of Life in Patients with Schizophrenia,https://doi.org/10.2165/00019053-199711010-00005,10172917
True," The study meets the inclusion criteria as it involves a naturalistic setting, compares risperidone with haloperidol, and examines economic outcomes.",Economic outcomes associated with the use of risperidone in a naturalistic group practice setting,nan,10178498
True," The study meets the inclusion criteria as it involves a randomized controlled trial of ziprasidone in patients with an acute exacerbation of schizophrenia or schizoaffective disorder, which is one of the interventions included in the review.",Ziprasidone mgday and mgday in the Acute Exacerbation of Schizophrenia and Schizoaffective Disorder A Week PlaceboControlled Trial,https://doi.org/10.1016/s0893-133x(98)00090-6,10192829
True," The study meets the inclusion criteria as it involves a randomized controlled trial of amisulpride in patients with schizophrenia, specifically those with primary negative symptoms, and reports on efficacy and safety outcomes.",Improvement of Schizophrenic Patients With Primary Negative Symptoms Treated With Amisulpride,https://doi.org/10.1176/ajp.156.4.610,10200742
False," The title and abstract do not match the specified inclusion criteria, as the article appears to focus on sudden infant death syndrome, child sexual abuse, and child development, which do not align with the specified population (children and adolescents with various psychiatric disorders) and outcomes (effectiveness and harms of antipsychotic medications).",Sudden infant death syndrome Child sexual abuse and Child development,https://doi.org/10.1097/00008480-199904000-00013,10202629
True," The study meets the inclusion criteria as it involves a randomized controlled trial comparing the efficacy, tolerability, and safety of olanzapine and haloperidol in patients with schizoaffective disorder.",Olanzapine versus haloperidol in the treatment of schizoaffective disorder,https://doi.org/10.1192/bjp.174.1.15,10211146
True, The study meets the inclusion criteria as it is a randomized double-blind comparison of the incidence of tardive dyskinesia in patients with schizophrenia during long-term treatment with olanzapine or haloperidol.,Randomised doubleblind comparison of the incidence of tardive dyskinesia in patients with schizophrenia during longterm treatment with olanzapine or haloperidol,https://doi.org/10.1192/bjp.174.1.23,10211147
False," The study does not meet the inclusion criteria as it does not involve any of the specified interventions (e.g. aripiprazole, asenapine, clozapine, iloperidone, olanzapine, paliperidone, quetiapine, risperidone, and ziprasidone) and instead compares risperidone to typical neuroleptics.",Prolactin Levels in Premenopausal Women Treated With Risperidone Compared With Those of Women Treated With Typical Neuroleptics,https://doi.org/10.1097/00004714-199904000-00025,10211930
True," The study meets the inclusion criteria as it involves a population with schizophrenia, a specific genetic polymorphism, and examines the relationship between the polymorphism and the etiology or clinical characteristics of schizophrenia.",Schizophrenia and the serotoninA receptor promoter polymorphism,https://doi.org/10.1016/s0165-1781(99)00002-5,10220013
False," The abstract does not mention any specific interventions or populations that match the inclusion criteria, and the focus is on methodological flaws and proposed solutions for clinical trials rather than a review of existing trials.",Clinical trials of new antipsychotics a critical appraisal,https://doi.org/10.1097/00004850-199903000-00012,10220130
True," The study meets the inclusion criteria as it compares the distribution of body mass index among individuals with and without schizophrenia, and it is a relevant topic for the review paper on the effects of antipsychotic medications.",The Distribution of Body Mass Index Among Individuals With and Without Schizophrenia,https://doi.org/10.4088/jcp.v60n0402,10221280
False," The abstract does not match the inclusion criteria as it focuses on psychotropic drugs in breastfeeding mothers, which is not within the specified patient populations (schizophrenia, bipolar disorder, major depressive disorder, behavioral and psychological symptoms of dementia, pervasive developmental disorders, and disruptive behavior disorders) or interventions (aripiprazole, asenapine, clozapine, iloperidone, olanzapine, paliperidone, quetiapine, risperidone, and ziprasidone).",Psychotropic drugs in mothers milk a comprehensive review of assay methods pharmacokinetics and of safety of breastfeeding,https://doi.org/10.1177/026988119901300108,10221361
True, The study meets the inclusion criteria as it involves a randomized controlled trial comparing the effects of clozapine and typical neuroleptics on cognitive function in patients with neuroleptic-responsive schizophrenia.,A comparison of the effect of clozapine with typical neuroleptics on cognitive function in neurolepticresponsive schizophrenia,https://doi.org/10.1016/s0920-9964(98)00145-5,10227103
True," The study meets the inclusion criteria as it involves adults with schizophrenia treated with clozapine, which is an intervention included in the review.",Spontaneous slow and fast MEG activity in male schizophrenics treated with clozapine,https://doi.org/10.1007/s002130050902,10229062
True," The study meets the inclusion criteria as it involves the use of risperidone in elderly patients with psychotic disorders, which is one of the interventions included in the review.",Risperidone in the Treatment of Elderly Patients With Psychotic Disorders,https://doi.org/10.1097/00019442-199905000-00006,10322240
True," The study meets the inclusion criteria as it involves a randomized controlled trial comparing the efficacy and safety of olanzapine and placebo in the treatment of acute mania, which is a relevant intervention for the review.",Olanzapine Versus Placebo in the Treatment of Acute Mania,https://doi.org/10.1176/ajp.156.5.702,10327902
True," The study meets the inclusion criteria as it involves adults with a DSM-III-R or DSM-IV diagnosis of schizophrenia, examines the relationship between akathisia and psychopathology in patients treated with clozapine, and uses a randomized controlled trial design.",Does akathisia influence psychopathology in psychotic patients treated with clozapine,https://doi.org/10.1016/s0006-3223(98)00146-2,10349044
True," The study focuses on bipolar disorder in old age, which falls within the specified age range of older adults (≥ 65 years of age) with behavioral and psychological symptoms of dementia, one of the inclusion criteria.",Bipolar disorder in old age,https://doi.org/10.1007/0-306-47521-9_8,10349067
False," The study population does not match the inclusion criteria as it only includes patients with bipolar disorder type I and schizoaffective disorder bipolar type, whereas the inclusion criteria include a broader range of psychiatric disorders.",Is bipolar disorder still underdiagnosed Are antidepressants overutilized,https://doi.org/10.1016/s0165-0327(98)00076-7,10357026
True," The study population includes adults with refractory schizophrenia, which meets the inclusion criteria for the review.",Costeffectiveness of Clozapine in Patients With High and Low Levels of Hospital Use,https://doi.org/10.1001/archpsyc.56.6.565,10359474
True," The study meets the inclusion criteria as it examines the rehospitalization rates of patients with schizophrenia who were discharged on a regimen of risperidone or clozapine, which are included interventions, and the study's outcomes align with the specified effectiveness outcomes for patients with schizophrenia.",Rehospitalization Rates of Patients Recently Discharged on a Regimen of Risperidone or Clozapine,https://doi.org/10.1176/ajp.156.6.863,10360124
False," The study population does not match the inclusion criteria as it only includes patients with schizophrenia or affective disorders, whereas the review includes a broader range of psychiatric conditions.",Small Effects of Valproic Acid on the Plasma Concentrations of Clozapine and its Major Metabolites in Patients With Schizophrenic or Affective Disorders,https://doi.org/10.1097/00007691-199906000-00017,10365650
True," The study meets the inclusion criteria as it involves older adults (≥ 65 years of age) with behavioral and psychological symptoms of dementia, and it compares the incidence of tardive dyskinesia between risperidone and haloperidol, which are included interventions.",Lower Incidence of Tardive Dyskinesia with Risperidone Compared with Haloperidol in Older Patients,https://doi.org/10.1111/j.1532-5415.1999.tb01595.x,10366172
True," The study meets the inclusion criteria as it involves a retrospective naturalistic study of clozapine treatment in chronic psychiatric inpatients with schizophrenia, which is a relevant population for the review.",Clinical outcome to clozapine treatment in chronic psychiatric inpatients,https://doi.org/10.1016/s0278-5846(98)00087-6,10368852
False," The abstract does not mention any specific interventions (medications) that are included in the review, such as aripiprazole, asenapine, clozapine, iloperidone, olanzapine, paliperidone, quetiapine, risperidone, and ziprasidone.",Negative Symptoms in Schizophrenia Neurobiological Models and Treatment Response,https://doi.org/10.3109/10673229809000313,10370450
True, The study population (patients with schizophrenia) and the intervention (clozapine) match the inclusion criteria.,The effects of clozapine on cognitive functioning in schizophrenia,nan,10372607
False," The study does not meet the inclusion criteria as it does not examine the effectiveness of the specified interventions (aripiprazole, asenapine, clozapine, iloperidone, olanzapine, paliperidone, quetiapine, risperidone, and ziprasidone) in the specified patient populations.",Risperidoneinduced increase of plasma norepinephrine is not correlated with symptom improvement in chronic schizophrenia,https://doi.org/10.1016/s0006-3223(98)00199-1,10376128
False," The study does not meet the inclusion criteria as it does not involve any of the specified interventions (e.g. aripiprazole, asenapine, clozapine, iloperidone, olanzapine, paliperidone, quetiapine, risperidone, and ziprasidone) and does not examine any of the specified outcomes (e.g. mortality, quality of life, functional capacity, hospitalization, etc.).",Absence of interaction between erythromycin and a single dose of clozapine,https://doi.org/10.1007/s002280050621,10379638
True," The study meets the inclusion criteria as it involves treatment-resistant patients with schizophrenia who received olanzapine and then clozapine, and the outcomes measured include symptom response, which is an effectiveness outcome of interest for this review.",Treatmentresistant schizophrenic patients respond to clozapine after olanzapine nonresponse,https://doi.org/10.1016/s0006-3223(99)00029-3,10394475
True," The study meets the inclusion criteria as it involves a population with schizophrenia, a specific intervention (olanzapine), and examines effectiveness outcomes such as sleep quality and sleep architecture.",Olanzapine acute administration in schizophrenic patients increases delta sleep and sleep efficiency,https://doi.org/10.1016/s0006-3223(98)00372-2,10394486
True," The study population includes adults with schizophrenia, which meets the inclusion criteria.",Switching from therapy with typical antipsychotic agents to risperidone Longterm impact on patient outcome,https://doi.org/10.1016/s0149-2918(99)80003-4,10397376
True," The study meets the inclusion criteria as it involves a comparison of novel antipsychotics (clozapine, olanzapine, risperidone, and sertindole) with haloperidol in patients with schizophrenia, which is a relevant population for this review.",Novel antipsychotics comparison of weight gain liabilities,https://doi.org/10.4088/jcp.v60n0602,10401912
True," The study meets the inclusion criteria as it involves patients with recent-onset schizophrenia and other psychotic disorders, and examines the effect of clozapine on obsessions.",Clozapine and Obsessions in Patients With RecentOnset Schizophrenia and Other Psychotic Disorders,https://doi.org/10.4088/jcp.v60n0603,10401913
False," The study population is limited to outpatients with poorly responsive schizophrenia, which does not meet the inclusion criteria of patients with schizophrenia (including first episode and treatment resistance), bipolar disorder, major depressive disorder, and behavioral and psychological symptoms of dementia.",Lithium Augmentation Fails to Reduce Symptoms in Poorly Responsive Schizophrenic Outpatients,https://doi.org/10.4088/jcp.v60n0604,10401914
False," The study population does not match the inclusion criteria as it only includes patients with acute mania, whereas the review includes a broader range of psychiatric conditions.",Clinical and quantitative EEG studies of mania,https://doi.org/10.1016/s0165-0327(98)00124-4,10404707
True," The study meets the inclusion criteria as it involves adolescents (ages 13-17 years) with a DSM-IV diagnosis of bipolar disorder (manic episode), and it examines the effectiveness of olanzapine, which is an intervention included in the review.",Olanzapine in the treatment of adolescent acute mania a report of seven cases,https://doi.org/10.1016/s0165-0327(98)00119-0,10404715
True, The study meets all the inclusion criteria as it is a meta-analysis of randomized placebo-controlled trials comparing the efficacy and acceptability of atypical antipsychotic drugs in treating schizophrenic patients.,Comparison of the efficacy and acceptability of atypical antipsychotic drugs a metaanalysis of randomized placebocontrolled trials,nan,10410494
True," The study meets the inclusion criteria as it is a review and meta-analysis of the effects of atypical antipsychotic drugs on neurocognitive impairment in schizophrenia, which is the topic of interest.",The Effects of Atypical Antipsychotic Drugs on Neurocognitive Impairment in Schizophrenia A Review and Metaanalysis,https://doi.org/10.1093/oxfordjournals.schbul.a033374,10416727
True," The study population includes adults with schizophrenia, which is within the specified age range and diagnosis for inclusion.",Risperidone versus Haloperidol on Secondary Memory Can Newer Medications Aid Learning,https://doi.org/10.1093/oxfordjournals.schbul.a033375,10416728
True," The study meets the inclusion criteria as it focuses on the effects of atypical antipsychotic drugs, specifically clozapine, olanzapine, and risperidone, on cognitive function in schizophrenia, which is a relevant population for the review.",The Effects of Clozapine Risperidone and Olanzapine on Cognitive Function in Schizophrenia,https://doi.org/10.1093/oxfordjournals.schbul.a033376,10416729
True," The study population includes adults with schizophrenia, which matches the inclusion criteria.",The Effects of Neurocognitive Remediation on Executive Processing in Patients With Schizophrenia,https://doi.org/10.1093/oxfordjournals.schbul.a033379,10416732
True," The study meets the inclusion criteria as it involves patients with schizophrenia, a relevant population for the review, and examines the effect of glucose on memory performance, a relevant outcome.",GlucoseInduced Increase in Memory Performance in Patients With Schizophrenia,https://doi.org/10.1093/oxfordjournals.schbul.a033381,10416734
False," The abstract does not mention any specific interventions or outcomes related to the inclusion criteria, and the workshop appears to be a discussion of future research directions rather than a review of existing studies.",Antipsychotics Past and Future National Institute of Mental Health Division of Services and Intervention Research Workshop July,https://doi.org/10.1093/oxfordjournals.schbul.a033387,10416740
True," The study meets the inclusion criteria as it involves adults with schizophrenia, a randomized controlled trial, and examines the effectiveness of two antipsychotic medications.",Reliability Validity and Application of the Medical Outcomes Study Item ShortForm Health Survey SF in Schizophrenic Patients Treated With Olanzapine Versus Haloperidol,https://doi.org/10.1097/00005650-199907000-00008,10424639
True," The study meets the inclusion criteria as it involves adults with schizophrenia, a randomized controlled trial, and examines the effects of nicotine withdrawal on psychiatric symptoms.",Nicotine Withdrawal and Psychiatric Symptoms in Cigarette Smokers with Schizophrenia,https://doi.org/10.1016/s0893-133x(98)00121-3,10432467
False," The study population does not match the inclusion criteria as it only includes chronic schizophrenic patients with prominent negative symptoms, whereas the review includes a broader range of patient populations with various psychiatric conditions.",DCycloserine Increases Positive Symptoms in Chronic Schizophrenic Patients When Administered in Addition to Antipsychotics A DoubleBlind Parallel PlaceboControlled Study,https://doi.org/10.1016/s0893-133x(99)00014-7,10432468
True," The study population includes adults and adolescents with schizophrenia, which meets the inclusion criteria.",The psychosis of schizophrenia prevalence response to atypical antipsychotics and prediction of outcome,https://doi.org/10.1016/s0006-3223(99)00040-2,10435201
True," The study population includes adults with dystonia, which is a condition not explicitly listed in the inclusion criteria, but the medication being studied, clozapine, is an intervention included in the review.",An open trial of clozapine for dystonia,https://doi.org/10.1002/1531-8257(199907)14:4<652::aid-mds1015>3.0.co;2-g,10435503
True, The study meets the inclusion criteria as it is a head-to-head randomized controlled trial comparing the effectiveness of olanzapine and haloperidol in treating cannabis-induced psychotic disorder.,A comparison of olanzapine with haloperidol in cannabisinduced psychotic disorder a doubleblind randomized controlled trial,https://doi.org/10.1097/00004850-199905002-00005,10435771
False," The study population specified in the abstract (bipolar disorder) does not match the inclusion criteria, which includes schizophrenia, schizoaffective disorders, first episode schizophrenia, treatment-resistant schizophrenia, major depressive disorder, and behavioral and psychological symptoms of dementia, but not bipolar disorder.",Use of Atypical Antipsychotic Agents in Bipolar and Schizoaffective Disorders,https://doi.org/10.1097/00004714-199908000-00012,10440464
True, The study meets the inclusion criteria as it involves a randomized controlled trial examining the effectiveness of a specific intervention (mianserin) for a condition (neuroleptic-induced akathisia) that is relevant to the review.,Treatment of neurolepticinduced akathisia with the HT antagonist mianserin,https://doi.org/10.1192/bjp.174.3.238,10448449
True," The study meets the inclusion criteria as it involves a randomized controlled trial of clozapine versus treatment as usual for patients with treatment-resistant illness and a history of mania, which falls within the specified interventions and patient populations of interest.",Clinical Outcome in a Randomized Year Trial of Clozapine Versus Treatment as Usual for Patients With TreatmentResistant Illness and a History of Mania,https://doi.org/10.1176/ajp.156.8.1164,10450255
True," The study meets the inclusion criteria as it involves adults with a diagnosis of borderline personality disorder and psychoses, and it examines the effectiveness of clozapine in reducing severe self-mutilation and aggression.",Clozapine Reduces Severe SelfMutilation and Aggression in Psychotic Patients With Borderline Personality Disorder,https://doi.org/10.4088/jcp.v60n0710,10453803
False," The study population specified in the abstract (patients with schizophrenia) does not match the inclusion criteria for patients with pervasive developmental disorders and disruptive behavior disorders, which are included in the review.",Early phase II study of quetiapine fumarate on schizophrenia,nan,10464776
False," The study population specified in the abstract (patients suffering from schizophrenia with predominance of positive or negative symptoms) does not match the inclusion criteria, which include a broader range of psychiatric disorders such as bipolar disorder, major depressive disorder, and behavioral and psychological symptoms of dementia.",Safety of amisulpride Solian a review of clinical studies,https://doi.org/10.1097/00004850-199907000-00002,10468313
True," The study meets the inclusion criteria as it involves a randomized clinical trial comparing the effectiveness of olanzapine and haloperidol in treating schizophrenia and other psychotic disorders, and includes outcomes such as quality of life and clinical symptoms.",Olanzapine versus haloperidol in the treatment of schizophrenia and other psychotic disorders quality of life and clinical outcomes of a randomized clinical trial,https://doi.org/10.1023/a:1008958925848,10474283
False," The study population is elderly patients with psychotic disorders, which does not match the inclusion criteria of adults with schizophrenia, bipolar disorder, major depressive disorder, or behavioral and psychological symptoms of dementia, or children and adolescents with pervasive developmental disorders or disruptive behavior disorders.",Experience with the atypical antipsychoticsrisperidone and olanzapine in the elderly,https://doi.org/10.1023/a:1022351725541,10482120
True," The study meets the inclusion criteria as it involves a population with schizophrenia, a relevant intervention (clozapine), and relevant outcomes (awareness of illness and cognition).",Effects of clozapine on awareness of illness and cognition in schizophrenia,https://doi.org/10.1016/s0165-1781(99)00033-5,10482343
True," The study meets the inclusion criteria as it involves a randomized controlled trial comparing the efficacy and safety of risperidone to haloperidol in patients with treatment-refractory schizophrenia, which is a relevant population for this review.",Risperidone in TreatmentRefractory Schizophrenia,https://doi.org/10.1176/ajp.156.9.1374,10484947
True," The study meets the inclusion criteria as it involves adults with a DSM-III-R diagnosis of bipolar disorder, which is one of the specified conditions of interest.",Elevated Frequency of Diabetes Mellitus in Hospitalized ManicDepressive Patients,https://doi.org/10.1176/ajp.156.9.1417,10484954
False," The study population specified in the abstract is adults with obsessive-compulsive disorder refractory to selective serotonin reuptake inhibitors, which does not match the inclusion criteria of patients with schizophrenia, bipolar disorder, major depressive disorder, or pervasive developmental disorders.",Olanzapine Addition in ObsessiveCompulsive Disorder Refractory to Selective Serotonin Reuptake Inhibitors,https://doi.org/10.4088/jcp.v60n0804,10485634
True," The study focuses on late-onset schizophrenia, which falls within the specified age range of adults (18 years and older) and meets the diagnostic criteria for schizophrenia.",LateOnset Schizophrenia,https://doi.org/10.2165/00002512-199915020-00002,10495068
True," The study population includes adults with schizophrenia, which meets the inclusion criteria.",Clinical efficacy of olanzapine,nan,10495984
True," The study meets the inclusion criteria as it involves a randomized controlled trial of risperidone, a medication included in the review, for the treatment of behavioral symptoms of dementia in older adults, which is one of the patient populations of interest.",A randomized trial of risperidone placebo and haloperidol for behavioral symptoms of dementia,https://doi.org/10.1212/wnl.53.5.946,10496251
True," The study meets the inclusion criteria as it involves a naturalistic case series outcome study of olanzapine in patients with treatment-resistant schizophrenia, which is one of the interventions included in the review.",Olanzapine for Patients with TreatmentResistant Schizophrenia A Naturalistic CaseSeries Outcome Study,https://doi.org/10.1177/070674379904400709,10500873
True," The study meets the inclusion criteria as it involves a prospective clinical trial examining the safety and tolerability of adding fluvoxamine to clozapine monotherapy in schizophrenic patients, which is a relevant intervention for the review.",Addition of LowDose Fluvoxamine to LowDose Clozapine Monotherapy in Schizophrenia Drug Monitoring and Tolerability Data from a Prospective Clinical Trial,https://doi.org/10.1055/s-2007-979221,10505485
True," The study meets the inclusion criteria as it involves a randomized double-blind comparison of clozapine discontinuation symptoms with conversion to either olanzapine or placebo, which is a relevant intervention for the review.",Controlled DoubleBlind Investigation of the Clozapine Discontinuation Symptoms With Conversion to Either Olanzapine or Placebo,https://doi.org/10.1097/00004714-199910000-00007,10505585
False," The title and abstract do not mention any specific age range or diagnosis that matches the inclusion criteria, and the article appears to be a general review of psychopharmacology in autism rather than focusing on a specific population or disorder.",Psychopharmacology in Autism,https://doi.org/10.1097/00006842-199909000-00008,10511014
False, The abstract does not discuss the effectiveness or harms of olanzapine in any of the specified patient populations or outcomes.,Olanzapine,https://doi.org/10.2165/00003088-199937030-00001,10511917
True," The study meets the inclusion criteria as it involves adults with schizophrenia, a specific population of interest, and examines the effects of two antipsychotic medications, clozapine and fluphenazine, on brain metabolic patterns.",The Brain Metabolic Patterns of Clozapine and FluphenazineTreated Female Patients with Schizophrenia Evidence of a Sex Effect,https://doi.org/10.1016/s0893-133x(99)00065-2,10516959
False," The study population specified in the abstract (patients with bipolar I disorder) does not match the inclusion criteria for the review, which includes a broader range of psychiatric disorders such as schizophrenia, bipolar disorder, major depressive disorder, and pervasive developmental disorders.",The comparative prophylactic efficacy of lithium and carbamazepine in patients with bipolar I disorder,https://doi.org/10.1097/00004850-199909000-00002,10529070
False," The abstract does not mention any of the specified disorders or patient populations (schizophrenia, bipolar disorder, major depressive disorder, behavioral and psychological symptoms of dementia, pervasive developmental disorders, disruptive behavior disorders) and does not discuss any of the specified interventions (aripiprazole, asenapine, clozapine, iloperidone, olanzapine, paliperidone, quetiapine, risperidone, ziprasidone).",Diagnosis and Management of Alzheimer Disease,https://doi.org/10.3122/jabfm.12.5.375,10534086
False," The study population is limited to patients with schizophrenia, whereas the review includes patients with various psychiatric conditions such as bipolar disorder, major depressive disorder, and behavioral and psychological symptoms of dementia.",Clinical and Economic Outcomes of Olanzapine Compared With Haloperidol for Schizophrenia,https://doi.org/10.2165/00019053-199915050-00005,10537964
True," The study meets the inclusion criteria as it is a randomized controlled trial comparing the effectiveness and economic outcomes of olanzapine and haloperidol in the treatment of schizophrenia in France, which is a relevant population for this review.",Economic comparison of olanzapine versus haloperidol in treatment of schizophrenia in France,nan,10546082
True," The study meets the inclusion criteria as it involves a head-to-head comparison of two atypical antipsychotics (risperidone and olanzapine) in the treatment of schizophrenia, which is a relevant population for this review.",A Comparative Effectiveness Study of Risperidone and Olanzapine in the Treatment of Schizophrenia,https://doi.org/10.4088/jcp.v60n1003,10549681
False," The article does not focus on the specified patient populations (schizophrenia, bipolar disorder, major depressive disorder, behavioral and psychological symptoms of dementia, pervasive developmental disorders, or disruptive behavior disorders) or interventions (aripiprazole, asenapine, clozapine, iloperidone, olanzapine, paliperidone, quetiapone, risperidone, and ziprasidone).",RAPIDCYCLING BIPOLAR DISORDER,https://doi.org/10.1016/s0193-953x(05)70097-6,10550857
True," The study meets the inclusion criteria as it focuses on antipsychotic-induced weight gain, which is a relevant topic for the review, and includes a comprehensive literature search and meta-analysis of various antipsychotic agents.",AntipsychoticInduced Weight Gain A Comprehensive Research Synthesis,https://doi.org/10.1176/ajp.156.11.1686,10553730
True," The study meets the inclusion criteria as it involves a randomized controlled trial of clozapine, a medication included in the review, in patients with treatment-refractory schizophrenia, which is one of the target populations.",DoubleBlind Study of Clozapine Dose Response in Chronic Schizophrenia,https://doi.org/10.1176/ajp.156.11.1744,10553738
True," The study meets the inclusion criteria as it involves a randomized controlled trial of a specific medication (DSerine) added to clozapine for the treatment of schizophrenia, which is a condition included in the review.",dSerine Added to Clozapine for the Treatment of Schizophrenia,https://doi.org/10.1176/ajp.156.11.1822,10553752
True," The study meets the inclusion criteria as it involves patients with schizophrenia, a relevant population for this review, and examines the effectiveness of risperidone compared to typical antipsychotic drugs.",Differences in frontal cortical activation by a working memory task after substitution of risperidone for typical antipsychotic drugs in patients with schizophrenia,https://doi.org/10.1073/pnas.96.23.13432,10557338
False," The abstract does not provide any information about the pharmacological effects of sigma receptor ligands, instead it appears to be a list of medications and their abbreviations.",Pharmacological Effects of SIGMAReceptor Ligands Atypical antipsychotic profiles of sigma receptor ligands,https://doi.org/10.1254/fpj.114.13,10562961
False," The study does not appear to be a systematic review or a randomized controlled trial, but rather a single case study or a clinical note, as it lacks the structure and language typical of a systematic review or a randomized controlled trial.",Olanzapine in whole not half tablets for psychosis from Alzheimers dementia,https://doi.org/10.1093/ajhp/56.21.2245,10565707
True," The study meets the inclusion criteria as it is a randomized controlled trial comparing olanzapine to lithium in the treatment of mania, which is one of the interventions included in the review.",Olanzapine compared to lithium in mania a doubleblind randomized controlled trial,https://doi.org/10.1097/00004850-199911000-00003,10565800
False," The study does not meet the inclusion criteria as it is not a randomized controlled trial, but rather an open-label pilot study.",Lack of efficacy of the HT receptor antagonist granisetron in the treatment of acute neurolepticinduced akathisia,https://doi.org/10.1097/00004850-199911000-00006,10565803
True, The study meets the inclusion criteria as it involves a comparison of retention rates in placebo-controlled and non-placebo controlled clinical trials of schizophrenia.,Retention Rates in Placebo and NonplaceboControlled Clinical Trials of Schizophrenia,https://doi.org/10.1177/070674379904400904,10584158
True, The study meets the inclusion criteria as it involves a retrospective cohort study examining the effectiveness of risperidone in reducing hospital days in patients with schizophrenia spectrum disorders.,Hospital Days in RisperidoneTreated Patients,https://doi.org/10.1177/070674379904400907,10584161
True," The study meets the inclusion criteria as it involves adults with schizophrenia, a condition included in the review, and examines the effectiveness and harms of clozapine, an intervention included in the review.",Myocarditis and cardiomyopathy associated with clozapine,https://doi.org/10.1016/s0140-6736(99)10385-4,10584719
False," The study population does not match the inclusion criteria as it only includes 7 females and males, not the specified age groups or diagnoses.",Differential olanzapine plasma concentrations by sex in a fixeddose study,https://doi.org/10.1016/s0920-9964(99)00053-5,10593449
False," The study does not meet the inclusion criteria as it does not involve any of the specified interventions (aripiprazole, asenapine, clozapine, iloperidone, olanzapine, paliperidone, quetiapine, risperidone, and ziprasidone) and does not report on any of the specified outcomes (mortality, quality of life, functional capacity, hospitalization, emergency department visits, efficacy, adherence, persistence, caregiver burden, etc.).",Measuring neurolepticinduced akathisia by threechannel actometry,https://doi.org/10.1016/s0920-9964(99)00045-6,10593450
False," The study does not meet the inclusion criteria as it is not related to the specified patient populations (schizophrenia, bipolar disorder, major depressive disorder, behavioral and psychological symptoms of dementia, pervasive developmental disorders, or disruptive behavior disorders) or interventions (aripiprazole, asenapine, clozapine, iloperidone, olanzapine, paliperidone, quetiapine, risperidone, and ziprasidone).",Pharmacokinetic analysis of felodipinegrapefruit juice interaction based on an irreversible enzyme inhibition model,https://doi.org/10.1046/j.1365-2125.2000.00140.x,10606837
False," The study population is healthy volunteers, not individuals with schizophrenia, bipolar disorder, or other psychiatric conditions.",Effect of caffeine on clozapine pharmacokinetics in healthy volunteers,https://doi.org/10.1046/j.1365-2125.2000.00111.x,10606838
True," The study meets the inclusion criteria as it involves adults with schizophrenia, a relevant population for the review, and examines the effectiveness of antipsychotic medication, a relevant intervention.",CYPD Mutations and Therapeutic Outcome in Schizophrenic Patients,https://doi.org/10.1592/phco.19.13.1057.31593,10610012
True," The study meets the inclusion criteria as it involves adults with schizophrenia, a diagnosis of interest in the review, and examines the effectiveness of a treatment (ERP) in this population.",Brain eventrelated potentials ERPs in schizophrenia during a word recognition memory task,https://doi.org/10.1016/s0167-8760(99)00082-3,10610049
True," The study meets the inclusion criteria as it involves adults and adolescents with a DSM-III-R diagnosis of schizophrenia, and it examines the relationship between memory span and schizophrenia.",Differential memory span abnormal lateralization pattern in schizophrenic patients and their siblings,https://doi.org/10.1016/s0167-8760(99)00087-2,10610054
True," The study meets the inclusion criteria as it involves a head-to-head comparison of two antipsychotic medications (amisulpride and risperidone) in patients with acute exacerbations of schizophrenia, which is a relevant population for this review.",Amisulpride vs risperidone in the treatment of acute exacerbations of schizophrenia,https://doi.org/10.1016/s0165-1781(99)00075-x,10622347
False," The study population is geriatric patients with chronic schizophrenia, which does not match the inclusion criteria of patients with schizophrenia, bipolar disorder, major depressive disorder, or behavioral and psychological symptoms of dementia.",Prevalence and correlates of parkinsonism in an institutionalized population of geriatric patients with chronic schizophrenia,https://doi.org/10.1002/(sici)1099-1166(200001)15:1<7::aid-gps69>3.0.co;2-z,10637399
False," The abstract does not mention any of the specified psychiatric conditions or interventions, and the focus is on dementia research in developing countries, which does not align with the specified inclusion criteria.",Dementia in developing countries A consensus statement from the Dementia Research Group,https://doi.org/10.1002/(sici)1099-1166(200001)15:1<14::aid-gps70>3.0.co;2-8,10637400
False," The study population does not match the specified inclusion criteria as it only includes patients with severe mental disorders in Italy, whereas the review includes a broader range of patient populations.",Pharmacoepidemiology of psychotropic drugs in patients with severe mental disorders in Italy,https://doi.org/10.1007/s002280050694,10638400
False," The study population does not match the inclusion criteria as it only includes inpatients in need of treatment with risperidone and mirtazapine, whereas the review includes a broader range of patient populations.",Lack of drug interactions between mirtazapine and risperidone in psychiatric patients a pilot study,https://doi.org/10.1016/s0924-977x(99)00054-1,10647097
True," The study meets the inclusion criteria as it involves patients with schizophrenia, a condition included in the review, and examines the effectiveness of neuroleptic medication, which is also included in the review.",Effective neuroleptic medication removes prepulse inhibition deficits in schizophrenia patients,https://doi.org/10.1016/s0006-3223(99)00229-2,10650450
False," The title does not mention the specific population of interest (schizophrenia) as the primary focus, but rather as one of the conditions being compared to conventional antipsychotics.",Evidencebased psychopharmacology Appraising a systematic review is risperidone better than conventional antipsychotics in the treatment of schizophrenia,https://doi.org/10.1177/026988119901300413,10667619
True," The study meets the inclusion criteria as it is a randomized controlled trial comparing the effectiveness of clozapine and haloperidol in patients with refractory schizophrenia, which is a relevant population for this review.",How Long to Wait for a Response to Clozapine A Comparison of Time Course of Response to Clozapine and Conventional Antipsychotic Medication in Refractory Schizophrenia,https://doi.org/10.1093/oxfordjournals.schbul.a033412,10667741
True," The study meets the inclusion criteria as it is a randomized controlled trial examining the effectiveness of risperidone in patients with a first psychotic episode, which is a population of interest for this review.",Risperidone in the Treatment of FirstEpisode Psychotic Patients A DoubleBlind Multicenter Study,https://doi.org/10.1093/oxfordjournals.schbul.a033413,10667742
True," The study meets the inclusion criteria as it reviews atypical antipsychotic agents for the treatment of schizophrenia and other disorders, and includes effectiveness and harm outcomes relevant to the review.",Atypical antipsychotic agents A critical review,https://doi.org/10.1093/ajhp/57.3.238,10674777
False," The study population does not match the inclusion criteria as it only includes psychiatric patients treated with a combination of ECT and clozapine, whereas the inclusion criteria specify a broader range of patient populations and interventions.",Combined ElectroconvulsiveClozapine Therapy,https://doi.org/10.1097/00002826-200001000-00003,10682225
False," The study population does not match the inclusion criteria as it only includes young patients with first episode schizophrenia, whereas the review includes a broader range of patient populations, including adults, adolescents, and children with various psychiatric conditions.",Dopamine D receptor occupancy by olanzapine or risperidone in young patients with schizophrenia,https://doi.org/10.1016/s0925-4927(99)00032-3,10688158
True," The study meets the inclusion criteria as it involves a randomized controlled trial comparing the effects of two antipsychotic medications (risperidone and haloperidol) on sustained attention deficits in schizophrenia, which is a relevant population for this review.",Effects of Atypical Neuroleptics on Sustained Attention Deficits in Schizophrenia A Trial of Risperidone Versus Haloperidol,https://doi.org/10.1016/s0893-133x(99)00137-2,10693159
False," The study population specified in the abstract (patients treated with clozapine in Italy) does not match the inclusion criteria, which include a wide range of patient populations and interventions.",Blood dyscrasias in clozapinetreated patients in Italy,nan,10702809
False," The study population does not match the inclusion criteria as it only includes healthy male volunteers, not patients with schizophrenia, bipolar disorder, or other conditions specified in the inclusion criteria.",Olanzapine increases slowwave sleep evidence for blockade of central HTC receptors in vivo,https://doi.org/10.1016/s0006-3223(99)00273-5,10704958
True," The study meets the inclusion criteria as it involves adults with a diagnosis of psychosis, specifically women with schizophrenia, and investigates the relationship between oestrogen and extrapyramidal symptoms.",Extrapyramidal symptoms and oestrogen,https://doi.org/10.1034/j.1600-0447.2000.90067.x,10706013
True," The study meets the inclusion criteria as it involves patients with schizophrenia, a condition included in the review, and examines the effects of atypical antipsychotics on the inflammatory response system.",Effects of atypical antipsychotics on the inflammatory response system in schizophrenic patients resistant to treatment with typical neuroleptics,https://doi.org/10.1016/s0924-977x(99)00062-0,10706993
False," The study population specified in the abstract (young patients with unipolar depression and schizophrenia) does not match the inclusion criteria, which includes a broader range of disorders such as bipolar disorder, major depressive disorder, and behavioral and psychological symptoms of dementia.",Executive functioning and verbal memory in young patients with unipolar depression and schizophrenia,https://doi.org/10.1016/s0165-1781(99)00110-9,10708264
True," The study population includes adults with treatment-resistant bipolar disorder, which is within the specified population of interest.",Mexiletine in treatmentresistant bipolar disorder,https://doi.org/10.1016/s0165-0327(99)00072-5,10708839
True," The study meets the inclusion criteria as it involves a randomized controlled trial examining the effectiveness of olanzapine, risperidone, and haloperidol in patients with early phase schizophrenia, which is a relevant population for this review.",Neuropsychological Change in Early Phase Schizophrenia During Months of Treatment With Olanzapine Risperidone or Haloperidol,https://doi.org/10.1001/archpsyc.57.3.249,10711911
True," The study meets the inclusion criteria as it is a randomized controlled trial comparing quetiapine with haloperidol in patients with schizophrenia, which is one of the patient populations of interest.",A multicentre doubleblind randomized comparison of quetiapine ICI Seroquel and haloperidol in schizophrenia,https://doi.org/10.1017/s0033291799001476,10722180
True, The study meets the inclusion criteria as it involves a randomized controlled trial examining the effectiveness of a psychoeducational multiplefamily group intervention for managing negative symptoms in patients with schizophrenia.,Management of Negative Symptoms Among Patients With Schizophrenia Attending MultipleFamily Groups,https://doi.org/10.1176/appi.ps.51.4.513,10737828
True," The study meets the inclusion criteria as it involves a randomized controlled trial of a first-episode schizophrenia patient population, examines the relationship between dopamine D receptor occupancy and clinical response, and includes a discussion of the implications for antipsychotic treatment.",Relationship Between Dopamine D Occupancy Clinical Response and Side Effects A DoubleBlind PET Study of FirstEpisode Schizophrenia,https://doi.org/10.1176/appi.ajp.157.4.514,10739409
True," The study meets the inclusion criteria as it involves adults with schizophrenia, a disorder included in the review, and examines the effectiveness of a treatment (prepulse inhibition of acoustic startle) for this population.",Impaired prepulse inhibition of acoustic startle in schizophrenia,https://doi.org/10.1016/s0006-3223(99)00148-1,10745060
True," The study meets the inclusion criteria as it involves a patient with schizophrenia, a condition included in the review, and examines the effectiveness of eicosapentaenoic acid (EPA) treatment, which is an intervention of interest.",Eicosapentaenoic acid treatment in schizophrenia associated with symptom remission normalisation of blood fatty acids reduced neuronal membrane phospholipid turnover and structural brain changes,nan,10750263
True," The study appears to meet all the inclusion criteria, including the population, interventions, outcomes, and study designs specified in the review.",The newer atypical antipsychotic drugstheir development and current therapeutic use,nan,10756621
True," The study meets the inclusion criteria as it is a randomized controlled trial examining the effectiveness of clozapine in patients with schizophrenia and other psychotic disorders, and it reports on outcomes such as relapse and clinical improvement.",Influence of Methodology on Outcomes of Randomised Clozapine Trials,https://doi.org/10.1055/s-2000-7971,10761820
True," The study population includes adults and adolescents with various psychiatric disorders, including schizophrenia, bipolar disorder, major depressive disorder, and behavioral and psychological symptoms of dementia, which aligns with the specified inclusion criteria.",Neurotransmitterrelated genes and antipsychotic response pharmacogenetics meets psychiatric treatment,https://doi.org/10.3109/07853890009011762,10766404
False, The study population specified in the abstract (patients with schizophrenia) does not match the inclusion criteria (which includes a wide range of psychiatric disorders and populations).,Subject Selection for the Placebo and ComparatorControlled Trials of Neuroleptics in Schizophrenia,https://doi.org/10.1097/00004714-200004000-00018,10770464
False," The study population specified in the abstract does not match the inclusion criteria, as it focuses on patients with bipolar disorder, whereas the inclusion criteria include a wide range of psychiatric disorders, including schizophrenia, major depressive disorder, and pervasive developmental disorders.",Placebo effect in randomized controlled studies of acute bipolar mania and depression,https://doi.org/10.1016/s0006-3223(99)00311-x,10773184
True," The study population includes adults with treatment-refractory schizophrenia, which meets the inclusion criteria for patients with schizophrenia, including those with treatment resistance.",An Assessment of Clinical Practice of Clozapine Therapy for Veterans,https://doi.org/10.1176/appi.ps.51.5.669,10783190
True," The study meets the inclusion criteria as it is a randomized controlled trial examining the effectiveness of glycine added to clozapine in adults with schizophrenia, which is one of the patient populations of interest.",PlaceboControlled Trial of Glycine Added to Clozapine in Schizophrenia,https://doi.org/10.1176/appi.ajp.157.5.826,10784481
False," The abstract does not mention any of the specified patient populations (schizophrenia, bipolar disorder, major depressive disorder, behavioral and psychological symptoms of dementia, pervasive developmental disorders, or disruptive behavior disorders) or interventions (aripiprazole, asenapine, clozapine, iloperidone, olanzapine, paliperidone, quetiapine, risperidone, or ziprasidone).",Association of venous thromboembolism and clozapine,https://doi.org/10.1016/s0140-6736(00)02066-3,10791380
True," The study meets the inclusion criteria as it involves adults with schizophrenia or schizoaffective disorder, bipolar type, and examines the effectiveness of switching between atypical antipsychotics, specifically from sertindole to quetiapine.",Switching outpatients between atypical antipsychotics,https://doi.org/10.1016/s0278-5846(99)00095-0,10800756
False," The study population does not match the specified inclusion criteria as it focuses on pregnant women and their postpartum experiences, whereas the inclusion criteria specify various psychiatric disorders and populations.",Psychosocial correlates of prepartum and postpartum depressed mood,https://doi.org/10.1016/s0165-0327(99)00128-7,10814768
True," The study population includes adults and adolescents with a DSM-III-R or DSM-IV diagnosis of schizophrenia, including other psychotic disorders, which meets the inclusion criteria.",Secondgeneration antipsychotics in the emergency care setting A prospective naturalistic study,https://doi.org/10.1016/s0163-8343(00)00055-4,10822097
False," The study does not meet the inclusion criteria as it does not focus on the effectiveness of Risperidone in schizophrenia, but rather discusses the relationship between Gilbert's syndrome and schizophrenia.",Effectiveness of Risperidone in Simple Schizophrenia,https://doi.org/10.4088/jcp.v61n0410c,10830153
True," The study meets all the inclusion criteria as it involves a randomized controlled trial comparing the effectiveness of risperidone with conventional neuroleptics in patients with chronic schizophrenia, which is a relevant population for this review.",Longitudinal Comparative Study of Risperidone and Conventional Neuroleptics for Treating Patients With Schizophrenia,https://doi.org/10.1097/00004714-200006000-00002,10831015
False," The study population does not match the inclusion criteria as it only includes adults and adolescents with cocaine dependence, whereas the review includes a broader range of patient populations such as schizophrenia, bipolar disorder, major depressive disorder, and pervasive developmental disorders.",Risperidone for the Treatment of Cocaine Dependence Randomized DoubleBlind Trial,https://doi.org/10.1097/00004714-200006000-00003,10831016
False," The study does not meet the inclusion criteria for interventions, as it only focuses on clozapine, which is one of the included interventions, but does not include other interventions listed in the inclusion criteria.",Sudden Death in Patients Receiving Clozapine Treatment A Preliminary Investigation,https://doi.org/10.1097/00004714-200006000-00006,10831019
True," The study population includes adults and adolescents with schizophrenia and schizoaffective disorder, which matches the inclusion criteria.",Clozapine Diabetes Mellitus Weight Gain and Lipid Abnormalities A FiveYear Naturalistic Study,https://doi.org/10.1176/appi.ajp.157.6.975,10831479
True," The study meets the inclusion criteria as it involves a randomized controlled trial of amisulpride in patients with schizophrenia, which is a relevant population for this review.",Longterm safety and efficacy of amisulpride in subchronic or chronic schizophrenia,https://doi.org/10.1097/00004850-200015010-00002,10836281
True," The study meets the inclusion criteria as it involves adults and adolescents with a DSM-III-R or DSM-IV diagnosis of schizophrenia, and it examines the relationship between phosphodiesters and high-energy phosphates in the frontal lobe of schizophrenic patients using phosphorous magnetic resonance spectroscopy.",Reduced phosphodiesters and highenergy phosphates in the frontal lobe of schizophrenic patients a P chemical shift spectroscopicimaging study,https://doi.org/10.1016/s0006-3223(00)00235-3,10838063
True," The study meets the inclusion criteria as it involves a randomized controlled trial of quetiapine in patients with schizophrenia, which is one of the specified conditions, and examines effectiveness outcomes such as symptom response and adverse effects, which are also specified.",A Positron Emission Tomography Study of Quetiapine in Schizophrenia A Preliminary Finding of an Antipsychotic Effect With Only Transiently High Dopamine D Receptor Occupancy,https://doi.org/10.1001/archpsyc.57.6.553,10839333
False," The study population specified in the abstract (acute schizophrenic patients) does not match the inclusion criteria, which include patients with schizophrenia, bipolar disorder, major depressive disorder, and other conditions, but does not specify a focus on acute patients.",Neue bzw atypische Neuroleptika bei schizophrener Negativsymptomatik,https://doi.org/10.1007/s001150050568,10846709
True," The study meets the inclusion criteria for the population (patients with schizophrenia, schizoaffective disorder, or psychotic bipolar disorder) and intervention (clozapine), and the outcomes (improvement, mortality, quality of life, functional capacity, hospitalization, emergency department visits, efficacy, adherence, persistence) are relevant to the review.",Clozapine for TreatmentRefractory Schizophrenia Schizoaffective Disorder and Psychotic Bipolar Disorder,https://doi.org/10.4088/jcp.v61n0502,10847306
True," The study population includes adults with schizophrenia, which meets the inclusion criteria.",The Safety of Olanzapine Compared With Other Antipsychotic Drugs,https://doi.org/10.4088/jcp.v61n0503,10847307
True," The study meets the inclusion criteria as it compares the effectiveness of two antipsychotic medications (clozapine and haloperidol) in patients with schizophrenia, which is a relevant population for this review.",Medication continuation and compliance a comparison of patients treated with clozapine and haloperidol,nan,10847315
True," The study meets the inclusion criteria as it involves patients with schizophrenia, a relevant population for the review, and examines the effects of olanzapine and clozapine, which are included interventions.",A Comparison of the Effects of Clozapine and Olanzapine on the EEG in Patients with Schizophrenia,https://doi.org/10.1055/s-2000-7976,10855462
True," The study meets the inclusion criteria as it involves a comparative evaluation of conventional and novel antipsychotic drugs, and the population of interest (schizophrenic patients) aligns with the specified patient populations.",Comparative evaluation of conventional and novel antipsychotic drugs with reference to their subjective tolerability sideeffect profile and impact on quality of life,https://doi.org/10.1016/s0920-9964(99)00154-1,10858632
True," The study meets the inclusion criteria as it involves elderly patients (≥ 65 years of age) with a diagnosis of psychosis, and it examines the effectiveness of risperidone, which is an intervention included in the review.",A longterm multicenter openlabel study of risperidone in elderly patients with psychosis,https://doi.org/10.1002/1099-1166(200006)15:6<506::aid-gps146>3.0.co;2-v,10861916
False," The abstract does not mention any of the specified interventions (aripiprazole, asenapine, clozapine, iloperidone, olanzapine, paliperidone, quetiapine, risperidone, and ziprasidone) or patient populations (schizophrenia, bipolar disorder, major depressive disorder, behavioral and psychological symptoms of dementia, pervasive developmental disorders, and disruptive behavior disorders) that are relevant to the review.",Simultaneous determination of risperidone and hydroxyrisperidone in plasma by liquid chromatographyelectrospray tandem mass spectrometry,https://doi.org/10.1002/1096-9888(200006)35:6<718::aid-jms999>3.0.co;2-o,10862124
True," The study meets the inclusion criteria as it is a systematic review of atypical antipsychotics and their association with weight gain, which is relevant to the topic of interest.",Atypical antipsychotics and weightgain a systematic review,https://doi.org/10.1034/j.1600-0447.2000.101006416.x,10868465
True, The study meets the inclusion criteria as it involves a randomized controlled trial comparing the efficacy and tolerability of quetiapine and haloperidol in patients with schizophrenia who have a history of partial response to conventional antipsychotics.,A comparison of the effects of quetiapine Seroquel and haloperidol in schizophrenic patients with a history of and a demonstrated partial response to conventional antipsychotic treatment,https://doi.org/10.1097/00004850-200015030-00001,10870870
True," The study population (elderly patients with dementia) and the intervention (risperidone) meet the inclusion criteria, and the study design (open-label study) is not explicitly excluded.",Low Incidence of Persistent Tardive Dyskinesia in Elderly Patients With Dementia Treated With Risperidone,https://doi.org/10.1176/appi.ajp.157.7.1150,10873925
False," The article does not meet the inclusion criteria as it does not specify the age range of the participants, and the interventions and outcomes mentioned in the abstract do not match the specified inclusion criteria.",Clozapine Augmentation Safety and Efficacy,https://doi.org/10.1093/oxfordjournals.schbul.a033463,10885641
True," The study population includes adults with schizophrenia, which meets the inclusion criteria for the review.",The Effects of Clozapine on Alcohol and Drug Use Disorders Among Patients With Schizophrenia,https://doi.org/10.1093/oxfordjournals.schbul.a033464,10885642
True," The study meets the inclusion criteria as it involves patients with schizophrenia, a condition included in the review, and examines the effects of clozapine, an intervention included in the review.",Electrocardiographic Abnormalities in Patients Treated With Clozapine,https://doi.org/10.4088/jcp.v61n0609,10901343
False," The study population specified in the abstract (autistic disorder and other pervasive developmental disorders) does not match the inclusion criteria, which includes a broader range of psychiatric disorders.",The Pharmacotherapy of Target Symptoms Associated with Autistic Disorder and Other Pervasive Developmental Disorders,https://doi.org/10.1080/hrp_8.2.45,10902094
True," The study population includes adults with schizophrenia, which meets the inclusion criteria.",H antagonist nizatidine may control olanzapineassociated weight gain in schizophrenic patients,https://doi.org/10.1016/s0006-3223(00)00872-6,10903413
False," The study population does not match the inclusion criteria as it only includes schizophrenic patients, whereas the review includes a broader range of patient populations such as bipolar disorder, major depressive disorder, and pervasive developmental disorders.",Striatal and temporal cortical DD receptor occupancy by olanzapine and sertindole in vivo a Iepidepride single photon emission tomography SPET study,https://doi.org/10.1007/s002130000435,10907666
False," The study population does not match the inclusion criteria as it only includes adults with developmental stuttering, whereas the review focuses on patients with schizophrenia, bipolar disorder, major depressive disorder, behavioral and psychological symptoms of dementia, pervasive developmental disorders, and disruptive behavior disorders.",Risperidone for the Treatment of Stuttering,https://doi.org/10.1097/00004714-200008000-00013,10917410
True, The study meets the inclusion criteria as it is a randomized controlled trial examining the effectiveness of risperidone addition in patients with obsessive-compulsive disorder refractory to serotonin reuptake inhibitor monotherapy.,A Doubleblind PlaceboControlled Study of Risperidone Addition in Serotonin Reuptake InhibitorRefractory Obsessivecompulsive Disorder,https://doi.org/10.1001/archpsyc.57.8.794,10920469
False," The study population does not match the inclusion criteria as it only includes patients with severe Gilles de la Tourette syndrome, whereas the review includes a broader range of psychiatric disorders.",Olanzapine in severe Gilles de la Tourette syndrome a week doubleblind crossover study vs lowdose pimozide,https://doi.org/10.1007/s004150070173,10929273
False," The study population specified in the abstract (chronically institutionalized patients refractory to conventional antipsychotic agents) does not match the inclusion criteria (adults with schizophrenia, including other psychotic disorders, and bipolar disorder, major depressive disorder, and behavioral and psychological symptoms of dementia).",Comparative Efficacy of Risperidone and Clozapine in the Treatment of Patients With Refractory Schizophrenia or Schizoaffective Disorder,https://doi.org/10.4088/jcp.v61n0707,10937608
False," The study does not focus on the specified patient populations (schizophrenia, bipolar disorder, major depressive disorder, behavioral and psychological symptoms of dementia, pervasive developmental disorders, or disruptive behavior disorders) or interventions (aripiprazole, asenapine, clozapine, iloperidone, olanzapine, paliperidone, quetiapine, risperidone, and ziprasidone).",Interrater Reliability Levels of Multiple Clinical Examiners in the Evaluation of a Schizophrenic Patient Quality of Life Level of Functioning and Neuropsychological Symptomatology,https://doi.org/10.1076/clin.13.2.157.1965,10949157
False," The study population does not match the inclusion criteria as it only includes adults and adolescents with psychotic disorders, whereas the review includes children and adolescents with pervasive developmental disorders and disruptive behavior disorders.",Efficacy cardiac safety and tolerability of sertindole a drug surveillance,https://doi.org/10.1097/00004850-200015040-00003,10954060
False," The study population does not match the inclusion criteria as it includes nonpsychotic subjects with renal or hepatic impairment, whereas the review is focused on patients with schizophrenia, bipolar disorder, major depressive disorder, and other specified conditions.",Singledose pharmacokinetics of quetiapine in subjects with renal or hepatic impairment,https://doi.org/10.1016/s0278-5846(00)00090-7,10958148
False," The study does not focus on the effectiveness or harms of antipsychotic medications in the specified patient populations, but rather on the haematological safety of antipsychotic drugs in general.",Haematological safety of antipsychotic drugs,https://doi.org/10.1177/026988119801200309,10958256
False," The study does not meet the inclusion criteria as it does not specify the age range of the participants, and the population of interest is not clearly defined as one of the specified conditions (schizophrenia, bipolar disorder, major depressive disorder, etc.).",Clozapine in the treatment of schizophrenia,nan,10959316
True," The study meets the inclusion criteria as it is a randomized controlled trial examining the efficacy of olanzapine in the treatment of acute bipolar mania, which is one of the interventions included in the review.",Efficacy of Olanzapine in Acute Bipolar ManiasubtitleA Doubleblind PlaceboControlled Studysubtitle,https://doi.org/10.1001/archpsyc.57.9.841,10986547
False," The study does not meet the inclusion criteria as it does not involve any of the specified interventions (aripiprazole, asenapine, clozapine, iloperidone, olanzapine, paliperidone, quetiapine, risperidone, and ziprasidone) and instead focuses on mazindol.",Mazindol Treatment of Negative Symptoms,https://doi.org/10.1016/s0893-133x(00)00115-9,10989263
True," The study meets the inclusion criteria as it compares the effectiveness of two antipsychotic medications (olanzapine and haloperidol) in patients with schizophrenia, which is a relevant population for this review.",Functional outcomes in schizophrenia a comparison of olanzapine and haloperidol in a European sample,https://doi.org/10.1097/00004850-200015050-00001,10993126
False," The study population specified in the abstract does not match the inclusion criteria, as it only includes inpatients with schizophrenia participating in a clinical trial comparing clozapine and haloperidol, whereas the inclusion criteria specify a broader range of patient populations, including those with bipolar disorder, major depressive disorder, and behavioral and psychological symptoms of dementia.",Quality of Life in Schizophrenia A Comparison of Instruments,https://doi.org/10.1093/oxfordjournals.schbul.a033484,10993404
True," The study meets the inclusion criteria as it is a randomized controlled trial examining the effectiveness and safety of two antipsychotic medications (olanzapine and clozapine) in patients with Parkinson's disease (PD) and chronic hallucinations, which is a relevant population for this review.",Olanzapine and clozapine comparative effects on motor function in hallucinating PD patients,10.1212/wnl.55.6.789,10993997
False," The study population does not match the inclusion criteria as it only includes patients with Parkinson's disease (PD) and levodopa-induced dyskinesias (LID), which is not one of the specified patient populations.",Lowdose olanzapine for levodopa induced dyskinesias,https://doi.org/10.1212/wnl.55.6.795,10993998
True," The study meets the inclusion criteria as it involves adults with a DSM-IV diagnosis of schizophrenia, which is one of the specified conditions, and examines the effectiveness of an intervention (intravenous biperiden) on a specific outcome (akathisia).",Intravenous Biperiden in Akathisia An Open Pilot Study,https://doi.org/10.2190/rafd-axdf-rjad-fl1r,11001281
False," The study population does not match the inclusion criteria as it specifically targets patients with Alzheimer's disease, whereas the inclusion criteria include a wide range of psychiatric disorders and conditions.",Olanzapine Treatment of Psychotic and Behavioral Symptoms in Patients With Alzheimer Disease in Nursing Care Facilities,https://doi.org/10.1001/archpsyc.57.10.968,11015815
True," The study meets the inclusion criteria as it is a randomized controlled trial examining the cost-effectiveness of clozapine compared to conventional antipsychotic medication in patients with schizophrenia, which is one of the specified patient populations.",Costeffectiveness of Clozapine Compared With Conventional Antipsychotic Medication for Patients in State Hospitals,https://doi.org/10.1001/archpsyc.57.10.987,11015817
False," The abstract does not mention any of the specified patient populations (schizophrenia, bipolar disorder, major depressive disorder, behavioral and psychological symptoms of dementia, pervasive developmental disorders, or disruptive behavior disorders) or interventions (aripiprazole, asenapine, clozapine, iloperidone, olanzapine, paliperidone, quetiapine, risperidone, and ziprasidone) specified in the inclusion criteria.",Pharmacologic agents for the treatment of acute bipolar mania,https://doi.org/10.1016/s0006-3223(00)00961-6,11018226
False," The abstract does not mention any of the specified interventions (aripiprazole, asenapine, clozapine, iloperidone, olanzapine, paliperidone, quetiapine, risperidone, and ziprasidone) or patient populations (schizophrenia, first episode schizophrenia, treatment-resistant schizophrenia, major depressive disorder, behavioral and psychological symptoms of dementia, pervasive developmental disorders, disruptive behavior disorders) that are included in the review.",Bipolar disorder therapeutics maintenance treatment,https://doi.org/10.1016/s0006-3223(00)00991-4,11018228
True," The study meets the inclusion criteria as it focuses on treatment refractory schizophrenia, which is one of the specified conditions, and includes a review of various interventions and outcomes relevant to the review paper.",Treatment refractory schizophrenia,https://doi.org/10.1023/a:1004640408501,11025914
True," The study meets the inclusion criteria as it focuses on refractory schizophrenia, a specific population of interest, and examines the effects of clozapine on family burden, which is a relevant outcome for this review.",Clinical and Psychopharmacologic Factors Influencing Family Burden in Refractory Schizophrenia,https://doi.org/10.4088/jcp.v61n0913,11030488
True," The study meets the inclusion criteria as it involves adults with schizophrenia, a condition included in the review, and examines the effectiveness of olanzapine, an intervention included in the review.",The effectiveness of olanzapine in treatmentrefractory schizophrenia when patients are nonresponsive to or unable to tolerate clozapine,https://doi.org/10.1016/s0149-2918(00)80082-x,11048902
True," The study meets the inclusion criteria as it examines the effects of olanzapine, risperidone, and haloperidol on plasma prolactin levels in patients with schizophrenia, which is a relevant population for this review.",The effects of olanzapine risperidone and haloperidol on plasma prolactin levels in patients with schizophrenia,https://doi.org/10.1016/s0149-2918(00)80086-7,11048906
True," The study meets the inclusion criteria as it involves adults with schizophrenia, a randomized controlled trial, and examines the effectiveness of a specific intervention (nicotine transdermal patch and atypical antipsychotic medications) on smoking cessation.",Nicotine Transdermal Patch and Atypical Antipsychotic Medications for Smoking Cessation in Schizophrenia,https://doi.org/10.1176/appi.ajp.157.11.1835,11058482
True," The study meets the inclusion criteria as it involves adults with a diagnosis of schizophrenia, uses a specific antipsychotic medication (risperidone), and examines the effects of the medication on brain activity and symptom alleviation.",Immediate effects of risperidone on corticostriatothalamic loops and the hippocampus,https://doi.org/10.1192/bjp.177.5.402,11059992
True," The study meets the inclusion criteria as it involves a comparison of the neurologic side effects of risperidone and haloperidol in neuroleptic-naive patients, which is a relevant intervention for the review, and the study design is a prospective study, which is a type of observational study that is included in the review.",Neurologic side effects in neurolepticnaive patients treated with haloperidol or risperidone,https://doi.org/10.1212/wnl.52.4.782,11061283
False," The study population is not limited to adults (18 years and older) and adolescents (13-17 years) with a DSM III-R or DSM-IV diagnosis of schizophrenia, including other psychotic disorders, bipolar disorder, major depressive disorder, or behavioral and psychological symptoms of dementia.",Antipsychotic drug use and risk of firsttime idiopathic venous thromboembolism a casecontrol study,https://doi.org/10.1016/s0140-6736(00)02784-7,11072939
False," The study population does not match the inclusion criteria as it specifically focuses on bipolar disorder, whereas the inclusion criteria include a broader range of psychiatric disorders such as schizophrenia, major depressive disorder, and pervasive developmental disorders.",Differential Efficacy of Lithium and Carbamazepine in the Prophylaxis of Bipolar Disorder Results of the MAP Study,https://doi.org/10.1159/000054844,11093063
True," The study meets the inclusion criteria as it is about the treatment of schizophrenia with iloperidone, an atypical antipsychotic agent, and discusses its efficacy and tolerability in patients.",An assessment of iloperidone for the treatment of schizophrenia,https://doi.org/10.1517/13543784.9.12.2935,11093363
True," The study meets the inclusion criteria as it involves adults and adolescents with schizophrenia, a DSM-III-R or DSM-IV diagnosis, and examines the effectiveness of clozapine.",Association Study of Apolipoprotein Ewith Clinical Phenotype and Clozapine Response in Schizophrenia,https://doi.org/10.1159/000026689,11096331
False," The study is a case report and literature review, not a randomized controlled trial, which is a required study design for inclusion.",Augmentation with sulpiride for a schizophrenic patient partially responsiveto clozapine,https://doi.org/10.1034/j.1600-0447.2000.102005390.x,11098812
False," The abstract does not mention any specific interventions (atypical antipsychotics) that are included in the review, and it does not discuss any outcomes or study designs that are relevant to the review.",Atypical antipsychotics,https://doi.org/10.1136/bmj.321.7273.1360,11099266
False," The study focuses on the comparison of atypical antipsychotics with conventional antipsychotics, but does not include a broad range of interventions and outcomes as specified in the inclusion criteria.",Atypical antipsychotics in the treatment of schizophrenia systematic overview and metaregression analysis,https://doi.org/10.1136/bmj.321.7273.1371,11099280
False," The article does not match the specified population of interest, which includes adults and adolescents with schizophrenia, bipolar disorder, major depressive disorder, and other specified conditions, whereas the article appears to focus on Tourette syndrome.",Current issues in Tourette syndrome,https://doi.org/10.1002/1531-8257(200011)15:6<1051::aid-mds1001>3.0.co;2-l,11104186
True," The study meets the inclusion criteria as it involves the use of risperidone, a medication included in the review, in the treatment of a condition (dopamine-induced psychosis in Parkinson's disease) that is also included in the review.",Risperidone in the treatment of dopamineinduced psychosis in Parkinsons disease An open pilot trial,https://doi.org/10.1002/1531-8257(200011)15:6<1230::aid-mds1026>3.0.co;2-9,11104211
True," The study meets the inclusion criteria as it involves adults with a DSM-IV diagnosis of schizophrenia or schizoaffective disorder, and it examines the effectiveness of switching from conventional antipsychotic drugs or risperidone to olanzapine.",Strategies for Switching From Conventional Antipsychotic Drugs or Risperidone to Olanzapine,https://doi.org/10.4088/jcp.v61n1105,11105736
False," The study does not meet the inclusion criteria as it does not focus on the effectiveness or harms of the specified interventions (antipsychotic medications) in the specified patient populations, but rather aims to establish reference ranges for hematologic parameters in patients with schizophrenia.",Hematologic Reference Ranges in a Population of Patients with Schizophrenia,https://doi.org/10.1097/00004714-200012000-00011,11106137
True," The study meets the inclusion criteria as it involves a population with schizophrenia, a relevant intervention (clozapine), and relevant outcomes (symptom response, tardive dyskinesia, and caudate nucleus volume).",The Effect of Clozapine on Caudate Nucleus Volume in Schizophrenic Patients Previously Treated with Typical Antipsychotics,https://doi.org/10.1016/s0893-133x(00)00172-x,11106875
True," The study meets the inclusion criteria as it involves patients with schizophrenia, a condition included in the review, and examines the effectiveness of risperidone, an intervention included in the review.",Effects of risperidone on affective symptoms in patients with schizophrenia,https://doi.org/10.1097/00004850-200015060-00005,11110010
True," The study meets the inclusion criteria as it involves patients with schizophrenia, a disorder included in the review, and examines the effectiveness of novel antipsychotic drugs compared to classic antipsychotics.",Improvement in cognition associated with novel antipsychotic drugs a direct drug effect or reduction of EPS,https://doi.org/10.1016/s0920-9964(00)00025-6,11120419
True, The study meets the inclusion criteria as it is a randomized double-blind multicenter trial comparing the effectiveness of risperidone and haloperidol in patients with schizophrenia and disturbing neuroleptic-induced extrapyramidal symptoms.,Risperidone versus haloperidol in psychotic patients with disturbing neurolepticinduced extrapyramidal symptoms a doubleblind multicenter trial,https://doi.org/10.1016/s0920-9964(00)00009-8,11120421
True," The study meets the inclusion criteria as it involves patients with schizophrenia, a condition included in the review, and examines the effectiveness of a novel antipsychotic medication (risperidone) in improving cognitive skills.",Practicerelated improvement in information processing with novel antipsychotic treatment,https://doi.org/10.1016/s0920-9964(00)00033-5,11120426
False," The study population does not match the inclusion criteria as it only includes adults and adolescents with treatment-resistant depression, whereas the inclusion criteria specify a broader range of disorders, including schizophrenia, bipolar disorder, and dementia.",A Novel Augmentation Strategy for Treating Resistant Major Depression,https://doi.org/10.1176/appi.ajp.158.1.131,11136647
True," The study meets the inclusion criteria as it involves a population with a DSM-III-R or DSM-IV diagnosis of schizophrenia, which is one of the specified disorders, and examines the effectiveness of risperidone, which is one of the included interventions.",Impact of Risperidone on Seclusion and Restraint at a State Psychiatric Hospital,https://doi.org/10.1177/070674370004500907,11143833
True," The study population includes adults and adolescents with schizophrenia, which matches the inclusion criteria.",Clozapineinduced Agranulocytosis and Hereditary Polymorphisms of Clozapine Metabolizing Enzymes No Association with Myeloperoxidase and Cytochrome PD,https://doi.org/10.1055/s-2000-8359,11147929
True," The study meets the inclusion criteria as it involves patients with schizophrenia, a relevant population for this review, and examines the effectiveness of a specific medication (ciprofloxacin) in relation to clozapine.",Ciprofloxacin increases serum clozapine and Ndesmethylclozapine a study in patients with schizophrenia,https://doi.org/10.1007/s002280000192,11151749
False," The study population specified in the abstract does not match the inclusion criteria, as it focuses on the elderly population with Alzheimer's disease, whereas the inclusion criteria specify a broader range of populations, including adults and adolescents with various psychiatric disorders.",Antipsychotic treatment of psychosis and agitation in the elderly,nan,11154017
True," The study meets the inclusion criteria as it examines the effectiveness of clozapine in reducing arrest rates in psychotic patients with criminal histories, which is a relevant population for this review.",ClozapineAssociated Reduction in Arrest Rates of Psychotic Patients With Criminal Histories,https://doi.org/10.1176/appi.ajp.158.2.270,11156810
True," The study meets all the inclusion criteria as it is a randomized controlled trial comparing the efficacy and safety of olanzapine versus clozapine in treatment-resistant schizophrenic patients, which is one of the interventions included in the review.",Doubleblind comparison of olanzapine versus clozapine in schizophrenic patients clinically eligible for treatment with clozapine,https://doi.org/10.1016/s0006-3223(00)01026-x,11163780
False," The study does not examine the effectiveness of atypical antipsychotics in the specified patient populations, but rather discusses the consistency of atypical antipsychotic superiority to placebo in clinical trials.",Consistency of atypical antipsychotic superiority to placebo in recent clinical trials,https://doi.org/10.1016/s0006-3223(00)00973-2,11163781
True," The study population includes adults with treatment refractory schizophrenia, which meets the inclusion criteria.",Concurrent validity of negative symptom assessments in treatment refractory schizophrenia relationship between interviewbased ratings and inpatient ward observations,https://doi.org/10.1016/s0022-3956(00)00041-8,11165312
False," The study population in the abstract does not match the inclusion criteria as it specifically mentions children with bipolar disorder, whereas the inclusion criteria specify adults and adolescents (13-17 years) with bipolar disorder, and children under 13 years are excluded.",Decreased Anterior Cingulate MyoinositolCreatine Spectroscopy Resonance with Lithium Treatment in Children with Bipolar Disorder,https://doi.org/10.1016/s0893-133x(00)00207-4,11182531
True," The study focuses on antipsychotic-induced movement disorders in the elderly, which falls within the scope of the review's inclusion criteria.",AntipsychoticInduced Movement Disorders in the Elderly,https://doi.org/10.2165/00002512-200017050-00004,11190417
False," The title and abstract do not mention the specific age range of the participants, which is a required inclusion criterion.",Does risperidone have a place in the treatment of nonschizophrenic patients,https://doi.org/10.1097/00004850-200101000-00001,11195255
True," The study meets the inclusion criteria as it focuses on the treatment of refractory schizophrenia with atypical antipsychotics, which is within the specified population of interest.",Refractory schizophrenia and atypical antipsychotics,https://doi.org/10.1177/026988110001400411,11198061
True," The study meets the inclusion criteria as it involves adults with schizophrenia, a diagnosis included in the review, and examines the effectiveness of olanzapine, an intervention included in the review.",Olanzapine Plasma Concentrations and Clinical Response Acute Phase Results of the North American Olanzapine Trial,https://doi.org/10.1097/00004714-200102000-00004,11199942
True," The study meets the inclusion criteria as it involves adults with schizoaffective disorder, a condition included in the review, and examines the effectiveness of ziprasidone, an intervention included in the review.",Ziprasidone in the ShortTerm Treatment of Patients with Schizoaffective Disorder Results from Two DoubleBlind PlaceboControlled Multicenter Studies,https://doi.org/10.1097/00004714-200102000-00007,11199944
True," The study meets the inclusion criteria as it involves a comparison of the effects of atypical antipsychotics (amisulpride, olanzapine, sertindole, and clozapine) on autonomic neurocardiac function in patients with schizophrenia.",Effects of Newer Atypical Antipsychotics on Autonomic Neurocardiac Function A Comparison Between Amisulpride Olanzapine Sertindole and Clozapine,https://doi.org/10.1097/00004714-200102000-00003,11199953
False," The study population does not match the specified inclusion criteria as it only includes patients with DSM-IV diagnosed schizophrenia, schizoaffective disorder, or bipolar disorder, whereas the review includes a broader range of diagnoses.",The Effects of Concomitant Phenytoin Administration on the SteadyState Pharmacokinetics of Quetiapine,https://doi.org/10.1097/00004714-200102000-00016,11199955
True," The study meets the inclusion criteria as it involves adults with a DSM-IV diagnosis of schizophrenia, a randomized controlled trial, and examines the effects of acute tryptophan depletion on symptoms, mood, and cognition.",Acute tryptophan depletion in schizophrenia,https://doi.org/10.1017/s0033291799003062,11200962
True," The study meets the inclusion criteria as it involves patients with schizophrenia, a relevant population for this review, and examines the relationship between plasma concentrations of risperidone and its active metabolite and clinical response.",Relationship between plasma risperidone and hydroxyrisperidone concentrations and clinical response in patients with schizophrenia,https://doi.org/10.1007/s002130000576,11205425
True," The study meets the inclusion criteria as it involves adults with acute psychosis, a randomized controlled trial, and examines the effectiveness and tolerability of intramuscular ziprasidone compared to haloperidol.",Intramuscular Ziprasidone Compared With Intramuscular Haloperidol in the Treatment of Acute Psychosis,https://doi.org/10.4088/jcp.v61n1208,11206599
True," The study population includes adults with Parkinson's disease, which is not explicitly excluded from the inclusion criteria, and the intervention is clozapine, which is included in the list of interventions.",Clozapine for the treatment of druginduced psychosis in Parkinsons disease Results of the week open label extension in the PSYCLOPS trial,https://doi.org/10.1002/1531-8257(200101)16:1<135::aid-mds1006>3.0.co;2-q,11215574
False," The study population does not match the inclusion criteria as it only includes adults and adolescents with schizophrenia, bipolar disorder, and major depressive disorder, but does not include children under 13 years old with pervasive developmental disorders or disruptive behavior disorders.",Bodyweight Gain with Atypical Antipsychotics,https://doi.org/10.2165/00002018-200124010-00005,11219487
False," The study only includes adults and adolescents with schizophrenia, whereas the inclusion criteria specify that children under 13 years old with pervasive developmental disorders and disruptive behavior disorders should be included.",Olanzapine versus Risperidone,https://doi.org/10.2165/00019053-200018060-00004,11227395
True," The study meets the inclusion criteria as it involves a randomized controlled trial examining the effectiveness of pindolol augmentation in patients with schizophrenia, which is a relevant population for this review.",Pindolol augmentation in aggressive schizophrenic patients a doubleblind crossover randomized study,https://doi.org/10.1097/00004850-200103000-00006,11236069
True, The study population (male geriatric inpatients) falls within the age range specified in the inclusion criteria (≥ 65 years of age) and the intervention (atypical antipsychotics) is included in the review.,Tolerability and effectiveness of atypical antipsychotics in male geriatric inpatients,https://doi.org/10.1002/1099-1166(200102)16:2<223::aid-gps323>3.0.co;2-r,11241729
False," The study population does not match the inclusion criteria as it specifically focuses on patients with treatment-resistant depression, whereas the inclusion criteria include a broader range of psychiatric disorders such as schizophrenia, bipolar disorder, and pervasive developmental disorders.",Adjunctive gabapentin in treatmentresistant depression a retrospective chart review,https://doi.org/10.1016/s0165-0327(00)00187-7,11246103
True," The study meets the inclusion criteria as it involves adults and adolescents with schizophrenia and related disorders, and examines the effects of olanzapine treatment on weight change and related health factors.",Longterm olanzapine treatment weight change and weightrelated health factors in schizophrenia,nan,11247108
False," The study does not focus on the specified patient populations (schizophrenia, bipolar disorder, major depressive disorder, behavioral and psychological symptoms of dementia, pervasive developmental disorders, and disruptive behavior disorders) or interventions (atypical antipsychotics) as specified in the inclusion criteria.",The new atypical antipsychotics a review of pharmacoeconomic studies,https://doi.org/10.1517/14656566.1.2.249,11249546
False," The abstract does not mention any of the specified patient populations (schizophrenia, bipolar disorder, major depressive disorder, behavioral and psychological symptoms of dementia, pervasive developmental disorders, disruptive behavior disorders) or interventions (aripiprazole, asenapine, clozapine, iloperidone, olanzapine, paliperidone, quetiapine, risperidone, ziprasidone) that are relevant to the review.",The Evaluation of Multiple Surrogate Endpoints,https://doi.org/10.1111/j.0006-341x.2001.00081.x,11252622
True," The study meets the inclusion criteria as it involves a randomized controlled trial of a medication (olanzapine) in patients with bipolar I disorder, specifically those experiencing their first manic episode, and reports on symptom response and other relevant outcomes.",Response to placebo among bipolar I disorder patients experiencing their first manic episode,https://doi.org/10.1034/j.1399-5618.2000.020407.x,11252646
False," The abstract does not mention any of the specified patient populations (schizophrenia, bipolar disorder, major depressive disorder, behavioral and psychological symptoms of dementia, pervasive developmental disorders, or disruptive behavior disorders) or interventions (aripiprazole, asenapine, clozapine, iloperidone, olanzapine, paliperidone, quetiapine, risperidone, and ziprasidone) that are included in the review.",Pharmacologic loading in the treatment of acute mania,https://doi.org/10.1034/j.1399-5618.2000.020106.x,11254019
True," The study population includes adults with schizophrenia, which meets the inclusion criteria.",Neuroleptic Treatment of LateLife Schizophrenia,https://doi.org/10.1080/10673220127880,11266405
True," The study population includes adults with schizophrenia, which meets the inclusion criteria.",Antipsychotic prescription use and costs for persons with schizophrenia in the s current trends and five year time series forecasts,https://doi.org/10.1016/s0920-9964(00)00108-0,11278146
True," The study meets the inclusion criteria as it involves adults with a DSM-IV diagnosis of chronic schizophrenia, examines the effects of olanzapine and other antipsychotics on cognitive function, and is a longitudinal study.",Effects of olanzapine and other antipsychotics on cognitive function in chronic schizophrenia a longitudinal study,https://doi.org/10.1016/s0920-9964(00)00112-2,11278151
True," The study meets the inclusion criteria as it involves a randomized controlled trial with adults with schizophrenia, examining the effectiveness of estrogen as a treatment, and reports on symptom response, which is a relevant outcome of interest.",Estrogen a potential treatment for schizophrenia,https://doi.org/10.1016/s0920-9964(00)00088-8,11278160
True, The study meets all the inclusion criteria as it is a review and meta-analysis of randomized trials examining the effectiveness of second-generation antipsychotics in patients with treatment-resistant schizophrenia.,Effectiveness of SecondGeneration Antipsychotics in Patients With TreatmentResistant Schizophrenia A Review and MetaAnalysis of Randomized Trials,https://doi.org/10.1176/appi.ajp.158.4.518,11282684
True," The study meets all the inclusion criteria as it involves first-episode schizophrenia patients treated with risperidone, which is an intervention included in the review, and examines the effects of the medication on basal ganglia volumes, which is a relevant outcome for the review.",An MRI Study of Basal Ganglia Volumes in FirstEpisode Schizophrenia Patients Treated With Risperidone,https://doi.org/10.1176/appi.ajp.158.4.625,11282699
False," The study focuses on short-term inpatient pharmacotherapy of schizophrenia, which does not match the inclusion criteria of examining the relationship between improved adherence or persistence and improved outcomes in various psychiatric conditions.",ShortTerm Inpatient Pharmacotherapy of Schizophrenia,https://doi.org/10.1080/10673220127892,11287404
True," The study meets the inclusion criteria as it is a randomized controlled trial examining the effectiveness of quetiapine in patients with schizophrenia, which is one of the specified patient populations.",Neuropsychological change in patients with schizophrenia after treatment with quetiapine or haloperidol,nan,11291531
False," The study population does not match the inclusion criteria as it only includes patients with refractory mood and schizoaffective disorders who responded to levothyroxine treatment, whereas the inclusion criteria specify a broader range of psychiatric disorders.",Subjective response to and tolerability of longterm supraphysiological doses of levothyroxine in refractory mood disorders,https://doi.org/10.1016/s0165-0327(00)00215-9,11292518
False," The study population does not match the inclusion criteria as it specifically targets patients with intellectual disability and bipolar spectrum disorders, whereas the review includes a broader range of psychiatric conditions.",Adjunctive gabapentin in patients with intellectual disability and bipolar spectrum disorders,https://doi.org/10.1046/j.1365-2788.2001.00330.x,11298253
False," The study population does not include children under 13 years old, which is outside the specified age range for children with pervasive developmental disorders and disruptive behavior disorders.",Risperidone Liquid Concentrate and Oral Lorazepam Versus Intramuscular Haloperidol and Intramuscular Lorazepam for Treatment of Psychotic Agitation,https://doi.org/10.4088/jcp.v62n0303,11305699
True," The study meets the inclusion criteria as it involves a comparison of two antipsychotic medications (risperidone and typical antipsychotics) in patients with first-episode schizophrenia, which is a relevant population for this review.",A Comparison of LongTerm Outcome in FirstEpisode Schizophrenia Following Treatment With Risperidone or a Typical Antipsychotic,https://doi.org/10.4088/jcp.v62n0308,11305704
True," The study meets the inclusion criteria as it involves adults and adolescents with schizophrenia and related psychoses, and examines the effects of olanzapine on the QTc interval.",Analysis of the QTc Interval During Olanzapine Treatment of Patients With Schizophrenia and Related Psychosis,https://doi.org/10.4088/jcp.v62n0310,11305706
False," The study population does not match the inclusion criteria as it only includes adults and adolescents with DSM-IV diagnoses of schizophrenia, schizoaffective disorder, bipolar disorder with psychosis, or atypical psychosis with mood disorder, which is a subset of the inclusion criteria.",Clinical effects of a randomized switch of patients from clozaril to generic clozapine,nan,11305843
False, The study population does not match the specified inclusion criteria as it only includes patients with olanzapine treatment and does not cover the broad range of disorders and interventions specified in the inclusion criteria.,Effect of amantadine on weight gain during olanzapine treatment,https://doi.org/10.1016/s0924-977x(01)00072-4,11313165
True," The study meets the inclusion criteria as it involves a double-blind placebo-controlled design, examines the effectiveness of donepezil augmentation in a patient with schizoaffective disorder, and includes functional MRI correlates.",A Doubleblind Placebocontrolled Case Study of the Use of Donepezil to Improve Cognition in a Schizoaffective Disorder Patient Functional MRI Correlates,https://doi.org/10.1093/neucas/7.2.105,11320158
False," The study population does not match the inclusion criteria as it only includes inpatients with schizophrenia, whereas the review includes a broader range of patient populations, including those with bipolar disorder, major depressive disorder, and behavioral and psychological symptoms of dementia.",Subjective and objective evaluation of treating schizophrenia with classic or atypical drugs,nan,11324382
True, The study meets the inclusion criteria as it is a randomized double-blind study comparing the efficacy and safety of risperidone and olanzapine in the treatment of schizophrenia or schizoaffective disorder.,A Randomized DoubleBlind Study of Risperidone and Olanzapine in the Treatment of Schizophrenia or Schizoaffective Disorder,https://doi.org/10.1176/appi.ajp.158.5.765,11329400
True," The study meets the inclusion criteria as it involves adults and adolescents with schizophrenia, and it examines the effectiveness of olanzapine compared to haloperidol and risperidone in terms of extrapyramidal symptoms and concomitant use of anticholinergic drugs.",Incidence of extrapyramidal symptoms during treatment with olanzapine haloperidol and risperidone results of an observational study,nan,11333516
False," The study population specified in the abstract (children and adolescents with paediatric bipolar disorder) does not match the inclusion criteria, which includes adults and adolescents with schizophrenia, bipolar disorder, and other specified conditions.",Special issues in the treatment of paediatric bipolar disorder,https://doi.org/10.1517/14656566.2.4.613,11336611
False, The study does not meet the inclusion criteria as it is a case report and does not fit within the specified patient populations or interventions of interest.,OlanzapineInduced Diabetes Mellitus,https://doi.org/10.1345/aph.10280,11346063
False," The abstract does not mention any of the specified disorders (schizophrenia, bipolar disorder, major depressive disorder, behavioral and psychological symptoms of dementia, pervasive developmental disorders, or disruptive behavior disorders) or the specified interventions (aripiprazole, asenapine, clozapine, iloperidone, olanzapine, paliperidone, quetiapone, risperidone, and ziprasidone).",Alzheimers disease and related disorders,10.1016/s0025-7125(05)70341-2,11349485
False," The study does not meet the inclusion criteria as it does not focus on the effectiveness or harms of the specified interventions (e.g. aripiprazole, clozapine) in the specified patient populations, but rather examines the genetic linkage of a specific receptor polymorphism to schizophrenia.",A familybased study of the CysSer HTC serotonin receptor polymorphism in schizophrenia,https://doi.org/10.1002/ajmg.1260,11353441
False," The study population specified in the abstract does not match the inclusion criteria, as it only includes patients with schizophrenia, whereas the inclusion criteria include a broader range of psychiatric disorders.",Detecting Improvement in Quality of Life and Symptomatology in Schizophrenia,https://doi.org/10.1093/oxfordjournals.schbul.a006869,11354590
True," The study meets the inclusion criteria as it compares the weight gain in patients with schizophrenia treated with olanzapine and risperidone, which is one of the interventions included in the review.",Weight gain over months in schizophrenia patients a comparison of olanzapine and risperidone,https://doi.org/10.1016/s0920-9964(00)00080-3,11356587
True," The study meets the inclusion criteria as it examines the relation between antipsychotic drugs and myocarditis and cardiomyopathy, which is a relevant topic for the review, and uses a suitable methodology (data mining using Bayesian statistics in a neural network architecture) to analyze international pharmacovigilance data.",Antipsychotic drugs and heart muscle disorder in international pharmacovigilance data mining study,https://doi.org/10.1136/bmj.322.7296.1207,11358771
True," The study meets the inclusion criteria as it involves adults with schizophrenia, a DSM-III diagnosis, and examines the effects of clozapine treatment on quantitative EEG.",Quantitative EEG in schizophrenia and in response to acute and chronic clozapine treatment,https://doi.org/10.1016/s0920-9964(00)00165-1,11378313
False," The study population specified in the abstract (schizophrenic patients) does not match the inclusion criteria, which includes a broader range of disorders such as bipolar disorder, major depressive disorder, and behavioral and psychological symptoms of dementia.",Improvement of schizophrenic patients subjective wellbeing under atypical antipsychotic drugs,https://doi.org/10.1016/s0920-9964(00)00166-3,11378316
True, The study meets the inclusion criteria as it involves a randomized controlled trial comparing the effectiveness of risperidone and haloperidol in long-term hospitalized chronic patients with schizophrenia.,Risperidone versus haloperidol in longterm hospitalized chronic patients in a double blind randomized trial a post hoc analysis,https://doi.org/10.1016/s0920-9964(00)00163-8,11378317
False," The study population does not match the inclusion criteria as it only includes children of adults with schizophrenia, whereas the inclusion criteria specify adults and adolescents with schizophrenia, bipolar disorder, major depressive disorder, and other specified disorders.",Diagnosis and treatment of psychiatric disorders in children with a schizophrenic parent,https://doi.org/10.1016/s0920-9964(00)00043-8,11378320
True," The study meets the inclusion criteria as it involves adults and adolescents with schizophrenia treated with olanzapine, haloperidol, or risperidone, and examines factors influencing acute weight change.",Factors Influencing Acute Weight Change in Patients With Schizophrenia Treated With Olanzapine Haloperidol or Risperidone,https://doi.org/10.4088/jcp.v62n0404,11379836
True, The study meets the inclusion criteria as it involves a randomized controlled trial of an intervention (risperidone) for a population (adolescents with subaverage cognitive abilities and disruptive behavior disorders) that is relevant to the review.,A Randomized Controlled Trial of Risperidone in the Treatment of Aggression in Hospitalized Adolescents With Subaverage Cognitive Abilities,https://doi.org/10.4088/jcp.v62n0405,11379837
False," The study population does not match the inclusion criteria as it only includes adults and adolescents with bipolar I disorder, whereas the inclusion criteria include a broader range of populations such as schizophrenia, other psychotic disorders, major depressive disorder, and pervasive developmental disorders.",LongTerm Olanzapine Therapy in the Treatment of Bipolar I Disorder,https://doi.org/10.4088/jcp.v62n0410,11379842
False," The study does not focus on a specific medication (risperidone) but rather discusses optimal dosing in general, and does not match the specified inclusion criteria of focusing on a specific medication.",Optimal Dosing With Risperidone,https://doi.org/10.4088/jcp.v62n0411,11379843
False," The study does not meet the inclusion criteria as it is a methodological paper focused on developing a capillary electrophoretic method for determining clozapine and desmethylclozapine in human plasma, rather than an effectiveness study of clozapine in patients with schizophrenia or other psychiatric disorders.",Rapid capillary electrophoretic method for the determination of clozapine and desmethylclozapine in human plasma,https://doi.org/10.1016/s0021-9673(01)00520-9,11382303
False," The title does not specify the population of interest (schizophrenia) as the primary focus, but rather mentions it as one of the conditions treated with olanzapine.",Hyperglycemia in Patients With Schizophrenia Who Are Treated With Olanzapine,https://doi.org/10.1097/00004714-200106000-00022,11386505
True, The study meets the inclusion criteria as it is a randomized controlled trial examining the effectiveness of ziprasidone in reducing acute agitation associated with psychosis.,Intramuscular IM ziprasidone mg is effective in reducing acute agitation associated with psychosis a doubleblind randomized trial,https://doi.org/10.1007/s002130000658,11401000
True," The study meets the inclusion criteria as it involves a comparison of the effects of two antipsychotic medications (olanzapine and haloperidol) on serum prolactin levels in male schizophrenic patients, which is a relevant intervention for the review.",Effects of olanzapine and haloperidol on serum prolactin levels in male schizophrenic patients,https://doi.org/10.1016/s0306-4530(01)00016-6,11403983
False," The title and abstract do not mention amisulpride as the primary focus of the study, but rather as a treatment option in the context of schizophrenia treatment.",Consensus on the Practical Use of Amisulpride an Atypical Antipsychotic in the Treatment of Schizophrenia,https://doi.org/10.1159/000054913,11408792
True," The study focuses on the treatment of suicidality in schizophrenia, which matches the topic of interest.",Treatment of Suicidality in Schizophrenia,https://doi.org/10.1111/j.1749-6632.2001.tb05797.x,11411190
True, The study meets the inclusion criteria as it is a head-to-head randomized controlled trial comparing the speed of onset of therapeutic effect between risperidone and haloperidol in patients with schizophrenia.,Rapid Onset of Therapeutic Effect of Risperidone Versus Haloperidol in a DoubleBlind Randomized Trial,https://doi.org/10.4088/jcp.v62n0506,11411815
False, The study population does not match the specified inclusion criteria as it only includes patients at one site and does not specify the age range of the participants.,The Apparent Effects of Ziprasidone on Plasma Lipids and Glucose,https://doi.org/10.4088/jcp.v62n0507,11411816
False," The abstract does not mention any of the specified patient populations or interventions, and the study appears to focus on a statistical method for analyzing data rather than a review of treatment effectiveness.",Inference in Randomized Studies with Informative Censoring and Discrete TimetoEvent Endpoints,https://doi.org/10.1111/j.0006-341x.2001.00404.x,11414563
True," The study meets the inclusion criteria for children (under age 13 years) with a DSM-III-R or DSM-IV diagnosis of a pervasive developmental disorder, including autistic disorder.",Risperidone Monotherapy in Preschool Children With Pervasive Developmental Disorders,https://doi.org/10.1177/088307380101600602,11417603
False," The study does not meet the inclusion criteria as it does not involve any of the specified patient populations (schizophrenia, bipolar disorder, major depressive disorder, behavioral and psychological symptoms of dementia, pervasive developmental disorders, or disruptive behavior disorders) and does not examine the specified interventions or outcomes.",Acute Necrotizing Encephalopathy Presenting as a Basal Ganglia Syndrome,https://doi.org/10.1177/088307380101600618,11417619
False," The abstract does not mention any of the specified psychiatric disorders or interventions, and the meeting appears to focus on neurodegenerative diseases rather than psychiatric conditions.",Neurotoxicity as a Mechanism for Neurodegenerative Disorders Basic and Clinical Aspects,https://doi.org/10.1517/13543784.10.5.985,11424902
False," The study does not meet the inclusion criteria as it focuses on typical antipsychotic agents in bipolar disorder, whereas the review is focused on a broader range of antipsychotic medications and patient populations.",A metaanalysis of the use of typical antipsychotic agents in bipolar disorder,https://doi.org/10.1016/s0165-0327(00)00162-2,11426515
True," The study meets the inclusion criteria as it involves a randomized controlled trial comparing the efficacy and safety of intramuscular olanzapine and intramuscular haloperidol for the treatment of acute agitation in schizophrenia, which is a relevant population for this review.",DoubleBlind PlaceboControlled Comparison of Intramuscular Olanzapine and Intramuscular Haloperidol in the Treatment of Acute Agitation in Schizophrenia,https://doi.org/10.1176/appi.ajp.158.7.1149,11431240
False," The abstract does not mention any of the specified disorders or patient populations (schizophrenia, bipolar disorder, major depressive disorder, behavioral and psychological symptoms of dementia, pervasive developmental disorders, disruptive behavior disorders) that are the focus of the review.",Treatment of alzheimers disease,https://doi.org/10.1016/s1098-3597(01)90046-8,11432120
False," The abstract does not mention any of the specified psychiatric conditions or disorders, and the review appears to focus on long-term care for patients with dementia, which is not within the specified inclusion criteria.",Longterm care in dementia Patients and caregivers,https://doi.org/10.1016/s1098-3597(01)90048-1,11432122
False," The study focuses on dropout rates in randomised controlled trials of oral administration of conventional antipsychotic drugs and atypical antipsychotic drugs, but does not specifically examine the effectiveness or harms of the interventions included in the review.",Dropout rates in randomised antipsychotic drug trials,https://doi.org/10.1007/s002130100711,11432684
True," The study meets the inclusion criteria as it involves patients with schizophrenia, a relevant population for the review, and examines the effects of antipsychotic treatment on serum leptin levels.",Effects of longterm treatment with antipsychotics on serum leptin levels,https://doi.org/10.1192/bjp.179.1.59,11435270
False," The study population specified in the abstract does not match the inclusion criteria, as it only includes adults and adolescents with schizophrenia, whereas the inclusion criteria include a broader range of populations, including children, older adults, and individuals with other psychiatric conditions.",Metaanalysis comparing newer antipsychotic drugs for the treatment of schizophrenia evaluating the indirect approach,https://doi.org/10.1016/s0149-2918(01)80082-5,11440294
False," The abstract does not provide any information about the study, as it only contains a title and author information, and no abstract is available.",Safety and Efficacy of Risperidone in Substance Abusers with Psychosis,https://doi.org/10.1080/105504901750227831,11444160
False," The study population does not match the inclusion criteria as it only includes adults and adolescents with schizophrenia, bipolar disorder, and other specific conditions, whereas the study in question focuses on patients prescribed atypical antipsychotics in general, not specifically those with the mentioned conditions.",Comparative study of mortality rates and cardiac dysrhythmias in postmarketing surveillance studies of sertindole and two other atypical antipsychotic drugs risperidone and olanzapine,https://doi.org/10.1177/026988110101500212,11448085
True," The study meets the inclusion criteria as it involves a naturalistic study of patients with schizophrenia, comparing the efficacy and tolerability of risperidone and olanzapine, and reports outcomes such as time to discharge, efficacy, and adverse events.",Risperidone Olanzapine Drug Outcomes studies in Schizophrenia RODOS efficacy and tolerability results of an international naturalistic study,https://doi.org/10.1097/00004850-200107000-00001,11459331
False," The study population does not match the inclusion criteria as it specifically focuses on posttraumatic stress disorder (PTSD), which is not mentioned in the inclusion criteria.",Olanzapine in the treatment of posttraumatic stress disorder a pilot study,https://doi.org/10.1097/00004850-200107000-00003,11459333
False," The abstract does not mention the specific population of interest (schizophrenia, bipolar disorder, major depressive disorder, behavioral and psychological symptoms of dementia, pervasive developmental disorders, or disruptive behavior disorders) or the specific interventions (aripiprazole, asenapine, clozapine, iloperidone, olanzapine, paliperidone, quetiapine, risperidone, and ziprasidone) specified in the inclusion criteria.",Perospirone,https://doi.org/10.2165/00023210-200115040-00006,11463136
False," The title and abstract do not indicate that the study focuses on mood stabilizers, but rather on defining the term ""mood stabilizer"".",On defining mood stabilizer,https://doi.org/10.1034/j.1399-5618.2001.030304.x,11465676
True," The study meets the inclusion criteria as it involves a population with schizophrenia, a specific intervention (clozapine), and a relevant outcome (electroencephalographic changes).",Nonlinear dynamic analysis of clozapineinduced electroencephalographic changes in schizophrenic patients a preliminary study,https://doi.org/10.1016/s0278-5846(01)00183-x,11474842
True," The study meets the inclusion criteria as it is a randomized controlled trial examining the efficacy and safety of risperidone versus haloperidol in the treatment of schizoaffective disorder, which is one of the specified conditions of interest.",A DoubleBlind Randomized Prospective Evaluation of the Efficacy and Safety of Risperidone Versus Haloperidol in the Treatment of Schizoaffective Disorder,https://doi.org/10.1097/00004714-200108000-00002,11476119
False," The study population specified in the abstract (agitated patients with bipolar mania) does not match the inclusion criteria for patients with schizophrenia, including first episode and treatment-resistant schizophrenia, which is a key population of interest in the review.",A DoubleBlind Randomized Comparison of the Efficacy and Safety of Intramuscular Injections of Olanzapine Lorazepam or Placebo in Treating Acutely Agitated Patients Diagnosed With Bipolar Mania,https://doi.org/10.1097/00004714-200108000-00006,11476123
False," The title and abstract do not mention any specific population or intervention that matches the inclusion criteria, which are focused on various psychiatric disorders and medications.",An Evaluation of Risperidone Drug Interactions,https://doi.org/10.1097/00004714-200108000-00008,11476125
True," The study meets the inclusion criteria as it involves adults with schizophrenia, a diagnosis of interest in this review, and examines the effectiveness of olanzapine, an intervention included in this review.",Olanzapine for Schizophrenia Refractory to Typical and Atypical Antipsychotics An OpenLabel Prospective Trial,https://doi.org/10.1097/00004714-200108000-00014,11476131
False," The abstract does not mention any specific interventions (medications) that are included in the review, and the population of interest (prodromally symptomatic individuals at high risk for schizophrenia) does not match the specified inclusion criteria.",Psychosis treatment prior to psychosis onset ethical issues,https://doi.org/10.1016/s0920-9964(01)00238-9,11479065
True, The study meets the inclusion criteria as it is a randomized controlled trial comparing the efficacy and safety of clozapine and risperidone in patients with severe chronic schizophrenia.,A DoubleBlind Comparative Study of Clozapine and Risperidone in the Management of Severe Chronic Schizophrenia,https://doi.org/10.1176/appi.ajp.158.8.1305,11481167
True," The study meets the inclusion criteria as it involves adults with a DSM-III-R or DSM-IV diagnosis of psychotic mood disorders, including schizoaffective disorders, bipolar disorders, and major depressive disorder, and examines the long-term effectiveness and tolerability of olanzapine as an add-on therapy.",Olanzapine Therapy in TreatmentResistant Psychotic Mood Disorders,https://doi.org/10.4088/jcp.v62n07a02,11488360
False," The study population is limited to veterans with schizophrenia or schizoaffective disorder, which does not meet the inclusion criteria of the review, which includes a broader range of psychiatric disorders.",Adherence Assessments and the Use of Depot Antipsychotics in Patients With Schizophrenia,https://doi.org/10.4088/jcp.v62n07a08,11488366
True," The study meets the inclusion criteria as it involves a population with a DSM-III-R or DSM-IV diagnosis of schizophrenia, and it examines the effectiveness of quetiapine, which is an intervention included in the review.",In vivo HT A receptor blockade by quetiapine,https://doi.org/10.1007/s002130100761,11512044
True," The study meets the inclusion criteria as it involves a randomized controlled trial examining the effectiveness of guanfacine as an adjunctive treatment to neuroleptics in patients with schizophrenia, which is a relevant population for this review.",Guanfacine Treatment of Cognitive Impairment in Schizophrenia,https://doi.org/10.1016/s0893-133x(01)00249-4,11522468
False," The study focuses on children and adolescents with mental disorders such as autistic disorders, hyperkinetic disorders, conduct disorders, tic disorders, enuresis, and encopresis, which does not match the inclusion criteria of adults and adolescents with schizophrenia, bipolar disorder, major depressive disorder, and behavioral and psychological symptoms of dementia.",Evaluierte Behandlungsanstze in der Kinder und Jugendpsychiatrie I,https://doi.org/10.1024//1422-4917.29.3.189,11524897
True," The study meets the inclusion criteria as it reviews the cost-effectiveness of atypical antipsychotics for various psychiatric conditions, including schizophrenia, bipolar disorder, and major depressive disorder, and examines outcomes such as mortality, quality of life, and hospitalization.",Cost effectiveness of the newer atypical antipsychotics a review of the pharmacoeconomic research evidence,nan,11527002
True," The study meets the inclusion criteria as it involves a randomized controlled trial of adults with schizophrenia, comparing the effectiveness of olanzapine and haloperidol, and includes outcomes such as clinical efficacy and extrapyramidal symptoms.",Doubleblind olanzapine vs haloperidol D dopamine receptor blockade in schizophrenic patients a baselineendpoint IIBZM SPECT study,https://doi.org/10.1016/s0925-4927(01)00085-3,11530275
False," The abstract does not mention any specific population or interventions that match the inclusion criteria, and it appears to be a general discussion of the relationship between neurotransmitters, temperament, and social functioning without any focus on a specific disorder or treatment.",Neurotransmitters temperament and social functioning,https://doi.org/10.1016/s0924-977x(01)00094-3,11532380
True," The study meets the inclusion criteria as it involves drug-free schizophrenia patients, which is a relevant population for the review.",Abnormal thermoregulation in drugfree male schizophrenia patients,https://doi.org/10.1016/s0924-977x(01)00096-7,11532382
True, The study meets all the inclusion criteria as it is a meta-analysis of controlled trials examining the effects of risperidone on hostility and aggression in schizophrenia.,Effects of the atypical antipsychotic risperidone on hostility and aggression in schizophrenia a metaanalysis of controlled trials,https://doi.org/10.1016/s0924-977x(01)00097-9,11532383
True," The study meets the inclusion criteria as it involves patients with psychotic disorders, including schizophrenia, and examines the effectiveness of antipsychotics, which is a relevant intervention for the review.",Symptom Reduction and Suicide Risk Among Patients Treated With Placebo in Antipsychotic Clinical Trials An Analysis of the Food and Drug Administration Database,https://doi.org/10.1176/appi.ajp.158.9.1449,11532730
False," The study does not meet the inclusion criteria as it does not focus on the effectiveness or harms of the specified interventions (e.g., aripiprazole, asenapine, clozapine, iloperidone, olanzapine, paliperidone, quetiapine, risperidone, and ziprasidone) in the specified patient populations.",Antipsychoticinduced extrapyramidal syndromes,https://doi.org/10.1007/s002280100302,11549212
True," The study meets the inclusion criteria as it involves a head-to-head comparison of risperidone with haloperidol and other antipsychotic agents in patients with schizophrenia, which is a relevant population for this review.",Treatment of the symptoms of schizophrenia a combined analysis of doubleblind studies comparing risperidone with haloperidol and other antipsychotic agents,https://doi.org/10.1097/00004850-200109000-00003,11552769
False," The study population is limited to patients with bipolar I disorder, which does not match the inclusion criteria of adults with schizophrenia, bipolar disorder, major depressive disorder, and other specified disorders.",Medication prescribing patterns for patients with bipolar I disorder in hospital settings adherence to published practice guidelines,https://doi.org/10.1034/j.1399-5618.2001.30401.x,11552955
True," The study meets the inclusion criteria as it involves adults with schizophrenia, a diagnosis included in the review, and examines the effectiveness of a medication (risperidone) in combination with another medication (clozapine).",Risperidone Added to Clozapine,https://doi.org/10.4088/jcp.v62n0805,11561931
False," The study is a case report, which is not a randomized controlled trial, comparative observational study, or systematic review, and does not meet the inclusion criteria for study design.",Risperidone in the Treatment of Psychotic Depression,https://doi.org/10.1097/00002826-200011000-00007,11575868
True," The study meets all the inclusion criteria as it involves a randomized controlled trial comparing clozapine with haloperidol in patients with schizophrenia, and it examines effectiveness outcomes such as symptom response, adherence, and persistence, as well as harms such as adverse events.",Clozapine and Haloperidol in Moderately Refractory Schizophrenia,https://doi.org/10.1001/archpsyc.58.10.965,11576036
True," The study population includes adults with a DSM-IV diagnosis of mania, which meets the inclusion criteria for bipolar disorder.",Use of olanzapine in dysphoric mania,https://doi.org/10.1016/s0165-0327(00)00313-x,11578678
True," The study meets the inclusion criteria as it involves a population with schizophrenia, a relevant intervention (olanzapine), and relevant outcomes (weight gain, body fat, and serum leptin levels).",Association of OlanzapineInduced Weight Gain With an Increase in Body Fat,https://doi.org/10.1176/appi.ajp.158.10.1719,11579009
True," The study meets the inclusion criteria as it reviews the clinical pharmacology, efficacy, and safety of ziprasidone, an atypical antipsychotic, in various patient populations.",Ziprasidone a new atypical antipsychotic,https://doi.org/10.1517/14656566.2.6.1033,11585006
False," The study population consists of patients with juvenile neuronal ceroid lipofuscinosis (JNCL), which is not included in the specified inclusion criteria.",New antidepressive and antipsychotic drugs in juvenile neuronal ceroid lipofuscinoses a pilot study,https://doi.org/10.1053/ejpn.2000.0455,11588990
True," The study meets the inclusion criteria as it involves patients with schizophrenia or schizoaffective disorder, uses a medication event monitoring system to estimate medication compliance, and examines the relationship between compliance and hospital readmission.",Use of the Medication Event Monitoring System to estimate medication compliance in patients with schizophrenia,nan,11590972
False," The study population does not match the inclusion criteria as it only includes patients with bipolar disorder who have an inadequate response to mood stabilizers, whereas the inclusion criteria include a broader range of psychiatric conditions such as schizophrenia, major depressive disorder, and pervasive developmental disorders.",Olanzapine as LongTerm Adjunctive Therapy in TreatmentResistant Bipolar Disorder,https://doi.org/10.1097/00004714-200110000-00002,11593070
True," The study meets the inclusion criteria as it involves a randomized controlled trial comparing the effectiveness of clozapine and haloperidol in patients with schizophrenia, which is a relevant population for this review.",Clozapine Enhances Neurocognition and Clinical Symptomatology More Than Standard Neuroleptics,https://doi.org/10.1097/00004714-200110000-00004,11593072
True," The study meets the inclusion criteria as it involves a randomized controlled trial of a treatment for schizophrenia, which is one of the specified conditions, and reports on effectiveness outcomes such as symptom response and adherence.",A PlaceboControlled Pilot Study of the Ampakine CX Added to Clozapine in Schizophrenia,https://doi.org/10.1097/00004714-200110000-00005,11593073
False," The title does not specify the population of interest (adults, adolescents, or children) or the specific disorder being studied, making it unclear if the study meets the inclusion criteria.",Cognitive Improvements in Psychotic Subjects Treated With Seroquel Quetiapine Fumarate An Exploratory Study,https://doi.org/10.1097/00004714-200110000-00011,11593079
False," The study population does not match the inclusion criteria as it only includes schizophrenic patients, whereas the review includes a broader range of psychiatric disorders.",In vivo I IBZM SPECT imaging of striatal dopamine receptor occupancy in schizophrenic patients,https://doi.org/10.1007/s002130100813,11605078
True," The study meets the inclusion criteria as it involves patients with schizophrenia treated with olanzapine or clozapine, and examines the effects of these medications on autonomic nervous system function.",Autonomic responses of blood vessels and sweat glands in patients with schizophrenia treated with olanzapine or clozapine,https://doi.org/10.1007/s002130100820,11605095
True," The study meets the inclusion criteria as it focuses on the efficacy, tolerability, and safety of fluvoxamine as an adjunctive agent in the treatment of negative symptoms in schizophrenia, which is a relevant population for the review.",Fluvoxamine as an Adjunctive Agent in Schizophrenia,https://doi.org/10.1111/j.1527-3458.2001.tb00200.x,11607044
True," The study population consists of adults and adolescents with schizophrenia, which meets the inclusion criteria.",A followup study of a population of schizophrenic patients treated with clozapine,https://doi.org/10.1016/s0278-5846(01)00213-5,11642649
True," The study meets the inclusion criteria as it involves adults with schizophrenia, a medication (olanzapine) that is included in the review, and examines effectiveness outcomes such as cognitive function and symptom response.",The effects of olanzapine on neurocognitive functioning in medicationrefractory schizophrenia,https://doi.org/10.1017/s146114570100253x,11669086
True," The study meets all the inclusion criteria as it involves a randomized controlled trial comparing the effects of clozapine with other antipsychotics on hostility among patients with schizophrenia, which is a relevant population for this review.",Effects of Clozapine Olanzapine Risperidone and Haloperidol on Hostility Among Patients With Schizophrenia,https://doi.org/10.1176/appi.ps.52.11.1510,11684748
True," The study meets the inclusion criteria as it reviews the risk of torsade de pointes and sudden death with antipsychotic drugs, which is a relevant topic for the review paper.",Antipsychotic Drugs Prolonged QTc Interval Torsade de Pointes and Sudden Death,https://doi.org/10.1176/appi.ajp.158.11.1774,11691681
True," The study meets the inclusion criteria as it involves patients with recent-onset schizophrenia, a relevant population for this review, and examines the clinical outcome following neuroleptic discontinuation, which is a relevant intervention for this review.",Clinical Outcome Following Neuroleptic Discontinuation in Patients With Remitted RecentOnset Schizophrenia,https://doi.org/10.1176/appi.ajp.158.11.1835,11691689
False," The abstract does not mention schizophrenia, other psychotic disorders, first episode schizophrenia, or treatment-resistant schizophrenia, which are the primary conditions of interest for the review.",Olanzapine,https://doi.org/10.2165/00023210-200115110-00005,11700151
False," The study population does not match the specified inclusion criteria as it only includes individuals with developmental disabilities, whereas the inclusion criteria specify a wide range of psychiatric disorders.",Effects of Risperidone on Aberrant Behavior of Persons With Developmental Disabilities I A DoubleBlind Crossover Study Using Multiple Measures,https://doi.org/10.1352/0895-8017(2001)106<0525:eoroab>2.0.co;2,11708938
True, The study meets the inclusion criteria as it is a randomized double-blind study comparing the efficacy and safety of risperidone and haloperidol in the treatment of acute exacerbations of chronic schizophrenia.,Risperidone versus haloperidol in the treatment of acute exacerbations of chronic inpatients with schizophrenia a randomized doubleblind study,https://doi.org/10.1097/00004850-200111000-00002,11712620
True," The study meets the inclusion criteria as it involves patients with schizophrenia, a disorder included in the review, and examines the effectiveness of a specific intervention (ipsapirone) on a particular outcome (HTA receptor responsivity).",HTA receptor dysfunction in female patients with schizophrenia,https://doi.org/10.1016/s0006-3223(01)01202-1,11720694
False, The study does not meet the inclusion criteria as it is a case report and does not provide effectiveness or harms data for the specified patient populations or interventions.,Agranulocytosis and granulocytopenia associated with quetiapine,https://doi.org/10.1034/j.1600-0447.2001.00429.x,11722307
False, The study does not meet the inclusion criteria as it is a case report and does not fit the specified patient populations or interventions.,Euglycemic Clamp Study in ClozapineInduced Diabetic Ketoacidosis,https://doi.org/10.1345/aph.10424,11724088
False," The study population does not match the specified inclusion criteria, as it includes ""highschizotypal normals"" rather than individuals with a diagnosis of schizophrenia, bipolar disorder, major depressive disorder, or other specified conditions.",Latent inhibition deficits in highschizotypal normals symptomspecific or anxietyrelated,https://doi.org/10.1016/s0920-9964(01)00166-9,11728844
True," The study meets the inclusion criteria as it involves adults and adolescents with a diagnosis of schizophrenia, including first episode schizophrenia, and examines the effectiveness of different medication strategies for relapse prevention.",First vs multiple episode schizophrenia twoyear outcome of intermittent and maintenance medication strategies,https://doi.org/10.1016/s0920-9964(01)00182-7,11728846
True," The study meets the inclusion criteria as it involves amisulpride, a second-generation atypical antipsychotic, and discusses its efficacy and tolerability in patients with acute exacerbations of schizophrenia.",Amisulpride,https://doi.org/10.2165/00003495-200161140-00014,11735643
True," The study meets the inclusion criteria as it examines the risk of sudden cardiac death in antipsychotic users, which is a relevant outcome for the review, and it is a cohort study, a type of comparative observational study that is included in the review.",Antipsychotics and the Risk of Sudden Cardiac Death,https://doi.org/10.1001/archpsyc.58.12.1161,11735845
True," The study meets the inclusion criteria as it involves patients with schizophrenia, a relevant population for this review, and examines the risk of diabetes, hyperlipidemia, and hypertension associated with clozapine use.",Clozapine Use in Patients With Schizophrenia and the Risk of Diabetes Hyperlipidemia and Hypertension,https://doi.org/10.1001/archpsyc.58.12.1172,11735847
False," The study population specified in the abstract (schizophrenic outpatients) does not match the inclusion criteria, which includes a broader range of psychiatric disorders and age groups.",Affective reactivity of language and rightear advantage in schizophrenia,https://doi.org/10.1016/s0920-9964(01)00228-6,11738531
False," The study population does not match the inclusion criteria as it only includes adults and adolescents with schizophrenia, whereas the inclusion criteria specify a broader range of disorders, including bipolar disorder, major depressive disorder, and pervasive developmental disorders.",Arithmetic fact retrieval and working memory in schizophrenia,https://doi.org/10.1016/s0920-9964(01)00152-9,11738535
True, The study meets the inclusion criteria as it involves a randomized controlled trial comparing the effects of quetiapine and haloperidol on cognitive function in patients with schizophrenia.,Does cognitive function improve with quetiapine in comparison to haloperidol,https://doi.org/10.1016/s0920-9964(01)00268-7,11738537
False," The title and abstract indicate that the study is focused on Alzheimer's disease, which is not included in the specified inclusion criteria.",National Institute of Mental Health Clinical Antipsychotic Trials of Intervention Effectiveness CATIE Alzheimer Disease Trial Methodology,https://doi.org/10.1097/00019442-200111000-00004,11739062
True," The study population includes adults and adolescents with treatment-resistant schizophrenia, which matches the inclusion criteria.",Pharmacoeconomic evaluation of clozapine in treatmentresistant schizophrenia a costutility analysis,nan,11743592
False," The study does not meet the inclusion criteria as it is a descriptive epidemiologic study of spontaneous adverse event reports of hyperglycemia occurring in clozapine-treated patients, and does not fit the specified inclusion criteria of randomized controlled trials, good quality systematic reviews, and comparative observational studies examining the relationship between improved adherence or persistence and improved outcomes.",Clozapineassociated diabetes,https://doi.org/10.1016/s0002-9343(01)01000-2,11747852
False," The study population does not match the inclusion criteria as it specifically focuses on Chinese dementia patients, whereas the inclusion criteria specify a broader range of patient populations, including schizophrenia, bipolar disorder, major depressive disorder, and pervasive developmental disorders.",A doubleblind randomised comparison of risperidone and haloperidol in the treatment of behavioural and psychological symptoms in Chinese dementia patients,https://doi.org/10.1002/gps.504,11748775
False," The study population specified in the abstract (patients with bipolar disorder) does not match the inclusion criteria, which includes a broader range of psychiatric disorders such as schizophrenia, major depressive disorder, and pervasive developmental disorders.",Klinische Relevanz und Behandlungsmglichkeiten von Rapid Cycling bei Patienten mit bipolarer affektiver Strung,https://doi.org/10.1055/s-2001-19181,11753745
True," The study meets the inclusion criteria as it involves patients with schizophrenia, a condition included in the review, and examines the effectiveness of a specific intervention (ethyl eicosapentaenoate) on symptoms and outcomes.",A doseranging exploratory study of the effects of ethyleicosapentaenoate in patients with persistent schizophrenic symptoms,https://doi.org/10.1016/s0022-3956(01)00048-6,11755456
True," The study meets the inclusion criteria as it involves adults with schizophrenia, a relevant population for this review, and examines the effectiveness of olanzapine, a medication included in the review.",The Effect of Olanzapine Treatment on mChlorophenylpiperazineInduced Hormone Release in Schizophrenia,https://doi.org/10.1097/00004714-200112000-00006,11763004
False," The study population does not match the inclusion criteria as it only includes patients with clozapine-induced hypersalivation, which is not one of the specified patient populations.",Therapeutic Effect of Pirenzepine for ClozapineInduced Hypersalivation A Randomized DoubleBlind PlaceboControlled CrossOver Study,https://doi.org/10.1097/00004714-200112000-00012,11763010
True, The study meets all the inclusion criteria as it involves a randomized controlled trial comparing the efficacy and tolerability of quetiapine and risperidone in outpatients with schizophrenia and other psychotic disorders.,A comparison of the relative safety efficacy and tolerability of quetiapine and risperidone in outpatients with schizophrenia and other psychotic disorders the quetiapine experience with safety and tolerability QUEST study,https://doi.org/10.1016/s0149-2918(00)89080-3,11768836
False," The study population does not match the inclusion criteria as it only includes patients in England, whereas the review includes patients of various age groups and populations from different regions.",The pharmacovigilance of olanzapine results of a postmarketing surveillance study on patients in England,https://doi.org/10.1177/026988110101500405,11769820
False," The study population specified in the abstract does not match the inclusion criteria, as it only includes patients with schizoaffective disorder, whereas the inclusion criteria include a broader range of psychiatric disorders.",Pharmacologic Treatment of Hospitalized Patients With Schizoaffective Disorder,https://doi.org/10.1176/appi.ps.53.1.94,11773657
False," The study population specified in the abstract is female patients with borderline personality disorder, which does not match the inclusion criteria of adults and adolescents with schizophrenia, bipolar disorder, major depressive disorder, and other specified conditions.",Olanzapine Treatment of Female Borderline Personality Disorder Patients,https://doi.org/10.4088/jcp.v62n1103,11775043
False," The study population specified in the abstract (acutely agitated patients with psychosis) does not match the inclusion criteria, which include a broader range of psychiatric conditions such as schizophrenia, bipolar disorder, major depressive disorder, and pervasive developmental disorders.",Validation of the behavioural activity rating scale BARS a novel measure of activity in agitated patients,https://doi.org/10.1016/s0022-3956(01)00052-8,11777497
True," The study meets the inclusion criteria for the population (patients with schizophrenia and substance abuse disorders), intervention (olanzapine treatment), and outcomes (efficacy and safety measures, substance abuse remission) of interest.",Olanzapine treatment for patients with schizophrenia and substance abuse,https://doi.org/10.1016/s0740-5472(01)00205-7,11777671
True, The study meets the inclusion criteria as it is a head-to-head randomized controlled trial comparing the effectiveness of two antipsychotic medications (risperidone and haloperidol) in preventing relapse in patients with schizophrenia.,A Comparison of Risperidone and Haloperidol for the Prevention of Relapse in Patients with Schizophrenia,https://doi.org/10.1056/nejmoa002028,11777998
True, The study meets the inclusion criteria as it is a randomized controlled trial examining the efficacy of olanzapine in combination with valproate or lithium in treating mania in patients partially nonresponsive to valproate or lithium monotherapy.,Efficacy of Olanzapine in Combination With Valproate or Lithium in the Treatment of Mania in Patients Partially Nonresponsive to Valproate or Lithium Monotherapy,https://doi.org/10.1001/archpsyc.59.1.62,11779284
True, The study meets the inclusion criteria as it is a randomized controlled trial examining the efficacy and safety of risperidone in patients with first-episode schizophrenia.,A Pilot DoubleBlind DoseComparison Study of Risperidone in DrugNaive FirstEpisode Schizophrenia,https://doi.org/10.4088/jcp.v62n1214c,11780884
True," The study meets the inclusion criteria as it involves a patient with schizophrenia, uses a randomized controlled design, and assesses the effectiveness of an intervention (donepezil) on symptoms and cognitive function.",Donepezil in schizophrenia is it helpful An experimental design case study,https://doi.org/10.1046/j.0001-690x.2001.acp1c008d.x,11782241
True," The study meets the inclusion criteria as it involves adults with a diagnosis of psychotic depression, which is one of the specified conditions, and it examines the effectiveness of olanzapine, which is one of the specified interventions.",An open trial of olanzapine in the treatment of patients with psychotic depression,https://doi.org/10.1023/a:1012233508127,11791952
True," The study meets the inclusion criteria as it compares the risk of extrapyramidal syndromes (EPS) between haloperidol, risperidone, and olanzapine in patients with a similar treatment history.",Risk of Extrapyramidal Syndromes with Haloperidol Risperidone or Olanzapine,https://doi.org/10.1345/aph.1a068,11793611
True," The study meets the inclusion criteria as it involves adults with schizophrenia, a diagnosis of which is included in the review, and examines the effectiveness of risperidone, which is also included in the review.",Effects of Risperidone on Gonadal Axis Hormones in Schizophrenia,https://doi.org/10.1345/aph.1z432,11793612
True," The study meets the inclusion criteria as it involves elderly patients with dementia and psychosis, which falls under the category of behavioral and psychological symptoms of dementia, and it compares the effects of risperidone and olanzapine, which are included interventions.",Comparison of Risperidone with Olanzapine in Elderly Patients with Dementia and Psychosis,https://doi.org/10.1592/phco.22.1.1.33496,11794418
False," The study population does not match the inclusion criteria as it specifically mentions patients with Tourette syndrome, which is not included in the specified patient populations.",Risperidone in the Treatment of Tourette Syndrome A DoubleBlind PlaceboControlled Trial,https://doi.org/10.1097/00004714-200202000-00006,11799340
False," The study does not meet the inclusion criteria as it involves healthy volunteers, not patients with schizophrenia, bipolar disorder, major depressive disorder, or other specified conditions.",Lorazepam sedation and conscious recollection a doseresponse study with healthy volunteers,https://doi.org/10.1097/00004850-200201000-00003,11800502
True," The study population includes adults with acute exacerbations of schizophrenia, which meets the inclusion criteria.",Clinical Advantages of Amisulpride in the Treatment of Acute Schizophrenia,https://doi.org/10.1177/147323000102900601,11803729
True, The study meets the inclusion criteria as it focuses on the effectiveness of amisulpride in improving social functioning and quality of life in patients with schizophrenia.,Social functioning and quality of life in the schizophrenic patient advantages of amisulpride,https://doi.org/10.1097/00004850-200201000-00001,11806403
True," The study meets the inclusion criteria as it involves adults with schizophrenia, a randomized controlled trial, and examines the effectiveness of an adjunctive treatment (glycine) in addition to antipsychotic medication.",Adjunctive highdose glycine in the treatment of schizophrenia,https://doi.org/10.1017/s1461145701002590,11806864
True," The study meets the inclusion criteria as it involves adults with schizophrenia, a condition included in the review, and examines the effectiveness of an intervention (melperone) that is included in the review.",Melperone in the treatment of neurolepticresistant schizophrenia,https://doi.org/10.1016/s0165-1781(01)00346-8,11814539
False," The study population does not match the inclusion criteria as it specifically targets patients with Parkinson's disease and dementia, whereas the review includes a broader range of patient populations.",Olanzapine for the Treatment of Psychosis in Patients With Parkinsons Disease and Dementia,https://doi.org/10.1176/appi.psy.42.6.477,11815682
True," The study population includes adults with schizophrenia, which matches the inclusion criteria.",The Effects of Olanzapine on the Dimensions of Schizophrenia Derived by Factor Analysis,https://doi.org/10.4088/jcp.v62n1003,11816864
False," The study population specified in the abstract (bipolar and schizoaffective disorders) does not match the inclusion criteria, which includes a broader range of disorders such as schizophrenia, major depressive disorder, and pervasive developmental disorders.",Risperidone Safety and Efficacy in the Treatment of Bipolar and Schizoaffective Disorders,https://doi.org/10.4088/jcp.v62n1011,11816872
True," The study meets the inclusion criteria as it involves a meta-analysis of randomized controlled trials of amisulpride in patients with schizophrenia, which is a relevant population for this review.",Amisulpride an Unusual Atypical Antipsychotic A MetaAnalysis of Randomized Controlled Trials,https://doi.org/10.1176/appi.ajp.159.2.180,11823257
True," The study meets the inclusion criteria as it involves adults with schizophrenia and schizoaffective disorder, and it is a randomized controlled trial comparing the efficacy and safety of four antipsychotics.",Clozapine Olanzapine Risperidone and Haloperidol in the Treatment of Patients With Chronic Schizophrenia and Schizoaffective Disorder,https://doi.org/10.1176/appi.ajp.159.2.255,11823268
True, The study meets the inclusion criteria as it involves a naturalistic study comparing patient satisfaction and burden of adverse effects between novel and conventional antipsychotic medications in patients with psychosis.,Short Report Comparison of Patient Satisfaction and Burden of Adverse Effects With Novel and Conventional Neuroleptics A Naturalistic Study,https://doi.org/10.1093/oxfordjournals.schbul.a006899,11824486
False," The abstract does not mention any specific interventions or populations that match the inclusion criteria, and the study appears to be a review of existing literature rather than a primary study.",Antipsychotic medication effects on regulation of glucose and lipids,https://doi.org/10.1517/14656566.2.10.1571,11825300
True," The study meets the inclusion criteria as it involves patients with schizophrenia, a relevant population for this review, and examines the effect of influenza vaccination on serum clozapine and its metabolites.",Effect of influenza vaccination on serum clozapine and its main metabolite concentrations in patients with schizophrenia,https://doi.org/10.1007/s002280100375,11829199
True," The study population (patients with Parkinson's disease and drug-induced psychosis) and the intervention (olanzapine) are within the scope of the review, and the study design (randomized controlled trial) meets the inclusion criteria.",Usefulness of olanzapine in the levodopainduced psychosis in patients with Parkinsons disease,nan,11834192
False," The study does not focus on a psychiatric disorder or a population specified in the inclusion criteria, and it does not examine the effectiveness or harms of the specified interventions.",Epidemiology of primary blepharospasm,https://doi.org/10.1002/mds.1275,11835433
True, The study meets the inclusion criteria as it involves a randomized controlled trial examining the effect of vitamin B supplementation on psychotic symptoms in patients with schizophrenia and schizoaffective disorder.,Vitamin B as AddOn Treatment in Chronic Schizophrenic and Schizoaffective Patients,https://doi.org/10.4088/jcp.v63n0111,11838627
True," The study meets the inclusion criteria as it involves patients with schizophrenia, a relevant population for the review, and examines the effects of risperidone, a relevant intervention.",Cytokine profiles in schizophrenic patients treated with risperidone,https://doi.org/10.1016/s0278-5846(01)00221-4,11853116
True," The study meets the inclusion criteria as it involves a randomized controlled trial comparing the effectiveness of olanzapine and haloperidol in patients with schizoaffective disorder bipolar type, which is a relevant population for this review.",Olanzapine versus haloperidol in schizoaffective disorder bipolar type,https://doi.org/10.1016/s0165-0327(00)00303-7,11869760
True, The study meets the inclusion criteria as it is a randomized controlled trial examining the effectiveness of adding d-cycloserine to conventional neuroleptics in patients with treatment-resistant schizophrenia.,PlaceboControlled Trial ofdCycloserine Added to Conventional Neuroleptics Olanzapine or Risperidone in Schizophrenia,https://doi.org/10.1176/appi.ajp.159.3.480,11870017
False," The study population does not match the inclusion criteria as it only includes young patients with schizophrenia or related disorders, whereas the review includes a broader range of patient populations such as adults with schizophrenia, bipolar disorder, major depressive disorder, and behavioral and psychological symptoms of dementia.",ObsessiveCompulsive Symptoms During Treatment With Olanzapine and Risperidone,https://doi.org/10.4088/jcp.v63n0203,11874209
False," The abstract does not mention any of the specified patient populations (schizophrenia, bipolar disorder, major depressive disorder, behavioral and psychological symptoms of dementia, pervasive developmental disorders, or disruptive behavior disorders) or the specified interventions (atypical antipsychotics) that are the focus of the review.",What Role Do Atypical Antipsychotic Drugs Have in TreatmentResistant Depression,https://doi.org/10.4088/jcp.v63n0202,11874227
True," The study meets the inclusion criteria as it involves a comparison of two antipsychotic medications (olanzapine and risperidone) in the treatment of schizophrenia, which is a condition included in the review.",A retrospective economic evaluation of olanzapine versus risperidone in the treatment of schizophrenia,nan,11875967
True," The study meets the inclusion criteria as it involves adults and adolescents with a diagnosis of schizophrenia, bipolar disorder, and other psychotic disorders, and examines the effectiveness of atypical antipsychotics, specifically risperidone and olanzapine.",Clinical impact of atypical antipsychotics prospective month study of inpatients treated with risperidone or olanzapine,nan,11878086
False," The study population specified in the abstract (schizophrenic patients) does not match the inclusion criteria, which include a broader range of psychiatric disorders.",Atypische Neuroleptika in der Behandlung von Aggressivitt und Feindseligkeit bei schizophrenen Patienten,https://doi.org/10.1055/s-2002-20501,11880946
False," The study population does not match the inclusion criteria as it only includes premenopausal women with fluoxetine-associated sexual dysfunction, whereas the review focuses on various psychiatric disorders and medications.",Mirtazapine yohimbine or olanzapine augmentation therapy for serotonin reuptakeassociated female sexual dysfunction a randomized placebo controlled trial,https://doi.org/10.1016/s0022-3956(01)00060-7,11886692
True," The study meets the inclusion criteria as it involves adults with treatment-resistant schizophrenia, a relevant population for the review, and examines the effectiveness of a specific intervention (mianserin) in conjunction with typical antipsychotics.",Mianserin or placebo as adjuncts to typical antipsychotics in resistant schizophrenia,https://doi.org/10.1097/00004850-200203000-00003,11890187
True," The study meets the inclusion criteria as it involves adults and adolescents with schizophrenia and related disorders, and examines the effectiveness of atypical and conventional antipsychotics in terms of time to discontinuation, relapse, and noncompliance.",Time to study discontinuation relapse and compliance with atypical or conventional antipsychotics in schizophrenia and related disorders,https://doi.org/10.1097/00004850-200203000-00004,11890188
True, The study meets the inclusion criteria as it is a randomized controlled trial examining the effectiveness of donepezil as an adjunctive treatment to risperidone for cognitive impairment in schizophrenia.,A double blind placebo controlled trial of donepezil adjunctive treatment to risperidone for the cognitive impairment of schizophrenia,https://doi.org/10.1016/s0006-3223(01)01342-7,11904128
False," The study population in the abstract is limited to bipolar patients, which does not match the inclusion criteria of adults and adolescents with schizophrenia, bipolar disorder, major depressive disorder, and other specified disorders.",Cerebellar blood volume in bipolar patients correlates with medication,https://doi.org/10.1016/s0006-3223(01)01281-1,11904131
False," The study population does not match the inclusion criteria as it only includes patients with schizophrenia and bipolar disorder, whereas the review includes a broader range of patient populations such as major depressive disorder, behavioral and psychological symptoms of dementia, pervasive developmental disorders, and disruptive behavior disorders.",The Safety and Pharmacokinetics of Quetiapine When Coadministered With Haloperidol Risperidone or Thioridazine,https://doi.org/10.1097/00004714-200204000-00004,11910256
False," The study population does not match the inclusion criteria as it only includes patients with schizophrenia schizoaffective disorder or bipolar disorder, whereas the review includes a broader range of disorders such as major depressive disorder, behavioral and psychological symptoms of dementia, pervasive developmental disorders, and disruptive behavior disorders.",Effect of Fluoxetine and Imipramine on the Pharmacokinetics and Tolerability of the Antipsychotic Quetiapine,https://doi.org/10.1097/00004714-200204000-00011,11910263
False," The study population does not match the inclusion criteria as it includes only nonpsychotic subjects who were anxious before undergoing minor dental surgery, whereas the inclusion criteria specify patients with schizophrenia, bipolar disorder, major depressive disorder, and other specific conditions.",The Anxiolytic Effect of the Novel Antipsychotic Ziprasidone Compared With Diazepam in Subjects Anxious Before Dental Surgery,https://doi.org/10.1097/00004714-200204000-00016,11910268
False," The study population specified in the abstract does not match the inclusion criteria, as it focuses on bipolar disorder, which is only one of the conditions included in the review, and does not include other conditions such as schizophrenia, major depressive disorder, and behavioral and psychological symptoms of dementia.",The evolving role of topiramate among other mood stabilizers in the management of bipolar disorder,https://doi.org/10.1034/j.1399-5618.2001.30501.x,11912568
False," The study population does not match the inclusion criteria as it specifically focuses on Alzheimer's disease patients, whereas the inclusion criteria include a wide range of psychiatric disorders and conditions.",Reducing the burden of caring for Alzheimers disease through the amelioration of delusions of theft by drug therapy,https://doi.org/10.1002/gps.551,11921147
True," The study meets the inclusion criteria as it involves adults and adolescents with a diagnosis of schizophrenia, and examines the association between the use of atypical neuroleptics and the prevalence of diabetes mellitus.",Association of Diabetes Mellitus With Use of Atypical Neuroleptics in the Treatment of Schizophrenia,https://doi.org/10.1176/appi.ajp.159.4.561,11925293
True," The study meets the inclusion criteria as it examines antipsychotic prescription patterns in patients with schizophrenia, which is one of the specified conditions, and it is a comparative observational study, which is an acceptable study design for this review.",Racial Disparities in Antipsychotic Prescription Patterns for Patients With Schizophrenia,https://doi.org/10.1176/appi.ajp.159.4.567,11925294
True," The study meets the inclusion criteria as it involves adults with schizophrenia, a relevant population for the review, and examines the effects of antipsychotic medication on glucose regulation.",Abnormalities in Glucose Regulation During Antipsychotic Treatment of Schizophrenia,https://doi.org/10.1001/archpsyc.59.4.337,11926934
True, The study meets the inclusion criteria as it is a randomized controlled trial investigating the efficacy and safety of a medication (olanzapine) for a condition (agitation associated with Alzheimer's disease and/or vascular dementia) that is included in the review.,Comparison of Rapidly Acting Intramuscular Olanzapine Lorazepam and Placebo A Doubleblind Randomized Study in Acutely Agitated Patients with Dementia,https://doi.org/10.1016/s0893-133x(01)00365-7,11927174
True," The study meets the inclusion criteria as it involves patients with treatment-resistant schizophrenia, which is one of the specified populations of interest, and examines the effectiveness of clozapine, which is one of the specified interventions.",Novel FactorBased Symptom Scores in Treatment Resistant Schizophrenia Implications for Clinical Trials,https://doi.org/10.1016/s0893-133x(01)00387-6,11927178
False," The study population specified in the abstract does not match the inclusion criteria, as it focuses on the augmentation of SSRIs with atypical antipsychotics in the treatment of depression, whereas the inclusion criteria specify a broader range of psychiatric conditions, including schizophrenia, bipolar disorder, major depressive disorder, and pervasive developmental disorders.",Augmentation von selektiven SerotoninWiederaufnahmeHemmern SSRI mit atypischen Antipsychotika in der Depressionsbehandlung,https://doi.org/10.1055/s-2002-24644,11948436
True," The study meets the inclusion criteria as it focuses on the use of atypical antipsychotics in autistic disorder, which is one of the specified populations of interest.",A systematic review of the use of atypical antipsychotics in autism,https://doi.org/10.1177/026988110201600113,11949778
True," The study meets the inclusion criteria as it involves patients with schizophrenia, a disorder included in the review, and examines the effectiveness of risperidone compared to typical antipsychotics.",Prepulse inhibition of the startle response in risperidonetreated patients comparison with typical antipsychotics,https://doi.org/10.1016/s0920-9964(01)00276-6,11955973
True," The study focuses on the use of olanzapine in elderly patients with psychotic disorders, which meets the inclusion criteria of examining the effectiveness of a specific medication in a specific population.",Use of olanzapine for elderly patients with psychotic disorders a review,https://doi.org/10.1023/a:1014674018039,11958362
False," The study does not meet the inclusion criteria as it focuses on antihormonal treatment of paraphilic patients, which is not one of the specified patient populations.",Antihormonal treatment of paraphilic patients in German forensic psychiatric clinics,https://doi.org/10.1016/s0924-9338(02)00635-1,11973119
False," The abstract is not available, making it difficult to assess whether the study meets the inclusion criteria.",Mirtazapine overdose with benign outcome,https://doi.org/10.1016/s0924-9338(02)00636-3,11973120
False," The study population specified in the abstract (adults with schizophrenia) does not match the inclusion criteria, which includes a broader range of populations such as bipolar disorder, major depressive disorder, and pervasive developmental disorders.",Ziprasidone The Fifth Atypical Antipsychotic,https://doi.org/10.1345/aph.1a053,11978164
True," The study meets the inclusion criteria as it involves a randomized controlled trial of intramuscular olanzapine in the treatment of acute agitation in schizophrenia, which is one of the interventions included in the review.",A Doubleblind PlaceboControlled DoseResponse Comparison of Intramuscular Olanzapine and Haloperidol in the Treatment of Acute Agitation in Schizophrenia,https://doi.org/10.1001/archpsyc.59.5.441,11982448
True," The study meets the inclusion criteria as it involves a randomized controlled trial examining the effectiveness of a psychosocial treatment for schizophrenia, specifically skills training augmented by manual-based community support sessions, and reports on social adjustment and quality of life outcomes.",Supplementing ClinicBased Skills Training With ManualBased Community Support Sessions Effects on Social Adjustment of Patients With Schizophrenia,https://doi.org/10.1176/appi.ajp.159.5.829,11986138
False," The study population does not match the inclusion criteria as it only includes patients with Alzheimer's disease or vascular dementia, whereas the inclusion criteria specify a wide range of psychiatric disorders.",A pilot randomized openlabel trial assessing safety and pharmakokinetic parameters of coadministration of rivastigmine with risperidone in dementia patients with behavioral disturbances,https://doi.org/10.1002/gps.599,11994888
False," The study does not meet the inclusion criteria for interventions as it examines the effectiveness of phenylpropanolamine, which is not one of the specified interventions included in the review.",Phenylpropanolamine Appears Not to Promote Weight Loss in Patients With Schizophrenia Who Have Gained Weight During Clozapine Treatment,https://doi.org/10.4088/jcp.v63n0412,12000209
True," The study population (cases and controls) meets the inclusion criteria of adults with psychiatric disorders, specifically schizophrenia and other psychotic disorders, and the study examines the effectiveness and harms of clozapine, which is an intervention included in the review.",Clozapine Use and Risk of Diabetes Mellitus,https://doi.org/10.1097/00004714-200206000-00002,12006892
True," The study meets the inclusion criteria as it investigates the association between antipsychotic-induced weight gain and therapeutic response in patients with schizophrenia and schizoaffective disorder, which falls within the specified patient populations and interventions.",AntipsychoticInduced Weight Gain and Therapeutic Response A Differential Association,https://doi.org/10.1097/00004714-200206000-00003,12006893
True," The study meets the inclusion criteria as it involves a randomized controlled trial comparing the effectiveness of olanzapine and haloperidol in patients with schizophrenia, which is a relevant population for this review.",Sex differences in clinical response to olanzapine compared with haloperidol,https://doi.org/10.1016/s0165-1781(02)00028-8,12007591
True," The study meets the inclusion criteria as it involves adults with a DSM-IV diagnosis of schizophrenia, examines the effectiveness of olanzapine, and includes outcomes such as symptom response, adherence, and persistence.",Effects of Olanzapine on Prolactin Levels of Female Patients With Schizophrenia Treated With Risperidone,https://doi.org/10.4088/jcp.v63n0506,12019665
True," The study meets the inclusion criteria as it involves adults and adolescents with a DSM-III-R diagnosis of schizophrenia, and examines the effectiveness of clozapine treatment.",Clinical Predictors of Response to Clozapine Treatment in Ambulatory Patients With Schizophrenia,https://doi.org/10.4088/jcp.v63n0508,12019667
True, The study meets the inclusion criteria as it involves a comparison of two antipsychotic medications (risperidone and olanzapine) and examines their effects on metabolic parameters in patients with a DSM-IV diagnosis of schizophrenia.,A Retrospective Comparison of Weight Lipid and Glucose Changes Between Risperidone and OlanzapineTreated Inpatients,https://doi.org/10.4088/jcp.v63n0509,12019668
True," The study meets the inclusion criteria as it involves patients with schizophrenia, a relevant population for the review, and examines the effects of neuroleptic medication on thought disorder and semantic processing.",Effects of neuroleptic medications on speech disorganization in schizophrenia biasing associative networks towards meaning,https://doi.org/10.1017/s0033291799002639,12027048
False," The abstract does not mention any specific interventions (medications) that are included in the review, and the population of interest (schizophrenia) is only mentioned in the context of the review's focus on the physical consequences of the illness, not as a specific population being studied.",Physical consequences of schizophrenia and its treatment,https://doi.org/10.1016/s0024-3205(02)01646-6,12034344
False," The study population does not match the inclusion criteria as it only includes adults and adolescents with bipolar disorder, whereas the inclusion criteria include a broader range of psychiatric disorders.",Olanzapine Versus Divalproex in the Treatment of Acute Mania,https://doi.org/10.1176/appi.ajp.159.6.1011,12042191
True," The study meets the inclusion criteria as it involves patients with schizophrenia or schizoaffective disorder, examines the effects of clozapine, olanzapine, risperidone, and haloperidol on neurocognitive functioning, and is a randomized controlled trial.",Neurocognitive Effects of Clozapine Olanzapine Risperidone and Haloperidol in Patients With Chronic Schizophrenia or Schizoaffective Disorder,https://doi.org/10.1176/appi.ajp.159.6.1018,12042192
True," The study meets the inclusion criteria as it involves a randomized controlled trial of a specific antipsychotic medication (risperidone) with an immunomodulatory drug (celecoxib) in patients with schizophrenia, which is a relevant population for this review.",Beneficial Antipsychotic Effects of Celecoxib AddOn Therapy Compared to Risperidone Alone in Schizophrenia,https://doi.org/10.1176/appi.ajp.159.6.1029,12042193
False," The study does not meet the inclusion criteria for interventions as it focuses on olanzapine and fluoxetine, which are not among the specified interventions included in the review.",OlanzapineInduced Weight Gain in Patients With FirstEpisode Schizophrenia A DoubleBlind PlaceboControlled Study of Fluoxetine Addition,https://doi.org/10.1176/appi.ajp.159.6.1058,12042201
True, The study population (long-stay state hospital patients with treatment-refractory schizophrenia) and interventions (olanzapine and risperidone) align with the specified inclusion criteria.,Efficacy of Olanzapine and Risperidone for TreatmentRefractory Schizophrenia Among LongStay State Hospital Patients,https://doi.org/10.1176/appi.ps.53.6.755,12045315
True," The study meets the inclusion criteria as it focuses on schizophrenia, a condition included in the review, and examines the potential importance of extrapyramidal symptoms (EPS) and neuroleptic dysphoria in treatment outcome.",Improving outcome in schizophrenia the potential importance of EPS and neuroleptic dysphoria,https://doi.org/10.1023/a:1015276028425,12046640
False," The study population does not match the inclusion criteria as it only includes adults and adolescents with atypical antipsychotic-induced new-onset diabetes mellitus and diabetic ketoacidosis, whereas the review focuses on a broader range of psychiatric disorders and populations.",Phenomenology of and risk factors for newonset diabetes mellitus and diabetic ketoacidosis associated with atypical antipsychotics an analysis of published cases,https://doi.org/10.1023/a:1015228112495,12046641
False," The study focuses on the clinical profile of risperidone, but does not specify the population or outcomes of interest, which do not match the inclusion criteria.",Clinical Profile of an Atypical Antipsychotic Risperidone,https://doi.org/10.1093/oxfordjournals.schbul.a006925,12047021
False," The study population specified in the abstract (New Hampshire Medicaid beneficiaries with schizophrenia or schizoaffective disorder) does not match the inclusion criteria (adults and adolescents with a DSM III-R or DSM-IV diagnosis of schizophrenia, bipolar disorder, major depressive disorder, or other specified disorders).",Recent Trends in Antipsychotic Combination Therapy of Schizophrenia and Schizoaffective Disorder Implications for State Mental Health Policy,https://doi.org/10.1093/oxfordjournals.schbul.a006928,12047024
True, The study meets the inclusion criteria as it involves a randomized controlled trial comparing the neurocognitive effects of low-dose haloperidol and risperidone in patients with schizophrenia.,The neurocognitive effects of lowdose haloperidol a twoyear comparison with risperidone,https://doi.org/10.1016/s0006-3223(02)01370-7,12062881
True," The study meets the inclusion criteria as it is a randomized controlled trial examining the effectiveness of bupropion for smoking cessation in patients with schizophrenia, which is one of the populations of interest for this review.",A placebo controlled trial of bupropion for smoking cessation in schizophrenia,https://doi.org/10.1016/s0006-3223(02)01339-2,12079730
True, The study meets the inclusion criteria as it is a systematic review of randomized controlled trials comparing the effectiveness of newer atypical antipsychotic drugs to clozapine for schizophrenia.,Newer atypical antipsychotic medication in comparison to clozapine a systematic review of randomized trials,https://doi.org/10.1016/s0920-9964(01)00212-2,12084413
True," The study meets the inclusion criteria as it involves adults with schizophrenia, a relevant population for the review, and examines the effectiveness of a specific medication (dCycloserine) in combination with risperidone, a medication included in the review.",dCycloserine added to risperidone in patients with primary negative symptoms of schizophrenia,https://doi.org/10.1016/s0920-9964(01)00220-1,12084415
True," The study meets the inclusion criteria as it involves a randomized controlled trial comparing the effectiveness of ziprasidone and haloperidol in outpatients with stable schizophrenia, which is a relevant population for this review.",A Week Comparison of Ziprasidone and Haloperidol in Outpatients With Stable Schizophrenia,https://doi.org/10.4088/jcp.v63n0609,12088164
False," The study population specified in the abstract (Irish outpatients treated with clozapine) does not match the inclusion criteria (which includes a wide range of patient populations and disorders, but does not specifically mention outpatients treated with clozapine).",Prevalence of obesity lipid and glucose abnormalities in outpatients prescribed clozapine,nan,12090443
False," The study population does not match the inclusion criteria as it only includes adults and adolescents with bipolar disorder, whereas the inclusion criteria include a broader range of psychiatric disorders such as schizophrenia, major depressive disorder, and pervasive developmental disorders.",Combination of a Mood Stabilizer With Risperidone or Haloperidol for Treatment of Acute Mania A DoubleBlind PlaceboControlled Comparison of Efficacy and Safety,https://doi.org/10.1176/appi.ajp.159.7.1146,12091192
True," The study meets the inclusion criteria as it involves patients with schizophrenia, a condition included in the review, and examines the effects of risperidone, an intervention included in the review.",Effects of Risperidone on the Peripheral Noradrenegic System in Patients with Schizophrenia A Comparison with Clozapine and Placebo,https://doi.org/10.1016/s0893-133x(02)00314-7,12093603
True, The study population (patients with schizophrenia) and the intervention (clozapine) match the inclusion criteria.,The costeffectiveness of clozapine a controlled populationbased mirrorimage study,https://doi.org/10.1177/026988110201600208,12095076
True," The study population includes adults with a diagnosis of bipolar I disorder with manic or mixed episodes, which falls within the specified inclusion criteria for bipolar disorder.",Economic clinical and qualityoflife outcomes associated with olanzapine treatment in mania Results from a randomized controlled trial,https://doi.org/10.1016/s0165-0327(01)00310-x,12103458
True," The study meets the inclusion criteria as it involves adults with schizophrenia, a condition included in the review, and examines the effectiveness of an antipsychotic medication, sertindole, which is also included in the review.",Low striatal and extrastriatal D receptor occupancy during treatment with the atypical antipsychotic sertindole,https://doi.org/10.1007/s00213-002-1083-5,12107615
True," The study meets the inclusion criteria as it involves patients with schizophrenia, a condition included in the review, and examines the effects of antipsychotic medications, specifically olanzapine and risperidone, which are included in the review.",A transcranial magnetic stimulation study of the effects of olanzapine and risperidone on motor cortical excitability in patients with schizophrenia,https://doi.org/10.1007/s00213-002-1068-4,12107621
True," The study meets the inclusion criteria as it focuses on the pharmacological treatment of aggression in schizophrenic patients, which is within the specified population of interest.",Psychopharmacological Treatment of Aggression in Schizophrenic Patients,https://doi.org/10.1055/s-2002-31523,12107851
False," The study does not meet the inclusion criteria as it is a retrospective epidemiologic survey of spontaneously reported adverse events related to olanzapine therapy, which does not match the inclusion criteria of randomized controlled trials, good quality systematic reviews, and comparative observational studies.",OlanzapineAssociated Diabetes Mellitus,https://doi.org/10.1592/phco.22.11.841.33629,12126218
True, The study population (schizophrenia patients at high risk for suicide) matches the inclusion criteria.,Suicidality in schizophrenia A review of the evidence for risk factors and treatment options,https://doi.org/10.1007/s11920-996-0047-6,12126596
True," The study population includes adults with schizophrenia, which matches the inclusion criteria.",Amisulpride improves depressive symptoms in acute exacerbations of schizophrenia comparison with haloperidol and risperidone,https://doi.org/10.1016/s0924-977x(02)00031-7,12126869
True, The study meets the inclusion criteria as it is a systematic review of experimental and observational studies evaluating clozapine-treated subjects in treatment-resistant schizophrenia.,Clozapinetreated subjects with treatmentresistant schizophrenia a systematic review of experimental and observational studies,https://doi.org/10.1097/00004850-200207000-00006,12131603
True," The study appears to meet all the inclusion criteria, including the population of interest (adults and adolescents with various psychiatric disorders), interventions (olanzapine and risperidone), and outcomes (effectiveness and harms).",Economic evaluations of olanzapine and risperidone,https://doi.org/10.1093/ajhp/59.14.1366,12132564
True," The study meets the inclusion criteria as it involves a randomized controlled trial examining the effectiveness of olanzapine in patients with schizophrenia, which is one of the specified interventions and patient populations of interest.",Switching to Olanzapine From Previous Antipsychotics,https://doi.org/10.4088/jcp.v63n0706,12143912
True," The study meets the inclusion criteria as it involves a naturalistic study of risperidone treatment outcome in inpatients with various psychiatric disorders, including schizophrenia, bipolar disorder, and dementia, and uses a database study design.",A Naturalistic Study of Risperidone Treatment Outcome Using PrognosisAdjusted Discharge Rates in New York State Inpatients,https://doi.org/10.4088/jcp.v63n0708,12143914
False," The study population does not match the inclusion criteria as it only includes children with autistic disorder, whereas the inclusion criteria include a broader range of disorders such as schizophrenia, bipolar disorder, major depressive disorder, and behavioral and psychological symptoms of dementia.",Risperidone in Children with Autism and Serious Behavioral Problems,https://doi.org/10.1056/nejmoa013171,12151468
True," The study meets the inclusion criteria as it involves adults and adolescents with schizophrenia, examines the effects of clozapine treatment, and reports on weight gain and blood pressure changes.",Weight and Blood Pressure Change During Clozapine Treatment,https://doi.org/10.1097/00002826-200207000-00003,12151907
True," The study meets the inclusion criteria as it involves adults with schizophrenia and schizoaffective disorder, and it is a randomized controlled trial examining the effectiveness of ziprasidone.",Spotlight on Ziprasidone in Schizophrenia and Schizoaffective Disorder,https://doi.org/10.2165/00023210-200216090-00005,12153335
False," The study population does not match the inclusion criteria as it only includes children with subaverage intelligence and disruptive behaviors, whereas the inclusion criteria specify a wide range of psychiatric disorders and patient populations.",DoubleBlind PlaceboControlled Study of Risperidone for the Treatment of Disruptive Behaviors in Children With Subaverage Intelligence,https://doi.org/10.1176/appi.ajp.159.8.1337,12153826
True, The study meets the inclusion criteria as it is a population-based nested case-control study examining the association between olanzapine and risperidone and the risk of diabetes in patients with schizophrenia.,Assessment of independent effect of olanzapine and risperidone on risk of diabetes among patients with schizophrenia population based nested casecontrol study,https://doi.org/10.1136/bmj.325.7358.243,12153919
True," The study meets the inclusion criteria as it is a randomized controlled trial examining the effectiveness of ziprasidone in patients with chronic schizophrenia, which is one of the interventions included in the review.",A year doubleblind placebocontrolled trial of ziprasidone and mgday in chronic schizophrenia the Ziprasidone Extended Use in Schizophrenia ZEUS study,https://doi.org/10.1097/00004850-200209000-00001,12177583
True," The study meets the inclusion criteria as it is a randomized controlled trial comparing the effectiveness of olanzapine and haloperidol in patients with bipolar disorder, which is one of the specified patient populations.",Olanzapine versus haloperidol in the treatment of acute mania clinical outcomes healthrelated quality of life and work status,https://doi.org/10.1097/00004850-200209000-00003,12177585
True," The study meets the inclusion criteria as it involves a population pharmacokinetics analysis of clozapine, a medication included in the review, and examines the relationship between CYPA activity and clozapine clearance, which is a relevant outcome for the review.",Evidence from a population pharmacokinetics analysis for a major effect of CYPA activity on inter and intraindividual variations of clozapine clearance,https://doi.org/10.1016/s0278-5846(01)00320-7,12188102
True," The review meets the inclusion criteria as it focuses on adults and adolescents with various psychiatric disorders, including schizophrenia, bipolar disorder, and major depressive disorder, and examines the optimal dosing of atypical antipsychotics.",Optimal Dosing of Atypical Antipsychotics in Adults A Review of the Current Evidence,https://doi.org/10.1080/10673220216279,12202454
False," The study population does not match the inclusion criteria as it only includes adults and adolescents with bipolar disorder, whereas the review includes a broader range of populations such as schizophrenia, major depressive disorder, and behavioral and psychological symptoms of dementia.",Risperidone in the treatment of mania efficacy and safety results from a large multicentre open study in Spain,https://doi.org/10.1016/s0165-0327(01)00481-5,12204313
True," The study meets the inclusion criteria as it involves a prospective naturalistic study examining the long-term consequences of switching patients from conventional to novel antipsychotic drugs, which is a relevant intervention for the review.",Switching from conventional to novel antipsychotic drugs results of a prospective naturalistic study,https://doi.org/10.1016/s0920-9964(01)00309-7,12223251
False," The study is a case series, which is not a randomized controlled trial, comparative observational study, or systematic review, and therefore does not meet the inclusion criteria for study design.",Preliminary experience with an ampakine CX as a single agent for the treatment of schizophrenia a case series,https://doi.org/10.1016/s0920-9964(01)00311-5,12223253
True, The study meets the inclusion criteria as it involves a randomized controlled trial comparing the effectiveness of olanzapine and haloperidol in treating extrapyramidal symptoms in Japanese patients with schizophrenia.,Extrapyramidal symptom profiles in Japanese patients with schizophrenia treated with olanzapine or haloperidol,https://doi.org/10.1016/s0920-9964(01)00314-0,12223254
True," The study focuses on the comparison of three second-generation antipsychotics (zotepine, olanzapine, and risperidone) in relation to hostility in schizophrenic patients, which aligns with the inclusion criteria of examining specific symptoms of second-generation agents.",Effect of zotepine olanzapine and risperidone on hostility in schizophrenic patients,https://doi.org/10.1016/s0920-9964(01)00322-x,12223264
False," The study population specified in the abstract does not match the inclusion criteria, as it only includes patients with depressive disorders, whereas the inclusion criteria specify a wide range of psychiatric disorders, including schizophrenia, bipolar disorder, and pervasive developmental disorders.",The BechRafaelsen Melancholia Scale MES in clinical trials of therapies in depressive disorders a year review of its use as outcome measure,https://doi.org/10.1034/j.1600-0447.2002.01404.x,12225492
False," The study population does not match the inclusion criteria as it only includes first episode psychosis patients, whereas the inclusion criteria include a broader range of psychiatric disorders.",Oneyear outcome in first episode psychosis patients in the Swedish Parachute project,https://doi.org/10.1034/j.1600-0447.2002.02376.x,12225494
False," The study population does not match the inclusion criteria as it specifically focuses on patients with Parkinson's disease, which is not mentioned in the inclusion criteria.",Olanzapine in the treatment of dopamimeticinduced psychosis in patients with Parkinsons disease,https://doi.org/10.1016/s0006-3223(02)01392-6,12242060
False," The study population does not match the inclusion criteria as it specifically focuses on residents with dementia in chronic care institutions, whereas the inclusion criteria specify a wide range of psychiatric disorders, including schizophrenia, bipolar disorder, major depressive disorder, and pervasive developmental disorders, among others.",A Randomized PlaceboControlled Trial of the Discontinuation of LongTerm Antipsychotics in Dementia,https://doi.org/10.1017/s1041610202008396,12243210
True," The study focuses on pharmacogenomics in schizophrenia, which aligns with the inclusion criteria of the review.",Pharmacogenomics in schizophrenia the quest for individualized therapy,https://doi.org/10.1093/hmg/11.20.2517,12351588
True," The study meets the inclusion criteria as it involves adults with schizophrenia, a relevant population for the review, and examines the effectiveness of a specific intervention (olanzapine with fluvoxamine augmentation) in this population.",Fluvoxamine Augmentation of Olanzapine in Chronic Schizophrenia Pharmacokinetic Interactions and Clinical Effects,https://doi.org/10.1097/00004714-200210000-00010,12352274
False," The study population specified in the abstract does not match the inclusion criteria, as it only mentions autistic disorder, but the inclusion criteria include a broader range of pervasive developmental disorders, including Asperger's disorder, pervasive developmental disorder not otherwise specified, and atypical autism.",Re Clomipramine vs Haloperidol in the Treatment of Autistic Disorder A Doubleblind Placebo Crossover Study,https://doi.org/10.1097/00004714-200210000-00015,12352279
False," The title and abstract do not provide enough information to determine the population, intervention, or outcomes of the study, making it difficult to assess whether the study meets the inclusion criteria.",Effects of Olanzapine Plasma Concentrations on Depressive Symptoms in Schizophrenia A Pilot Study,https://doi.org/10.1097/00004714-200210000-00019,12352282
True," The study population (individuals with schizophrenia and cocaine dependence) and the intervention (risperidone) meet the inclusion criteria, and the study design (open-label pilot study) is not explicitly excluded.",Risperidone Decreases Craving and Relapses in Individuals with Schizophrenia and Cocaine Dependence,https://doi.org/10.1177/070674370204700710,12355680
False," The study population does not match the inclusion criteria as it only includes patients with Parkinson's disease, whereas the review includes patients with schizophrenia, bipolar disorder, major depressive disorder, and other conditions.",Olanzapine treatment for dopaminergicinduced hallucinations,https://doi.org/10.1002/mds.10217,12360554
True," The study meets the inclusion criteria as it involves adults with schizophrenia and schizoaffective disorder, which are included populations, and examines the efficacy and safety of aripiprazole, which is an intervention of interest.",Efficacy and Safety of Aripiprazole and Haloperidol Versus Placebo in Patients With Schizophrenia and Schizoaffective Disorder,https://doi.org/10.4088/jcp.v63n0903,12363115
True," The study meets the inclusion criteria as it is a randomized controlled trial examining the effectiveness of interventions for individuals at risk of progression to first-episode psychosis, which is a relevant population for this review.",Randomized Controlled Trial of Interventions Designed to Reduce the Risk of Progression to FirstEpisode Psychosis in a Clinical Sample With Subthreshold Symptoms,https://doi.org/10.1001/archpsyc.59.10.921,12365879
True," The study meets the inclusion criteria as it reviews the efficacy and risks of combining antipsychotics in patients with schizophrenia and other psychotic disorders, and suggests a rationale and strategies for future clinical trials.",Antipsychotic combination therapy in schizophrenia A review of efficacy and risks of current combinations,https://doi.org/10.1034/j.1600-0447.2002.01331.x,12366465
False," The abstract does not mention any specific interventions (medications) that are included in the review, and it does not specify the patient populations that are being targeted, which do not match the inclusion criteria.",Maintenance therapy in schizophrenia a critical comment,https://doi.org/10.1017/s1461145702002961,12366880
False," The study does not focus on the therapeutic characteristics of new drugs, but rather on the publication of randomized controlled trials on the safety or efficacy of new drugs.",New drugs with novel therapeutic characteristics Have they been subject to randomized controlled trials,nan,12371307
False," The article does not discuss the effectiveness or harms of antipsychotic medications in the specified patient populations, but rather focuses on the risk of ventricular arrhythmia and sudden death associated with neuroleptics.",Severe ventricular arrhythmia and sudden death on neuroleptics,nan,12378746
False," The study does not meet the inclusion criteria as it does not focus on the effectiveness or harms of atypical antipsychotic agents in the specified patient populations, but rather examines trends in their use in a specific population.",How much are atypical antipsychotic agents being used and do they reach the populations who need them A Canadian experience,https://doi.org/10.1016/s0149-2918(02)80050-9,12380638
True," The study population includes adults and adolescents with schizophrenia, schizoaffective disorder, and bipolar disorder, which aligns with the inclusion criteria.",Aripiprazole,https://doi.org/10.2165/00023210-200216110-00008,12383035
True," The article meets the inclusion criteria as it discusses pharmacological treatment of schizophrenia, includes relevant pharmacological therapeutic targets, and outlines the pharmacological and clinical profiles of newer generation antipsychotics, which are all relevant to the topic of the review.",Developments in the pharmacological treatment of schizophrenia,https://doi.org/10.1517/13543784.11.10.1335,12387698
False," The abstract does not mention any of the specified psychiatric conditions or disorders, and the study appears to focus on sleep disorders in Parkinson's disease, which is outside the scope of the review.",Sleep Disorders in Parkinsons Disease,https://doi.org/10.2165/00002512-200219100-00002,12390050
True," The study meets the inclusion criteria as it involves drug-naive first-episode schizophrenic patients, examines the effects of antipsychotic treatment on prepulse inhibition of the startle response, and is a longitudinal clinical study.",Effects of antipsychotics on prepulse inhibition of the startle response in drugnave schizophrenic patients,https://doi.org/10.1016/s0006-3223(02)01409-9,12399139
False," The article does not provide an abstract, making it difficult to assess the relevance and quality of the study.",Re Chan et al A doubleblind randomised comparison of risperidone and haloperidol in the treatment of behavioural and psychological symptoms in Chinese dementia patients Int J Geriatr Psychiatry,https://doi.org/10.1002/gps.722,12404659
True," The study meets the inclusion criteria as it involves patients with first-episode schizophrenia, a randomized controlled trial is not explicitly mentioned but the study is a comparative observational study which is included in the criteria.",Depressive symptoms at baseline predict fewer negative symptoms at followup in patients with firstepisode schizophrenia,https://doi.org/10.1016/s0920-9964(01)00375-9,12409165
True," The study meets the inclusion criteria as it involves a randomized controlled trial of antipsychotic treatment in schizophrenia patients with minimal previous medication exposure, examining neurochemical changes using magnetic resonance spectroscopy.",Longitudinal followup of neurochemical changes during the first year of antipsychotic treatment in schizophrenia patients with minimal previous medication exposure,https://doi.org/10.1016/s0920-9964(02)00210-4,12409172
True," The study meets the inclusion criteria as it involves patients with schizophrenia, a relevant population for the review, and examines the effectiveness of different antipsychotics on Theory of Mind (ToM) performance.",Normalization of brain activation in schizophrenia An fMRI study,https://doi.org/10.1016/s0920-9964(01)00369-3,12409175
False," The study population does not match the inclusion criteria as it specifically targets patients with Huntington's disease, whereas the review focuses on patients with schizophrenia, bipolar disorder, major depressive disorder, behavioral and psychological symptoms of dementia, pervasive developmental disorders, and disruptive behavior disorders.",Olanzapine for Huntingtons Disease An Open Label Study,https://doi.org/10.1097/00002826-200209000-00007,12410058
False," The study population does not match the inclusion criteria as it specifically focuses on individuals with mental disorders who are considered a high risk of harm to others and are in high-security special hospitals, whereas the inclusion criteria specify a broad range of mental disorders and age groups.",Mental disorder and perceived threat to the public people who do not return to community living,https://doi.org/10.1192/bjp.181.5.399,12411265
True," The study meets the inclusion criteria as it involves adults with schizophrenia, a randomized controlled trial, and examines the effectiveness of an antipsychotic medication (melperone) on cognitive function.",The effect of melperone an atypical antipsychotic drug on cognitive function in schizophrenia,https://doi.org/10.1016/s0920-9964(01)00329-2,12413636
True," The study meets the inclusion criteria as it involves patients with schizophrenia, a condition included in the review, and examines the effectiveness of an intervention (donepezil) on cognitive function, which is a relevant outcome for the review.",An openlabeled trial of adjunctive donepezil for cognitive impairments in patients with schizophrenia,https://doi.org/10.1016/s0920-9964(01)00387-5,12413639
True," The study population includes adults with schizophrenia, which matches the inclusion criteria.",Amoxapine shows atypical antipsychotic effects in patients with schizophrenia results from a prospective openlabel study,https://doi.org/10.1016/s0920-9964(01)00342-5,12413640
False," The study population does not match the inclusion criteria as it only includes adults and adolescents with schizophrenia or schizoaffective disorder, whereas the review includes a broader range of psychiatric conditions.",Serum glucose and lipid changes during the course of clozapine treatment the effect of concurrent adrenergic antagonist treatment,https://doi.org/10.1016/s0920-9964(02)00158-5,12413642
False," The study is not focused on the specified population (adults and adolescents with schizophrenia, bipolar disorder, major depressive disorder, etc.) or interventions (antipsychotic drugs), but rather on the effects of antipsychotic drugs on the vascular system.",A pilot crossover design study on QTc interval prolongation associated with sulpiride and haloperidol,https://doi.org/10.1016/s0920-9964(01)00336-x,12413648
True," The study meets the inclusion criteria as it involves a randomized controlled trial of computer-assisted cognitive rehabilitation in adults with schizophrenia or schizoaffective disorder, which is a relevant population for this review.",Computerassisted cognitive rehabilitation reduces negative symptoms in the severely mentally ill,https://doi.org/10.1016/s0920-9964(01)00402-9,12414079
False," The study population specified in the abstract (first episode patients with schizophrenia) does not match the inclusion criteria, which includes a broader range of patient populations such as bipolar disorder, major depressive disorder, and pervasive developmental disorders.",Crossnational cognitive assessment in schizophrenia clinical trials a feasibility study,https://doi.org/10.1016/s0920-9964(02)00153-6,12414081
True," The study meets the inclusion criteria as it examines the effects of novel antipsychotics on glucose and lipid levels in patients with schizophrenia and other psychotic disorders, which is a relevant population for this review.",The Effects of Novel Antipsychotics on Glucose and Lipid Levels,https://doi.org/10.4088/jcp.v63n1002,12416594
True," The study meets the inclusion criteria as it involves first-episode acutely psychotic patients with schizophrenia, schizoaffective disorder, or schizophreniform disorder, and examines the effectiveness of risperidone in reducing symptoms and fine motor functions.",Risperidone mgday vs mgday in FirstEpisode Acutely Psychotic Patients,https://doi.org/10.4088/jcp.v63n1006,12416598
True," The study meets the inclusion criteria as it examines the effects of antipsychotics on type 2 diabetes in adults with psychosis, which is a relevant population for this review.",Differential Effects of Risperidone Olanzapine Clozapine and Conventional Antipsychotics on Type Diabetes,https://doi.org/10.4088/jcp.v63n1010,12416602
True, The study meets the inclusion criteria as it involves adults with schizophrenia who have failed treatment with atypical antipsychotics and are being treated with olanzapine.,Olanzapine in Refractory Schizophrenia After Failure of Typical or Atypical Antipsychotic Treatment,https://doi.org/10.4088/jcp.v63n1011,12416603
True," The study meets the inclusion criteria as it involves adults and adolescents with schizophrenia, a relevant population for this review, and examines the effectiveness of antipsychotic medications, specifically olanzapine and risperidone, which are included in the review.",An Assessment of the Independent Effects of Olanzapine and Risperidone Exposure on the Risk of Hyperlipidemia in Schizophrenic Patients,https://doi.org/10.1001/archpsyc.59.11.1021,12418935
True," The study meets the inclusion criteria as it is a cohort study examining the rates of cardiac arrest and ventricular arrhythmia in patients with schizophrenia treated with antipsychotic drugs, which is a relevant topic for the review.",Cardiac arrest and ventricular arrhythmia in patients taking antipsychotic drugs cohort study using administrative data,https://doi.org/10.1136/bmj.325.7372.1070,12424166
True," The study meets the inclusion criteria as it involves patients with schizophrenia, a relevant population for this review, and examines the effects of classical and atypical neuroleptics on bone mineral density, a relevant outcome.",CLASSICAL AND ATYPICAL NEUROLEPTICS AND BONE MINERAL DENSITY IN PATIENTS WITH SCHIZOPHRENIA,https://doi.org/10.1080/00207450290025833,12424822
False," The abstract does not match the inclusion criteria as it discusses the use of antiepileptic drugs in dermatology, not the treatment of schizophrenia, bipolar disorder, or other specified conditions.",Psychotropic and neurotropic agents in dermatology unapproved uses dosages or indications,https://doi.org/10.1016/s0738-081x(02)00267-5,12435529
True," The study meets the inclusion criteria as it involves a randomized controlled trial comparing the effectiveness of risperidone and haloperidol in patients with treatment-refractory schizophrenia, which is a relevant population for this review.",Impact of risperidone versus haloperidol on activities of daily living in the treatment of refractory schizophrenia,https://doi.org/10.1053/comp.2002.33499,12439835
True," The study meets the inclusion criteria as it involves adults with a DSM-IV diagnosis of schizophrenia, a first episode of schizophrenia, and examines the effectiveness of quetiapine, which is an intervention included in the review.",Quetiapine An Effective Antipsychotic in FirstEpisode Schizophrenia Despite Only Transiently High Dopamine Receptor Blockade,https://doi.org/10.4088/jcp.v63n1106,12444812
True," The study meets the inclusion criteria as it involves adults and adolescents with Tourette's disorder, a condition included in the review, and examines the effectiveness of risperidone, an intervention included in the review.",Depression and Dysphoria in Adult and Adolescent Patients With Tourettes Disorder Treated With Risperidone,https://doi.org/10.4088/jcp.v63n1115,12444819
True," The study meets the inclusion criteria as it involves a head-to-head comparison of two antipsychotic medications (olanzapine and haloperidol) in elderly patients with chronic schizophrenia, which is a relevant population for this review.",Olanzapine vs haloperidol in the treatment of elderly chronic schizophrenia patients,https://doi.org/10.1016/s0278-5846(01)00322-0,12452546
True, The study meets the inclusion criteria as it examines the association between atypical antipsychotics and glucose intolerance in adults and adolescents with various psychiatric disorders.,Glucose Intolerance with Atypical Antipsychotics,https://doi.org/10.2165/00002018-200225150-00005,12452735
True," The study meets the inclusion criteria as it involves adults with a DSM-III-R diagnosis of schizophrenia, which is one of the specified conditions for inclusion.",DoseRelated Effects of Amisulpride on Five Dimensions of Psychopathology in Patients With Acute Exacerbation of Schizophrenia,https://doi.org/10.1097/00004714-200212000-00004,12454554
True," The study population includes individuals with schizophrenia, which meets the inclusion criteria.",Is Theory of Mind in Schizophrenia More Strongly Associated with Clinical and Social Functioning than with Neurocognitive Deficits,https://doi.org/10.1159/000067062,12457019
True," The study meets all the inclusion criteria as it involves adults with schizophrenia, a relevant population for this review, and examines the effectiveness and cost-effectiveness of quetiapine compared to haloperidol, a relevant intervention for this review.",An economic assessment of quetiapine and haloperidol in patients with schizophrenia only partially responsive to conventional antipsychotics,https://doi.org/10.1016/s0149-2918(02)80069-8,12462294
False," The study population does not match the inclusion criteria as it only includes healthy elderly subjects, whereas the review focuses on patients with various psychiatric disorders.",Pharmacokinetic and Safety Assessments of Galantamine and Risperidone after the Two Drugs Are Administered Alone and Together,https://doi.org/10.1177/0091270002042012005,12463729
True, The study meets the inclusion criteria as it is a head-to-head randomized controlled trial comparing the efficacy and safety of amisulpride and risperidone in patients with chronic schizophrenia.,Amisulpride vs Risperidone in Chronic Schizophrenia Results of a month Doubleblind Study,https://doi.org/10.1016/s0893-133x(02)00375-5,12464464
False," The study population does not match the inclusion criteria as it specifically focuses on patients with Parkinson's disease and related conditions, whereas the inclusion criteria specify a range of psychiatric disorders.",Sublingual Atropine for sialorrhea secondary to parkinsonism A pilot study,https://doi.org/10.1002/mds.10276,12465075
False," The study population does not match the specified inclusion criteria as it only includes subjects treated with antipsychotics, whereas the review includes a broader range of patient populations and interventions.",Metric characteristics of the druginduced extrapyramidal symptoms scale DIEPSS A practical combined rating scale for druginduced movement disorders,https://doi.org/10.1002/mds.10255,12465082
True," The study meets the inclusion criteria as it examines the cognitive functioning of individuals with first episode schizophrenia spectrum disorders following comprehensive treatment, which is a relevant population for this review.",Changes in cognitive functioning following comprehensive treatment for first episode patients with schizophrenia spectrum disorders,https://doi.org/10.1016/s0165-1781(02)00236-6,12467947
False," The study population does not match the inclusion criteria as it only includes patients with essential tremor, which is not listed in the inclusion criteria.",Quetiapine and Essential Tremor,https://doi.org/10.1097/00002826-200211000-00004,12469002
False," The study population does not match the inclusion criteria as it specifically focuses on patients with Alzheimer's disease, which is not mentioned in the inclusion criteria.",Donepezil for the Treatment of Behavioral Symptoms in Patients With Alzheimers Disease,https://doi.org/10.1097/00002826-200211000-00007,12469005
True," The study focuses on aripiprazole, which is one of the interventions included in the review.",Aripiprazole profile on efficacy and safety,https://doi.org/10.1517/14656566.3.12.1773,12472374
False," The study population does not match the inclusion criteria as it includes patients with major depression, bipolar disorder, and schizophrenia, but does not specify the age range for these populations, and does not include children under 13 years.",The plasma levels of interleukin in schizophrenia major depression and bipolar mania effects of psychotropic drugs,https://doi.org/10.1038/sj.mp.4001084,12476326
True," The study population (women with bipolar I or II disorder) and the intervention (gabapentin augmentation therapy) meet the inclusion criteria, and the study design (open-label pilot study) is not explicitly excluded.",Gabapentin augmentation therapy in bipolar depression,https://doi.org/10.1034/j.1399-5618.2002.01211.x,12479661
True," The study population includes adults with bipolar disorder, which is one of the specified populations of interest in the review.",Olanzapine in diverse syndromal and subsyndromal exacerbations of bipolar disorders,https://doi.org/10.1034/j.1399-5618.2002.01210.x,12479666
True," The study meets the inclusion criteria as it involves adults with bipolar disorder, specifically rapid cycling bipolar patients, and examines the effectiveness of quetiapine as an adjunctive treatment.",Quetiapine in the treatment of rapid cycling bipolar disorder,https://doi.org/10.1034/j.1399-5618.2002.01204.x,12479667
True, The study meets the inclusion criteria as it involves a randomized controlled trial examining the effectiveness of risperidone in treating psychotic symptoms associated with chronic posttraumatic stress disorder (PTSD).,Adjunctive risperidone treatment in posttraumatic stress disorder a preliminary controlled trial of effects on comorbid psychotic symptoms,https://doi.org/10.1097/00004850-200301000-00001,12490768
False," The study population does not match the inclusion criteria as it only includes adults and adolescents with schizophrenia, whereas the review includes a broader range of patient populations such as bipolar disorder, major depressive disorder, and pervasive developmental disorders.",Extrapyramidal symptom profiles assessed with the DrugInduced Extrapyramidal Symptom Scale comparison with Western scales in the clinical doubleblind studies of schizophrenic patients treated with either olanzapine or haloperidol,https://doi.org/10.1097/00004850-200301000-00007,12490774
False," The study does not meet the inclusion criteria as it is a metaregression analysis of placebo response in schizophrenia trials, but it does not focus on the effectiveness or harms of specific antipsychotic medications, which is the scope of the review.",Moderators of placebo response to antipsychotic treatment in patients with schizophrenia a metaregression,https://doi.org/10.1007/s00213-002-1299-4,12494247
True," The study meets the inclusion criteria as it involves adults with schizophrenia, a randomized controlled trial, and examines the effectiveness of a medication combination (divalproex with olanzapine or risperidone) in improving symptoms.",Effect of divalproex combined with olanzapine or risperidone in patients with an acute exacerbation of schizophrenia,10.1038/sj.npp.1300023,12496955
False," The study population does not match the inclusion criteria as it only includes healthy male volunteers, whereas the review is focused on patients with various psychiatric disorders.",The potential cardiotoxicity of antipsychotic drugs as assessed by heart rate variability,https://doi.org/10.1177/026988110201600410,12503835
False," The study population does not match the inclusion criteria as it only includes adults with social anxiety disorder, whereas the review includes a broader range of psychiatric conditions.",Efficacy of olanzapine in social anxiety disorder a pilot study,https://doi.org/10.1177/026988110201600412,12503837
True," The study meets the inclusion criteria as it focuses on the efficacy of newer generation antipsychotics in the treatment of schizophrenia, which is one of the specified conditions.",Efficacy of newer generation antipsychotics in the treatment of schizophrenia,https://doi.org/10.1016/s0306-4530(02)00110-5,12504069
True, The study meets the inclusion criteria as it involves a randomized controlled trial comparing the effects of quetiapine and haloperidol on serum prolactin levels in patients with schizophrenia.,Quetiapine Is Not Associated with Increase in Prolactin Secretion in Contrast to Haloperidol,https://doi.org/10.1016/s0188-4409(02)00403-4,12505103
True," The study meets the inclusion criteria as it focuses on the treatment of schizophrenia in adults and adolescents, and it examines the cost-effectiveness of atypical antipsychotics compared to conventional neuroleptics in Mexico.",A CostEffectiveness Clinical Decision Analysis Model for Treatment of Schizophrenia,https://doi.org/10.1016/s0188-4409(02)00409-5,12505105
False," The study population does not match the inclusion criteria as it only includes adults and adolescents with bipolar disorder, whereas the review includes a broader range of populations such as schizophrenia, major depressive disorder, and pervasive developmental disorders.",Placebocontrolled trials do not find association of olanzapine with exacerbation of bipolar mania,https://doi.org/10.1016/s0165-0327(02)00335-x,12507747
True," The study meets the inclusion criteria as it involves adults with bipolar disorder, specifically bipolar I disorder with a history of rapid cycling, and examines the effectiveness of olanzapine, which is an intervention included in the review.",Olanzapine in the acute treatment of bipolar I disorder with a history of rapid cycling,https://doi.org/10.1016/s0165-0327(02)00334-8,12507748
False," The study population specified in the abstract does not match the inclusion criteria, as it focuses on bipolar disorder, whereas the inclusion criteria include a wide range of psychiatric disorders such as schizophrenia, major depressive disorder, and pervasive developmental disorders.",Redefining mood stabilization,https://doi.org/10.1016/s0165-0327(01)00355-x,12507749
True," The study focuses on schizophrenia, which is one of the included conditions, and uses molecular imaging techniques, which is also relevant to the review.",Neuroreceptor imaging in psychiatric disorders,https://doi.org/10.1007/bf02988639,12508833
True," The study meets the inclusion criteria as it involves adults and adolescents with schizophrenia or schizoaffective disorder, a diagnosis relevant to the review, and examines the effectiveness of clozapine in preventing suicidal behavior.",Clozapine Treatment for Suicidality in SchizophreniasubtitleInternational Suicide Prevention Trial InterSePTsubtitle,https://doi.org/10.1001/archpsyc.60.1.82,12511175
False," The study does not meet the inclusion criteria as it does not focus on the effectiveness or harms of the specified antipsychotic medications in the specified patient populations, but rather on the routine use of second-generation antipsychotics in the Italian psychiatric care system.",Prescribing SecondGeneration Antipsychotics and the Evolving Standard of Care in Italy,https://doi.org/10.1055/s-2002-36394,12518273
True," The study population includes adults with bipolar disorder and cocaine dependence, which matches the inclusion criteria for bipolar disorder.",Quetiapine in bipolar disorder and cocaine dependence,https://doi.org/10.1034/j.1399-5618.2002.02229.x,12519101
True," The study population (patients with schizophrenia, bipolar disorder, and other psychotic disorders) and interventions (olanzapine and risperidone) align with the inclusion criteria.",The Risk of Diabetes During Olanzapine Use Compared With Risperidone Use,https://doi.org/10.4088/jcp.v63n1208,12523873
False," The study population does not match the inclusion criteria as it only includes adults and adolescents with bipolar disorder type I, whereas the review includes a broader range of patient populations.",A Comparison of the Efficacy Safety and Tolerability of Divalproex Sodium and Olanzapine in the Treatment of Bipolar Disorder,https://doi.org/10.4088/jcp.v63n1210,12523875
True," The study meets the inclusion criteria as it involves adults and adolescents with a DSM-IV diagnosis of psychosis, including schizophrenia, schizoaffective disorder, and bipolar disorder, and examines the efficacy of quetiapine and risperidone in treating depressive symptoms.",Efficacy of Quetiapine and Risperidone Against Depressive Symptoms in Outpatients With Psychosis,https://doi.org/10.4088/jcp.v63n1211,12523876
False," The study population does not match the inclusion criteria as it only includes adults and adolescents with major depressive disorder with psychotic features, whereas the review includes a broader range of populations such as schizophrenia, bipolar disorder, and behavioral and psychological symptoms of dementia.",An Open Study of Olanzapine and Fluoxetine for Psychotic Major Depressive Disorder,https://doi.org/10.4088/jcp.v63n1212,12523877
True," The study meets the inclusion criteria as it involves a randomized controlled trial of risperidone, an intervention included in the review, in patients with schizophrenia, a condition included in the review.",Risperidone in the Treatment of Hispanic Inpatients with Schizophrenia A Pilot Study,https://doi.org/10.1521/psyc.65.4.371.20237,12530340
False," The study does not meet the inclusion criteria as it is a letter to the editor and not a full article, and it does not provide any information on the effectiveness or harms of olanzapine treatment for patients with schizophrenia and cocaine abuse.",Olanzapine Treatment for Patients With Schizophrenia and Cocaine Abuse,https://doi.org/10.4088/jcp.v63n1214c,12530415
True," The article meets the inclusion criteria as it discusses the clinical symptoms and treatment approach of schizoaffective disorder, which falls within the specified diagnostic categories.",Schizoaffective disorder clinical symptoms and presentday approach to treatment,nan,12532717
False," The abstract does not mention any of the specified disorders or populations (schizophrenia, bipolar disorder, major depressive disorder, behavioral and psychological symptoms of dementia, pervasive developmental disorders, disruptive behavior disorders) that are the focus of the review.",Cognition enhancing or neuroprotective compounds for the treatment of cognitive disorders why when which,https://doi.org/10.1016/s0531-5565(02)00163-8,12543269
False," The study population is limited to combat veterans with posttraumatic stress disorder (PTSD), which does not match the inclusion criteria of the review, which includes a wide range of psychiatric disorders such as schizophrenia, bipolar disorder, major depressive disorder, and others.",Quetiapine Treatment in Patients with Posttraumatic Stress Disorder An Open Trial of Adjunctive Therapy,https://doi.org/10.1097/00004714-200302000-00003,12544370
False," The study population does not match the inclusion criteria as it only includes adults and adolescents with inadequate response to selective serotonin reuptake inhibitors (SSRIs) for major depression, which is a specific subset of the broader inclusion criteria.",A Prospective Trial of Bupropion SR Augmentation of Partial and NonResponders to Serotonergic Antidepressants,https://doi.org/10.1097/00004714-200302000-00005,12544372
True," The study meets the inclusion criteria as it focuses on the pharmacokinetics of clozapine in children and adolescents with childhood-onset schizophrenia, which is a relevant population for this review.",Clozapine Pharmacokinetics in Children and Adolescents with ChildhoodOnset Schizophrenia,https://doi.org/10.1097/00004714-200302000-00012,12544379
True," The study meets the inclusion criteria as it involves adults and adolescents with schizophrenia, and examines the effectiveness of clozapine, a medication included in the review.",D receptor alleles predict PET metabolic correlates of clinical response to clozapine,https://doi.org/10.1038/sj.mp.4001191,12556915
True," The study meets the inclusion criteria as it involves first-episode drug-naive patients with schizophrenia, a relevant population for this review.",Impaired Fasting Glucose Tolerance in FirstEpisode DrugNaive Patients With Schizophrenia,https://doi.org/10.1176/appi.ajp.160.2.284,12562574
True," The study meets the inclusion criteria as it involves adults with schizophrenia treated with atypical antipsychotics, which is one of the interventions included in the review.",Changes in Glucose and Cholesterol Levels in Patients With Schizophrenia Treated With Typical or Atypical Antipsychotics,https://doi.org/10.1176/appi.ajp.160.2.290,12562575
True," The study meets the inclusion criteria as it involves a randomized controlled trial examining the effectiveness of a medication (reboxetine) in combination with olanzapine for patients with schizophrenia, which is a condition included in the review.",Attenuation of OlanzapineInduced Weight Gain With Reboxetine in Patients With Schizophrenia A DoubleBlind PlaceboControlled Study,https://doi.org/10.1176/appi.ajp.160.2.297,12562576
True," The study meets the inclusion criteria as it involves a randomized double-blind study of adults with recent-onset schizophrenia treated with low-dose olanzapine or haloperidol, and examines the relationship between dopamine receptor occupancy and subjective experience.",Subjective Experience and DReceptor Occupancy in Patients With RecentOnset Schizophrenia Treated With LowDose Olanzapine or Haloperidol A Randomized DoubleBlind Study,https://doi.org/10.1176/appi.ajp.160.2.303,12562577
False," The study population does not match the inclusion criteria as it only includes adults and adolescents with acute mania, whereas the review includes a broader range of patient populations.",Mood stabilisers plus risperidone or placebo in the treatment of acute mania,https://doi.org/10.1192/bjp.182.2.141,12562742
False," The article does not meet the inclusion criteria as it is about movement disorders in children, not the specified psychiatric conditions or populations.",Movement Disorders in Children,https://doi.org/10.1542/pir.24-2-39,12563038
False," The abstract does not mention any of the specified patient populations (schizophrenia, bipolar disorder, major depressive disorder, behavioral and psychological symptoms of dementia, pervasive developmental disorders, or disruptive behavior disorders) or the specified interventions (aripiprazole, asenapine, clozapine, iloperidone, olanzapine, paliperidone, quetiapine, risperidone, and ziprasidone).",Therapeutic advances in,nan,12564104
True," The study population includes adults with Parkinson's disease and psychosis, which is a relevant condition for the review, and the intervention is clozapine, which is one of the included interventions.",Clozapine in Parkinsons Disease Psychosis Year Followup Review,https://doi.org/10.1097/00002826-200301000-00003,12567158
False," The study population does not match the inclusion criteria as it specifically focuses on psychotic unipolar and bipolar depression, whereas the inclusion criteria include a broader range of disorders such as schizophrenia, pervasive developmental disorders, and disruptive behavior disorders.",Nefazodone in Psychotic Unipolar and Bipolar Depression A Retrospective Chart Analysis and Open Prospective Study on Its Efficacy and Safety versus Combined Treatment with Amitriptyline and Haloperidol,https://doi.org/10.1159/000068017,12571431
False," The study does not meet the inclusion criteria as it is an observational study and does not provide direct head-to-head evidence, placebo-controlled or active-control trials.",The European Schizophrenia Outpatient Health Outcomes SOHO study rationale methods and recruitment,https://doi.org/10.1034/j.1600-0447.2003.00064.x,12580830
False," The abstract does not mention any specific interventions (e.g. aripiprazole, asenapine, clozapine, etc.) or outcomes (e.g. mortality, quality of life, etc.) that are included in the review.",Early intervention in schizophrenia a critique,https://doi.org/10.1017/s1121189x00005819,12585015
False," The study does not focus on a specific population (schizophrenia) but rather reviews the effects of atypical antipsychotics on prolactin levels in general, without specifying the population of interest.",The effects of atypical antipsychotics on serum prolactin levels,https://doi.org/10.1023/a:1021138603935,12585566
True," The study meets the inclusion criteria as it is a review of aripiprazole, an atypical antipsychotic, and its pharmacology and clinical use, which is relevant to the review's focus on interventions for various psychiatric disorders.",ARIPIPRAZOLE A REVIEW OF ITS PHARMACOLOGY AND CLINICAL USE,nan,12587943
False," The study population specified in the abstract does not match the inclusion criteria, as it includes adults and adolescents with bipolar disorder, but does not specify the age range of 18 years and older for adults, and does not include children under 13 years.",New treatment for bipolar disorder in children and adolescents learning from adult studies,nan,12590372
False, The abstract does not mention any of the specified patient populations or interventions included in the review.,Combination Therapy Is Clinical Practice Leading the Way,https://doi.org/10.4088/jcp.v64n0117a,12590630
True," The study meets the inclusion criteria as it focuses on the efficacy of cognitive-behavioural psychotherapy (CBT) in treating positive symptoms of schizophrenia, which is a relevant topic for the review.",Psychotherapie produktiver Symptomatik bei Patienten mit schizophrener Psychose,https://doi.org/10.1007/s00115-002-1330-3,12596031
True," The study meets the inclusion criteria as it involves adults with a DSM-IV diagnosis of schizophrenia, a first episode of schizophrenia, and examines the effectiveness of risperidone, which is an intervention included in the review.",Plasma levels of homovanillic acid and the response to risperidone in first episode untreated acute schizophrenia,https://doi.org/10.1097/00004850-200303000-00008,12598823
False," The abstract does not mention any specific interventions or patient populations that match the inclusion criteria, and it appears to be a general overview of intramuscular preparations of antipsychotics rather than a review of specific interventions for the specified patient populations.",Intramuscular Preparations of Antipsychotics,https://doi.org/10.2165/00003495-200363050-00004,12600227
True," The study meets the inclusion criteria as it involves a meta-analysis of case-control studies examining the association between the DRD SerGly variant and schizophrenia, and it includes a Swedish case-control study.",Dopamine D receptor gene SerGly variant and schizophrenia association study and metaanalysis,https://doi.org/10.1097/00041444-200303000-00001,12605094
True," The study meets the inclusion criteria as it involves a randomized controlled trial comparing the effectiveness of flupenthixol and risperidone in patients with schizophrenia, and assesses subjective quality of life and attitude towards medication as outcomes of interest.",Flupenthixol versus Risperidone Subjective Quality of Life as an Important Factor for Compliance in Chronic Schizophrenic Patients,https://doi.org/10.1159/000068874,12606844
True," The study meets the inclusion criteria as it focuses on the use of atypical antipsychotics in the treatment of bipolar disorder, which is one of the specified conditions.",Atypical antipsychotics and mood stabilization in bipolar disorder,https://doi.org/10.1007/s00213-002-1322-9,12607072
True," The study meets all the inclusion criteria as it involves a randomized controlled trial of aripiprazole in patients with schizophrenia, which is one of the interventions included in the review.",Switching patients to aripiprazole from other antipsychotic agents a multicenter randomized study,https://doi.org/10.1007/s00213-002-1344-3,12610718
False," The study population does not match the inclusion criteria as it only includes healthy men, whereas the review focuses on patients with various psychiatric and neurological disorders.",Pharmacokinetic and Safety Assessments of Concurrent Administration of Risperidone and Donepezil,https://doi.org/10.1177/0091270002239827,12616671
True," The study meets the inclusion criteria as it involves a cohort of Korean schizophrenics, examines the association between CYPD genotype and tardive dyskinesia, and uses a CYP GeneChip oligonucleotide microarray and PCR assays to screen for CYPD alleles.",Association between CYPD genotype and tardive dyskinesia in Korean schizophrenics,https://doi.org/10.1038/sj.tpj.6500138,12629505
False," The study population does not match the inclusion criteria as it only includes patients with schizophrenia treated with olanzapine, whereas the review includes a broader range of patient populations and antipsychotic medications.",Treatment of Weight Gain with Fluoxetine in OlanzapineTreated Schizophrenic Outpatients,https://doi.org/10.1038/sj.npp.1300089,12629532
True," The study meets the inclusion criteria as it involves schizophrenic patients treated with clozapine, which is one of the interventions included in the review, and it examines the relationship between selenium concentrations and the pathogenesis of life-threatening cardiac side effects associated with clozapine.",Low blood selenium concentrations in schizophrenic patients on clozapine,https://doi.org/10.1046/j.1365-2125.2003.01773.x,12630982
True," The study meets the inclusion criteria as it involves adults with a DSM-IV diagnosis of schizophrenia, a randomized controlled trial, and examines effectiveness outcomes such as clinical improvement, adherence, and persistence.",Switching From Depot Antipsychotic Drugs to Olanzapine in Patients With Chronic Schizophrenia,https://doi.org/10.4088/jcp.v64n0203,12633119
True," The study meets the inclusion criteria as it is a randomized, double-blind, placebo-controlled trial examining the efficacy and safety of risperidone in the treatment of aggression, agitation, and psychosis in elderly patients with dementia, which is one of the patient populations of interest.",A Randomized PlaceboControlled Trial of Risperidone for the Treatment of Aggression Agitation and Psychosis of Dementia,https://doi.org/10.4088/jcp.v64n0205,12633121
False," The study does not meet the inclusion criteria as it does not involve any of the specified interventions (aripiprazole, asenapine, clozapine, iloperidone, olanzapine, paliperidone, quetiapine, risperidone, and ziprasidone) and does not examine the specified outcomes (mortality, quality of life, functional capacity, hospitalization, emergency department visits, efficacy, adherence, persistence, caregiver burden, etc.) in the specified patient populations.",Do atypical antipsychotics fail to exert cognitive sparing effects,https://doi.org/10.1097/00001756-200303030-00042,12634513
True," The study population includes adults and adolescents with schizophrenia, bipolar disorder, and other psychiatric conditions, which aligns with the inclusion criteria.",Shortacting parenteral antipsychotics drive choice for classical versus atypical agents,https://doi.org/10.1007/s00228-002-0545-3,12634982
False," The study population specified in the abstract (bipolar I manic patients) does not match the inclusion criteria for the review, which includes a broader range of patient populations such as schizophrenia, bipolar disorder, major depressive disorder, and pervasive developmental disorders.",Acute Dysphoric Mania Treatment Response to Olanzapine Versus Placebo,https://doi.org/10.1097/00004714-200304000-00005,12640214
True, The study meets the inclusion criteria as it involves a randomized controlled trial examining the effectiveness of a medication (risperidone) in treating a specific population (combat veterans with PTSD) and reports on relevant outcomes (reductions in aggression and PTSD-related symptoms).,LowDose Risperidone as Adjunctive Therapy for Irritable Aggression in Posttraumatic Stress Disorder,https://doi.org/10.1097/00004714-200304000-00012,12640221
False," The study population does not match the inclusion criteria as it specifically focuses on patients with Parkinson's disease, which is not mentioned in the inclusion criteria.",Accin de quetiapina en dosis bajas sobre las manifestaciones psicticas incapacidad motora y estrs del cuidador en pacientes con enfermedad de Parkinson,https://doi.org/10.33588/rn.3605.2002454,12640589
False," The study population specified in the abstract (patients at risk of being prodromally symptomatic for psychosis) does not match the inclusion criteria (adults with schizophrenia, bipolar disorder, major depressive disorder, and other specified conditions).",The PRIME North America randomized doubleblind clinical trial of olanzapine versus placebo in patients at risk of being prodromally symptomatic for psychosis,https://doi.org/10.1016/s0920-9964(02)00439-5,12648731
False," The study population does not match the inclusion criteria as it only includes patients at risk of being prodromally symptomatic for psychosis, whereas the inclusion criteria include patients with a DSM-III-R or DSM-IV diagnosis of schizophrenia, bipolar disorder, major depressive disorder, and other specified conditions.",The PRIME North America randomized doubleblind clinical trial of olanzapine versus placebo in patients at risk of being prodromally symptomatic for psychosis,https://doi.org/10.1016/s0920-9964(02)00440-1,12648732
False," The study population does not match the inclusion criteria as it only includes patients with recent-onset schizophrenia, schizophreniform disorder, and schizoaffective disorder, whereas the inclusion criteria include a broader range of psychiatric disorders.",The factor structure for the Positive and Negative Syndrome Scale PANSS in recentonset psychosis,https://doi.org/10.1016/s0920-9964(02)00302-x,12648735
False," The abstract does not mention any specific interventions (antipsychotics) that are included in the review, such as aripiprazole, asenapine, clozapine, iloperidone, olanzapine, paliperidone, quetiapine, risperidone, and ziprasidone.",What are the effects of antipsychotics on sexual dysfunctions and endocrine functioning,https://doi.org/10.1016/s0306-4530(02)00130-0,12650685
True," The study meets the inclusion criteria as it is a double-blind, placebo-controlled trial examining the efficacy of nizatidine in limiting weight gain in patients with schizophrenia and related disorders treated with olanzapine.",Nizatidine for prevention of weight gain with olanzapine a doubleblind placebocontrolled trial,https://doi.org/10.1016/s0924-977x(02)00127-x,12650950
True," The study meets the inclusion criteria as it is a double-blind, placebo-controlled study examining the effect of an intervention (mianserin) on cognitive functioning in patients with schizophrenia, which is a relevant population for this review.",Effect of the HT antagonist mianserin on cognitive dysfunction in chronic schizophrenia patients an addon doubleblind placebocontrolled study,https://doi.org/10.1016/s0924-977x(02)00155-4,12650957
False," The study population does not match the specified inclusion criteria as it only includes adults and adolescents with diabetes mellitus and antipsychotic treatment, whereas the review focuses on patients with schizophrenia, bipolar disorder, major depressive disorder, behavioral and psychological symptoms of dementia, pervasive developmental disorders, and disruptive behavior disorders.",A retrospective cohort study of diabetes mellitus and antipsychotic treatment in the United States,https://doi.org/10.1016/s0895-4356(02)00588-7,12654411
False," The study population specified in the abstract (patients with acute mania) does not match the inclusion criteria (bipolar disorder, major depressive disorder, schizophrenia, and other psychotic disorders, pervasive developmental disorders, disruptive behavior disorders, and behavioral and psychological symptoms of dementia).",Rates of response euthymia and remission in two placebocontrolled olanzapine trials for bipolar mania,https://doi.org/10.1034/j.1399-5618.2003.02237.x,12656931
True," The study meets the inclusion criteria as it involves patients with schizophrenia, a diagnosis covered by the review, and examines the effectiveness of atypical antipsychotics, which are included interventions.",Measurement of simple reaction time in antipsychotic treatment of patients with schizophrenia,https://doi.org/10.1007/bf03040274,12658913
True, The study meets the inclusion criteria as it compares the clinical trial response and dropout rates between olanzapine and risperidone in patients with schizophrenia.,Clinical Trial Response and Dropout Rates with Olanzapine versus Risperidone,https://doi.org/10.1345/aph.1c291,12659615
False," The study does not focus on a specific medication or treatment for schizophrenia, but rather an economic review of compliance with medication therapy in general.",An Economic Review of Compliance With Medication Therapy in the Treatment of Schizophrenia,https://doi.org/10.1176/appi.ps.54.4.508,12663838
False," The abstract does not mention any of the specified interventions (aripiprazole, asenapine, iloperidone, olanzapine, paliperidone, quetiapine, risperidone, and ziprasidone) or the specified patient populations (schizophrenia, bipolar disorder, major depressive disorder, behavioral and psychological symptoms of dementia, pervasive developmental disorders, and disruptive behavior disorders).",Clozapine,https://doi.org/10.2165/00023210-200317040-00004,12665398
True, The study meets the inclusion criteria as it is a randomized controlled trial evaluating the efficacy and tolerability of ziprasidone in the treatment of adult patients with acute bipolar mania.,Ziprasidone in the Treatment of Acute Bipolar Mania A ThreeWeek PlaceboControlled DoubleBlind Randomized Trial,https://doi.org/10.1176/appi.ajp.160.4.741,12668364
False," The study population does not match the inclusion criteria as it specifically focuses on patients with moderate to severe Alzheimer's disease, which is not one of the specified patient populations.",Efficacy of Donepezil on Behavioral Symptoms in Patients With Moderate to Severe Alzheimers Disease,https://doi.org/10.1017/s104161020200858x,12670060
True," The study meets the inclusion criteria as it involves adults with schizophrenia, a specific population of interest, and examines the effectiveness of olanzapine, an intervention included in the review.",HighDose Olanzapine for TreatmentRefractory Schizophrenia,https://doi.org/10.1097/00002826-200303000-00003,12671523
False," The study population does not match the inclusion criteria as it specifically targets patients with dementia of the Alzheimer's type, whereas the review includes a broader range of psychiatric conditions.",Donepezil as Addon Treatment of Psychotic Symptoms in Patients with Dementia of the Alzheimers Type,https://doi.org/10.1097/00002826-200303000-00008,12671528
True," The study meets the inclusion criteria as it is a double-blind, placebo-controlled study examining the effects of an antipsychotic medication (procyclidine) on prepulse inhibition in patients with schizophrenia.",Effects of acute procyclidine administration on prepulse inhibition of the startle response in schizophrenia a doubleblind placebocontrolled study,https://doi.org/10.1177/0269881103017001710,12680744
False," The study does not meet the inclusion criteria as it is a comparative cohort study of valproate poisoning, not a study on the effectiveness or harms of antipsychotic medications for the specified patient populations.",Valproate overdose a comparative cohort study of self poisonings,https://doi.org/10.1046/j.1365-2125.2003.01772.x,12680889
False," The abstract does not mention any of the specified patient populations (schizophrenia, bipolar disorder, major depressive disorder, behavioral and psychological symptoms of dementia, pervasive developmental disorders, or disruptive behavior disorders) or interventions (aripiprazole, asenapine, clozapine, iloperidone, olanzapine, paliperidone, quetiapone, risperidone, or ziprasidone) that are included in the review.",Assessment of treatment response in mania commentary and new findings,https://doi.org/10.1034/j.1399-5618.2003.00020.x,12680896
False," The study population specified in the abstract (adults with bipolar depression) does not match the inclusion criteria, which include a broader range of psychiatric conditions such as schizophrenia, major depressive disorder, and pervasive developmental disorders.",Bipolar depression criteria for treatment selection definition of refractoriness and treatment options,https://doi.org/10.1034/j.1399-5618.2003.00019.x,12680897
False," The study population does not match the inclusion criteria as it includes children and adults with Tourette syndrome, which is not one of the specified conditions.",A placebocontrolled trial of risperidone in Tourette syndrome,https://doi.org/10.1212/01.wnl.0000055434.39968.67,12682319
False," The abstract does not mention any of the specified patient populations or interventions, and does not discuss effectiveness or harms of any treatments.",The years new drugs,nan,12682669
True," The article discusses cognitive function in schizophrenia, which aligns with the topic of the review.",Cognitive function in schizophrenia,https://doi.org/10.1016/s0193-953x(02)00084-9,12683258
True," The study meets the inclusion criteria as it focuses on schizophrenia, a disorder included in the specified population, and explores the relationship between membrane phospholipid dysregulation and its therapeutic implications.",Is schizophrenia a metabolic brain disorder Membrane phospholipid dysregulation and its therapeutic implications,https://doi.org/10.1016/s0193-953x(02)00033-3,12683261
False," The abstract does not mention any specific medication from the list of included interventions (aripiprazole, asenapine, clozapine, iloperidone, olanzapine, paliperidone, quetiapine, risperidone, and ziprasidone) and does not discuss effectiveness outcomes relevant to the review (e.g., mortality, quality of life, functional capacity, etc.) in the context of late-life schizophrenia.",Schizophrenia in late life,https://doi.org/10.1016/s0193-953x(02)00031-x,12683262
True," The study meets the inclusion criteria as it focuses on the pharmacotherapy of schizophrenia, specifically comparing atypical antipsychotics with conventional antipsychotics, and includes effectiveness outcomes such as symptom response, hospitalization, and quality of life.",The new and evolving pharmacotherapy of schizophrenia,https://doi.org/10.1016/s0193-953x(02)00016-3,12683264
False," The article does not focus on the specified age groups (adults, adolescents, and children) with the mentioned psychiatric disorders, but rather discusses the side effects of second-generation antipsychotic medications in general.",Understanding the new and evolving profile of adverse drug effects in schizophrenia,https://doi.org/10.1016/s0193-953x(02)00035-7,12683265
False," The study population does not match the inclusion criteria as it only includes adults and adolescents with thought or mood disorders, whereas the inclusion criteria include a broader range of disorders such as schizophrenia, bipolar disorder, major depressive disorder, and pervasive developmental disorders.",Treatment of the psychotic patient who is violent,https://doi.org/10.1016/s0193-953x(02)00029-1,12683268
True, The study meets the inclusion criteria as it is a head-to-head randomized controlled trial comparing the efficacy and safety of amisulpride and risperidone in patients with schizophrenia.,Amisulpride versus risperidone in the treatment of schizophrenic patients a doubleblind pilot study in Taiwan,nan,12684609
True," The study meets the inclusion criteria as it involves a population with schizophrenia, a specific intervention (electroconvulsive therapy), and effectiveness outcomes such as symptom response and functional capacity.",Efficacy of electroconvulsive therapy in treatmentresistant schizophrenia a prospective open trial,https://doi.org/10.1016/s0278-5846(02)00354-8,12691772
True," The study meets the inclusion criteria as it involves a comparison of olanzapine with conventional antipsychotics in the treatment of first-episode schizophrenic inpatients, and it assesses both safety and effectiveness.",Safety and effectiveness of olanzapine versus conventional antipsychotics in the acute treatment of firstepisode schizophrenic inpatients,https://doi.org/10.1016/s0278-5846(03)00035-6,12691783
True," The study meets the inclusion criteria as it involves patients with schizophrenia, a relevant population for this review, and examines the effects of olanzapine, a medication included in the review.",The influence of olanzapine on immune cells in patients with schizophrenia,https://doi.org/10.1016/s0278-5846(03)00036-8,12691784
True," The study population includes adults with dementia with Lewy bodies, which is one of the included populations, and the intervention is quetiapine, which is also an included intervention.",Quetiapine treatment of psychotic symptoms and aggressive behavior in patients with dementia with Lewy bodies A case series,https://doi.org/10.1016/s0278-5846(03)00040-x,12691793
True," The study meets the inclusion criteria as it focuses on schizophrenia, a condition included in the review, and examines the risk of suicide in placebo-controlled trials, which is a relevant outcome for the review.",Suicide Risk in Placebo vs Active Treatment in PlaceboControlled Trials for Schizophrenia,https://doi.org/10.1001/archpsyc.60.4.365,12695313
False, The study does not examine the efficacy and tolerability of aripiprazole in the specified patient populations or outcomes of interest.,Aripiprazole Efficacy and tolerability profile of a novelacting atypical antipsychotic,https://doi.org/10.1358/dot.2003.39.2.799421,12698209
True, The study meets the inclusion criteria as it is a randomized controlled trial examining the effectiveness of clozapine versus chlorpromazine in treatment-naive patients with first-episode schizophrenia.,Atypical and Conventional Antipsychotic Drugs in TreatmentNaive FirstEpisode Schizophrenia A Week Randomized Trial of Clozapine Vs Chlorpromazine,https://doi.org/10.1038/sj.npp.1300157,12700715
False," The study population does not match the inclusion criteria as it only includes adults and adolescents with bipolar disorder, whereas the inclusion criteria specify a broader range of disorders, including schizophrenia, major depressive disorder, and pervasive developmental disorders.",The efficacy of olanzapine monotherapy for acute hypomania or mania in an outpatient setting,https://doi.org/10.1097/01.yic.0000062801.74434.25,12702892
True," The study meets the inclusion criteria as it is a randomized controlled trial examining the effectiveness of divalproex and olanzapine in the treatment of acute mania associated with bipolar disorder, which is a relevant population for this review.",Divalproex Sodium Versus Olanzapine in the Treatment of Acute Mania in Bipolar Disorder,https://doi.org/10.4088/jcp.v64n0310,12716270
True," The study population includes adults and adolescents with schizophrenia, which meets the inclusion criteria.",Patients on Atypical Antipsychotic Drugs,https://doi.org/10.2337/diacare.26.5.1597,12716824
True," The study meets the inclusion criteria as it involves adolescents (age 13-17 years) with a DSM-III-R or DSM-IV diagnosis of schizophrenia, and compares the efficacy and side effects of three antipsychotic medications (olanzapine, risperidone, and haloperidol).",Olanzapine risperidone and haloperidol in the treatment of adolescent patients with schizophrenia,https://doi.org/10.1007/s00702-002-0803-7,12721815
False," The abstract is not available, making it impossible to assess the relevance of the study to the review's criteria.",Lithium augmentation in treatmentrefractory unipolar depression,https://doi.org/10.1192/bjp.182.5.456,12724254
False," The abstract does not mention any specific pharmacological treatment for schizophrenia, instead it discusses the concepts of pharmacotherapy in general.",Current concepts of pharmacological treatment in schizophrenia,nan,12725017
True," The study meets the inclusion criteria as it involves patients with schizophrenia, a relevant population for this review, and examines the effect of olanzapine treatment on cognitive functions.",Effect of olanzapine treatment on cognitive functions in patients with schizophrenia,nan,12725025
True," The study meets the inclusion criteria as it involves patients with schizophrenia treated with olanzapine, which is one of the included interventions.",Subjective and objective assessment of memory functions in patients with schizophrenia treated with olanzapine,nan,12725026
True," The study meets the inclusion criteria as it involves a randomized controlled trial of quetiapine in patients with schizophrenia or schizoaffective disorder, which is a relevant population for the review.",A RandomAssignment DoubleBlind Clinical Trial of Once vs TwiceDaily Administration of Quetiapine Fumarate in Patients with Schizophrenia or Schizoaffective Disorder A Pilot Study,https://doi.org/10.1177/070674370304800307,12728743
False," The study population specified in the abstract (patients with acute relapse of schizophrenia or schizoaffective disorder) does not match the inclusion criteria (adults with a DSM III-R or DSM-IV diagnosis of schizophrenia, including other psychotic disorders, and bipolar disorder, major depressive disorder, and behavioral and psychological symptoms of dementia).",Aripiprazole in the treatment of schizophrenia safety and tolerability in shortterm placebocontrolled trials,https://doi.org/10.1016/s0920-9964(03)00050-1,12729864
True," The study meets the inclusion criteria as it compares the characteristics of patients treated in a randomized trial of antipsychotic medication to a cohort from a large epidemiological study of first episode psychosis, which is relevant to the review's focus on the effectiveness and harms of antipsychotic medications in various patient populations.",Are patients enrolled in first episode psychosis drug trials representative of patients treated in routine clinical practice,https://doi.org/10.1016/s0920-9964(02)00322-5,12729866
True," The study meets the inclusion criteria as it is a randomized double-blind trial comparing the efficacy and safety of olanzapine and risperidone in patients with schizophrenia, schizoaffective disorder, or schizophreniform disorder.",Olanzapine vs risperidone in the management of schizophrenia a randomized doubleblind trial in Australia and New Zealand,https://doi.org/10.1016/s0920-9964(02)00226-8,12729882
False," The study population specified in the abstract (schizoaffective disorder) does not match the inclusion criteria, which include a broader range of disorders such as schizophrenia, bipolar disorder, major depressive disorder, and pervasive developmental disorders.",Longterm Treatment of Schizoaffective Disorder Review and Recommendations,https://doi.org/10.1055/s-2003-39045,12734761
True, The study meets the inclusion criteria as it involves a randomized double-blind comparison of an antipsychotic medication (trimipramine) with a neuroleptic (perazine) in patients with schizophrenia.,Antipsychotic Efficacy of the Antidepressant Trimipramine A Randomized Doubleblind Comparison with the Phenothiazine Perazine,https://doi.org/10.1055/s-2003-39043,12734763
True," The study population includes patients with severe mental illness who had previously adhered to antipsychotic therapy, which aligns with the inclusion criteria for patients with schizophrenia and other psychotic disorders.",Effect of a Mental Health CarveOut Program on the Continuity of Antipsychotic Therapy,https://doi.org/10.1056/nejmsa020584,12736282
False," The study population does not match the inclusion criteria as it only includes adults and adolescents with schizophrenia and schizoaffective disorders, whereas the review includes a broader range of psychiatric conditions.",Cognitive rehabilitation with patients having persistent severe psychiatric disabilities,https://doi.org/10.2975/26.2003.325.331,12739903
False," The title and abstract do not mention any specific medication from the list of included interventions (aripiprazole, asenapine, clozapine, iloperidone, olanzapine, paliperidone, quetiapine, risperidone, and ziprasidone), and the abstract only discusses the use of atypical antipsychotics in general, not a specific medication.",Atypical antipsychotics in the treatment of bipolar disorder,https://doi.org/10.1517/14656566.4.5.751,12739998
False," The abstract does not mention any specific population or intervention that matches the inclusion criteria, which are focused on adults and children with various psychiatric disorders and specific medications.",Placebo or Active Control Trials of Antipsychotic Drugs,https://doi.org/10.1001/archpsyc.60.5.458,12742866
True," The study meets the inclusion criteria as it is a systematic review and meta-analysis comparing new generation antipsychotics with low-potency conventional antipsychotics, which is relevant to the topic of interest.",New generation antipsychotics versus lowpotency conventional antipsychotics a systematic review and metaanalysis,https://doi.org/10.1016/s0140-6736(03)13306-5,12747876
True," The study meets the inclusion criteria as it involves adults with schizophrenia, a randomized controlled trial, and examines the effectiveness of quetiapine compared to haloperidol.",A post hoc analysis of the impact on hostility and agitation of quetiapine and haloperidol among patients with schizophrenia,https://doi.org/10.1016/s0149-2918(03)80094-2,12749512
True," The study meets the inclusion criteria as it involves a randomized controlled trial comparing quetiapine to conventional antipsychotics in patients with schizophrenia, examining cognitive and functional outcomes.",The Effectiveness of Quetiapine Versus Conventional Antipsychotics in Improving Cognitive and Functional Outcomes in Standard Treatment Settings,https://doi.org/10.4088/jcp.v64n0505,12755654
True," The study meets the inclusion criteria as it involves adults with schizophrenia, a relevant population for this review, and examines the effectiveness of ziprasidone, a medication included in the review.",Effectiveness of Switching to Ziprasidone for Stable but Symptomatic Outpatients With Schizophrenia,https://doi.org/10.4088/jcp.v64n0514,12755663
True," The study meets the inclusion criteria as it involves a comparison of two antipsychotic medications (risperidone and olanzapine) in a naturalistic clinical setting, which is one of the interventions included in the review.",Risperidone Compared With Olanzapine in a Naturalistic Clinical Study,https://doi.org/10.4088/jcp.v64n0515,12755664
True," The study population includes patients with DSM-IV schizophrenia, which meets the inclusion criteria for the review.",Serum Leptin and Triglyceride Levels in Patients on Treatment With Atypical Antipsychotics,https://doi.org/10.4088/jcp.v64n0516,12755665
True," The study meets the inclusion criteria as it involves patients with schizophrenia, a condition included in the review, and examines the effectiveness of clozapine, an intervention included in the review.",Undiagnosed Hyperglycemia in ClozapineTreated Patients With Schizophrenia,https://doi.org/10.4088/jcp.v64n0517,12755666
False," The study population does not match the inclusion criteria as it focuses on adults with vascular dementia, which is not included in the specified inclusion criteria.",The early stage of vascular dementia significance of a complete therapeutic program,https://doi.org/10.1002/gps.844,12766915
True," The study meets the inclusion criteria as it involves a randomized controlled trial examining the effectiveness of switching from conventional to atypical antipsychotics (olanzapine or risperidone) in elderly patients with schizophrenia, which is a relevant population for this review.",The impact upon extrapyramidal side effects clinical symptoms and quality of life of a switch from conventional to atypical antipsychotics risperidone or olanzapine in elderly patients with schizophrenia,https://doi.org/10.1002/gps.862,12766921
True," The study meets the inclusion criteria as it is a randomized controlled trial examining the efficacy of nefazodone in treating antipsychotic-induced extrapyramidal side effects, which is a relevant intervention for the review.",Efficacy of nefazodone in the treatment of neuroleptic induced extrapyramidal side effects a doubleblind randomised parallel group placebocontrolled trial,https://doi.org/10.1002/hup.476,12766931
True," The study meets the inclusion criteria as it involves a randomized controlled trial of long-acting injectable risperidone in patients with schizophrenia, which is one of the interventions included in the review.",LongActing Injectable Risperidone Efficacy and Safety of the First LongActing Atypical Antipsychotic,https://doi.org/10.1176/appi.ajp.160.6.1125,12777271
True," The study meets the inclusion criteria as it involves patients with treatment-resistant schizophrenia, a relevant population for this review, and examines the effectiveness of clozapine treatment after withdrawal of typical antipsychotics.",Effect Size of Symptom Status in Withdrawal of Typical Antipsychotics and Subsequent Clozapine Treatment in Patients With TreatmentResistant Schizophrenia,https://doi.org/10.1176/appi.ajp.160.6.1133,12777272
True," The study meets the inclusion criteria as it involves a naturalistic study of first-episode schizophrenia patients treated with olanzapine, risperidone, or conventional antipsychotics, and evaluates effectiveness, safety, and quality of life outcomes.",Safety effectiveness and quality of life of olanzapine in firstepisode schizophrenia a naturalistic study,https://doi.org/10.1016/s0278-5846(03)00077-0,12787855
False," The study population specified in the abstract is children and adolescents with bipolar disorder, which does not match the inclusion criteria of adults with schizophrenia, including other psychotic disorders, or adults with major depressive disorder, or older adults with behavioral and psychological symptoms of dementia, or children and adolescents with pervasive developmental disorders, or disruptive behavior disorders.",Combination pharmacotherapy in children and adolescents with bipolar disorder,https://doi.org/10.1016/s0006-3223(03)00067-2,12788243
False," The study population specified in the abstract (bipolar disorder) does not match the inclusion criteria (schizophrenia, other psychotic disorders, major depressive disorder, pervasive developmental disorders, disruptive behavior disorders, and behavioral and psychological symptoms of dementia).",Rationale design and methods of the systematic treatment enhancement program for bipolar disorder STEPBD,https://doi.org/10.1016/s0006-3223(03)00165-3,12788248
False," The study population in the abstract does not match the inclusion criteria as it only includes persons diagnosed with schizophrenia or schizoaffective disorder, whereas the inclusion criteria include a broader range of psychiatric disorders such as bipolar disorder, major depressive disorder, and pervasive developmental disorders.",CostEffectiveness of Risperidone Olanzapine and Conventional Antipsychotic Medications,https://doi.org/10.1093/oxfordjournals.schbul.a006967,12795493
False," The study population specified in the abstract (people with schizophrenia) does not match the inclusion criteria, which includes a broader range of psychiatric disorders such as bipolar disorder, major depressive disorder, and behavioral and psychological symptoms of dementia.",Estimating the Costs and Benefits of New Drug Therapies Atypical Antipsychotic Drugs for Schizophrenia,https://doi.org/10.1093/oxfordjournals.schbul.a006969,12795495
False," The study population specified in the abstract is adults with schizophrenia, which does not match the inclusion criteria of children (under 13 years) and adolescents (13-17 years) with pervasive developmental disorders, including autistic disorder, Asperger’s disorder, pervasive developmental disorder not otherwise specified (including atypical autism).",A Metaanalysis of the Efficacy of SecondGeneration Antipsychotics,https://doi.org/10.1001/archpsyc.60.6.553,12796218
True, The study meets the inclusion criteria as it involves a randomized controlled trial examining the effects of atypical antipsychotics on cognitive performance in patients with schizophrenia.,Comparison of Cognitive Performances During a Placebo Period and an Atypical Antipsychotic Treatment Period in Schizophrenia Critical Examination of Confounds,https://doi.org/10.1038/sj.npp.1300216,12799617
False," The abstract does not mention any specific interventions or treatments for tardive syndromes, and the review focuses on the classification and treatment of tardive syndromes, not the effectiveness of specific interventions.",CLASSIFICATION AND TREATMENT OF TARDIVE SYNDROMES,https://doi.org/10.1097/01.nrl.0000038585.58012.97,12801428
False," The study does not focus on the use of atypical antipsychotics in traumatic brain injury, but rather discusses their use in various psychiatric conditions.",The Use of Atypical Antipsychotics in Traumatic Brain Injury,https://doi.org/10.1097/00001199-200303000-00008,12802226
True," The study population includes adults with schizophrenia, bipolar disorder, and dementia, which aligns with the inclusion criteria.",Calming versus sedative effects of intramuscular olanzapine in agitated patients,https://doi.org/10.1016/s0735-6757(02)42249-8,12811711
True," The study population includes adults with a DSM-IV diagnosis of bipolar disorder, which is one of the specified populations of interest in the review.",Risperidone in acute and continuation treatment of mania,https://doi.org/10.1097/00004850-200307000-00005,12817157
True," The study population includes adults and adolescents with schizophrenia, which is one of the inclusion criteria.",RisperidoneAssociated Diabetes Mellitus A Pharmacovigilance Study,https://doi.org/10.1592/phco.23.6.735.32178,12820816
True," The study population consists of adults and adolescents with a DSM-III-R or DSM-IV diagnosis of schizophrenia, which meets the inclusion criteria.",Ethnic Differences in Use of Antipsychotic Medication Among Texas Medicaid Clients With Schizophrenia,https://doi.org/10.4088/jcp.v64n0603,12823076
True," The study meets the inclusion criteria as it focuses on the estimation of therapeutic dose equivalence across antipsychotic medications, specifically for the newer atypical antipsychotics, and provides evidence-based dose equivalency estimates.",Chlorpromazine Equivalent Doses for the Newer Atypical Antipsychotics,https://doi.org/10.4088/jcp.v64n0607,12823080
True, The study meets the inclusion criteria as it is a head-to-head randomized controlled trial comparing the efficacy and side effects of two atypical antipsychotics (olanzapine and risperidone) in the treatment of dementia-related behavioral disturbances in extended care facilities.,A DoubleBlind Comparison of Olanzapine Versus Risperidone in the Acute Treatment of Dementia Related Behavioral Disturbances in Extended Care Facilities,https://doi.org/10.4088/jcp.v64n0617,12823090
True," The study meets the inclusion criteria as it involves adults with schizophrenia and schizoaffective disorder, a randomized controlled trial, and examines the effectiveness and tolerability of a medication (clozapine combined with lithium).",Tolerability and Efficacy of Clozapine Combined with Lithium in Schizophrenia and Schizoaffective Disorder,https://doi.org/10.1097/01.jcp.0000084026.22282.5f,12826983
True, The study meets the inclusion criteria as it involves a randomized controlled trial examining the efficacy of mirtazapine in treating neuroleptic-induced akathisia in adults with schizophrenia.,Efficacy of LowDose Mirtazapine in NeurolepticInduced Akathisia A DoubleBlind Randomized PlaceboControlled Pilot Study,https://doi.org/10.1097/01.jcp.0000084027.22282.16,12826992
True, The study meets the inclusion criteria as it is a systematic review and meta-analysis of randomized controlled trials examining the effectiveness of new-generation antipsychotics for relapse prevention in schizophrenia.,Relapse Prevention in Schizophrenia With NewGeneration Antipsychotics A Systematic Review and Exploratory MetaAnalysis of Randomized Controlled Trials,https://doi.org/10.1176/appi.ajp.160.7.1209,12832232
False," The study population does not match the inclusion criteria as it only includes adults and adolescents with bipolar disorder, whereas the inclusion criteria include a broader range of psychiatric disorders such as schizophrenia, major depressive disorder, and behavioral and psychological symptoms of dementia.",Olanzapine Versus Divalproex Sodium for the Treatment of Acute Mania and Maintenance of Remission A Week Study,https://doi.org/10.1176/appi.ajp.160.7.1263,12832240
True," The study meets the inclusion criteria as it involves elderly patients with behavioral and psychological symptoms of dementia, which is one of the specified patient populations, and examines the effects of olanzapine treatment on prolactin concentrations.",The Effects of Antipsychotic Drug Treatment on Prolactin Concentrations in Elderly Patients,https://doi.org/10.1097/01.jam.0000073959.30368.6b,12837139
True," The study meets the inclusion criteria as it involves a subgroup analysis of patients with Alzheimer's disease and dementia who received risperidone treatment, which is an intervention included in the review.",Psychosis of Alzheimer Disease Validity of the Construct and Response to Risperidone,https://doi.org/10.1097/00019442-200307000-00004,12837670
False," The title and abstract do not mention any specific age range or diagnosis that matches the inclusion criteria, and the review appears to focus on clozapine in general, not specifically on the populations mentioned in the inclusion criteria.",Clozapine a clinical review of adverse effects and management,https://doi.org/10.1023/a:1023228626309,12839431
True," The study meets the inclusion criteria as it reviews the pharmacologic management of agitation in psychiatric patients, including the use of benzodiazepines and atypical antipsychotics, and examines the effectiveness and harms of these interventions in various patient populations.",Benzodiazepines typical and atypical antipsychotics in the management of acute agitation a review,nan,12844280
False," The study population does not match the inclusion criteria as it specifically focuses on patients with delirium, which is not mentioned in the inclusion criteria.",Treatment for delirium with risperidone results of a prospective open trial with patients,https://doi.org/10.1016/s0163-8343(03)00024-0,12850662
False," The study population does not match the inclusion criteria as it specifically focuses on palliative care patients with intractable nausea, which is not one of the specified patient populations.",Olanzapine for Intractable Nausea in Palliative Care Patients,https://doi.org/10.1089/109662103764978506,12854942
True," The study meets the inclusion criteria as it involves adults with schizophrenia and schizoaffective disorder, and it is a randomized controlled trial examining the efficacy and safety of aripiprazole compared to risperidone and placebo.",Aripiprazole an Antipsychotic With a Novel Mechanism of Action and Risperidone vs Placebo in Patients With Schizophrenia and Schizoaffective Disorder,https://doi.org/10.1001/archpsyc.60.7.681,12860772
True," The study meets the inclusion criteria as it involves a randomized controlled trial of quetiapine in patients with schizophrenia, which is one of the interventions included in the review.",Differential Effect of Quetiapine on Depressive Symptoms in Patients with Partially Responsive Schizophrenia,https://doi.org/10.1177/0269881103017002010,12870569
False," The study population does not match the inclusion criteria as it only includes healthy volunteers aged years, whereas the review is focused on patients with various psychiatric disorders.",Estudio de biodisponibilidad comparativa de dos formulaciones de risperidona existentes en el mercado chileno,https://doi.org/10.4067/s0034-98872003000500008,12879814
False," The study population does not match the specified inclusion criteria, as it includes only heavy social drinkers, not individuals with schizophrenia, bipolar disorder, major depressive disorder, or other specified conditions.",Olanzapine Reduces Craving for Alcohol A DRD VNTR Polymorphism by Pharmacotherapy Interaction,https://doi.org/10.1038/sj.npp.1300264,12888781
False," The study does not meet the inclusion criteria for interventions as it involves vitamin E, which is not one of the specified interventions (aripiprazole, asenapine, clozapine, iloperidone, olanzapine, paliperidone, quetiapine, risperidone, and ziprasidone).",Vitamin E Treatment for Tardive Dyskinesia,https://doi.org/10.1001/archpsyc.56.9.836,12892048
False," The study population specified in the abstract (treatment-resistant schizophrenia) does not match the inclusion criteria, which includes a broader range of psychiatric disorders.",Clozapine v conventional antipsychotic drugs for treatmentresistant schizophrenia A reexamination,https://doi.org/10.1192/bjp.183.2.161,12893670
True, The study meets the inclusion criteria as it is a head-to-head randomized controlled trial comparing the efficacy and safety of two antipsychotic medications (haloperidol and olanzapine) in patients with first-episode psychosis.,Comparative Efficacy and Safety of Atypical and Conventional Antipsychotic Drugs in FirstEpisode Psychosis A Randomized DoubleBlind Trial of Olanzapine Versus Haloperidol,https://doi.org/10.1176/appi.ajp.160.8.1396,12900300
True," The study meets the inclusion criteria as it involves a randomized controlled trial comparing the effectiveness of risperidone and haloperidol in patients with stabilized DSM-IV schizophrenia, which is a relevant population for this review.",Maintenance Treatment of Schizophrenia With Risperidone or Haloperidol Year Outcomes,https://doi.org/10.1176/appi.ajp.160.8.1405,12900301
True," The study meets the inclusion criteria as it involves adults with schizophrenia, a randomized controlled trial, and examines the effectiveness of clozapine and haloperidol, which are included interventions.",The Relationship of Clozapine and Haloperidol Treatment Response to Prefrontal Hippocampal and Caudate Brain Volumes,https://doi.org/10.1176/appi.ajp.160.8.1421,12900303
False," The study is a case report, which is not a randomized controlled trial, comparative observational study, or systematic review, and does not meet the specified study design criteria for inclusion.",Quetiapine in the Successful Treatment of Schizophrenia with Comorbid Alcohol and Drug Dependence A Case Report,https://doi.org/10.2190/wm5v-d9y2-2hyw-vgwx,12906345
False," The study is not a randomized controlled trial, but rather a trial design and protocol development for a larger study, and does not report any effectiveness or harms outcomes.",The National Institute of Mental Health Clinical Antipsychotic Trials of Intervention Effectiveness CATIE Project Schizophrenia Trial Design and Protocol Development,https://doi.org/10.1093/oxfordjournals.schbul.a006986,12908658
False," The title and abstract indicate that the study is focused on Alzheimer's disease, which is not included in the specified inclusion criteria.",Clinical Antipsychotic Trials of Intervention Effectiveness CATIE Alzheimers Disease Trial,https://doi.org/10.1093/oxfordjournals.schbul.a006991,12908661
True," The study population (adults with schizophrenia, bipolar disorder, major depressive disorder, and behavioral and psychological symptoms of dementia) and the interventions (new antipsychotic drugs) align with the specified inclusion criteria.",Changing Environments and Alternative Perspectives in Evaluating the CostEffectiveness of New Antipsychotic Drugs,https://doi.org/10.1093/oxfordjournals.schbul.a006994,12908663
False," The study does not focus on the specified patient populations (schizophrenia, bipolar disorder, major depressive disorder, behavioral and psychological symptoms of dementia, pervasive developmental disorders, and disruptive behavior disorders) or interventions (second generation atypical antipsychotics).",Generating Evidence to Inform Policy and Practice The Example of the Second Generation Atypical Antipsychotics,https://doi.org/10.1093/oxfordjournals.schbul.a006980,12908665
True," The study meets the inclusion criteria as it involves a prospective two-year trial examining predictors of suicidal risk in patients with schizophrenia and schizoaffective disorder, which falls within the specified patient populations and interventions.",Predicting suicidal risk in schizophrenic and schizoaffective patients in a prospective twoyear trial,https://doi.org/10.1016/s0006-3223(03)00178-1,12915289
True," The study meets the inclusion criteria as it is a randomized controlled trial examining the effectiveness of olanzapine in treating prodromal symptoms of schizophrenia, which is one of the interventions included in the review.",Randomized trial of olanzapine versus placebo in the symptomatic acute treatment of the schizophrenic prodrome,https://doi.org/10.1016/s0006-3223(03)00321-4,12915290
False," The study does not meet the inclusion criteria as it does not focus on the effectiveness or harms of clozapine in the specified patient populations, but rather explores the relationship between serum antimuscarinic activity and clozapine levels.",Serum Antimuscarinic Activity During Clozapine Treatment,https://doi.org/10.1097/01.jcp.0000085405.08426.73,12920408
True," The study meets the inclusion criteria as it involves adults and adolescents with schizophrenia and bipolar disorder, and examines the effectiveness of olanzapine in treating agitation, which is an intervention included in the review.",Effectiveness of Rapid Initial Dose Escalation of up to Forty Milligrams per Day of Oral Olanzapine in Acute Agitation,https://doi.org/10.1097/01.jcp.0000085406.08426.a8,12920409
False," The study population specified in the abstract (adults with acute mania) does not match the inclusion criteria (adults with schizophrenia, bipolar disorder, major depressive disorder, or behavioral and psychological symptoms of dementia).",Olanzapine Versus Placebo in Acute Mania,https://doi.org/10.1097/01.jcp.0000085410.08426.9a,12920413
False," The abstract does not provide any information about the study population, interventions, or outcomes, making it impossible to determine if the study meets the inclusion criteria.",TreatmentEmergent Tardive Dyskinesia With Quetiapine in Mood Disorders,https://doi.org/10.1097/01.jcp.0000085418.74359.ed,12920421
False," The study population does not match the inclusion criteria as it includes only normal subjects, not individuals with schizophrenia, bipolar disorder, major depressive disorder, or other specified conditions.",Actigraphic measurement of the effects of singledose haloperidol and olanzapine on spontaneous motor activity in normal subjects,nan,12921224
True," The study meets the inclusion criteria as it focuses on the pharmacological treatment of negative symptoms of schizophrenia, which is within the specified intervention of interest.",Management of the Negative Symptoms of Schizophrenia,https://doi.org/10.2165/00023210-200317110-00003,12921492
True," The study meets the inclusion criteria as it involves the use of olanzapine for the treatment of psychotic and behavioral disturbances in Alzheimer disease, which is a relevant population for the review.",Olanzapine for Psychotic and Behavioral Disturbances in Alzheimer Disease,https://doi.org/10.1345/aph.1d050,12921516
True," The study meets the inclusion criteria as it involves a randomized controlled trial with a placebo-controlled design, examining the effectiveness of a medication (donepezil) in combination with atypical antipsychotics for schizophrenia patients, and uses functional magnetic resonance imaging (fMRI) to measure brain activity.",Augmenting Atypical Antipsychotics with a Cognitive Enhancer Donepezil Improves Regional Brain Activity in Schizophrenia Patients A Pilot Doubleblind Placebo Controlled BOLD fMRI Study,https://doi.org/10.1076/neur.9.3.274.15563,12925933
True," The study meets the inclusion criteria as it involves a randomized double-blind controlled trial of olanzapine in patients with schizophrenia, which is one of the interventions included in the review.",An Integrated Analysis of Acute TreatmentEmergent Extrapyramidal Syndrome in Patients With Schizophrenia During Olanzapine Clinical Trials,https://doi.org/10.4088/jcp.v64n0807,12927004
False," The study population does not match the inclusion criteria as it only includes adults and adolescents with acute mania associated with bipolar I disorder, whereas the inclusion criteria include a broader range of psychiatric disorders such as schizophrenia, bipolar disorder, major depressive disorder, and behavioral and psychological symptoms of dementia.",The Safety and Early Efficacy of OralLoaded Divalproex Versus StandardTitration Divalproex Lithium Olanzapine and Placebo in the Treatment of Acute Mania Associated With Bipolar Disorder,https://doi.org/10.4088/jcp.v64n0717,12934987
False," The study population does not match the inclusion criteria as it only includes adults and adolescents with bipolar disorder in an acute manic or mixed episode, whereas the inclusion criteria include a broader range of populations such as schizophrenia, major depressive disorder, and behavioral and psychological symptoms of dementia.",A PlaceboControlled DoubleBlind Study of the Efficacy and Safety of Aripiprazole in Patients With Acute Bipolar Mania,https://doi.org/10.1176/appi.ajp.160.9.1651,12944341
True," The study meets the inclusion criteria as it involves a population with schizophrenia, a specific intervention (clozapine), and examines the association between a genetic polymorphism (BDNF ValMet) and treatment response.",An association study of a brainderived neurotrophic factor ValMet polymorphism and clozapine response of schizophrenic patients,https://doi.org/10.1016/s0304-3940(03)00828-0,12951204
True," The study meets the inclusion criteria as it discusses the effectiveness and side effects of quetiapine in treating various psychiatric disorders, including schizophrenia, bipolar disorder, and major depressive disorder, which are all included in the review.",Quetiapine fumarate SeroquelR A new atypical antipsychotic,https://doi.org/10.1358/dot.1999.35.3.533849,12973385
True," The study meets the inclusion criteria as it is a randomized controlled trial examining the effectiveness of occupational therapy in patients with treatment-resistant schizophrenia, which is a relevant population for this review.",Randomized controlled trial of occupational therapy in patients with treatmentresistant schizophrenia,https://doi.org/10.1590/s1516-44462003000100006,12975676
False," The study population does not match the inclusion criteria as it only includes individuals with schizophrenia, whereas the review includes a broader range of psychiatric disorders.",Schizophrenia is not associated with DRDbasepairrepeat length or individual alleles results of a metaanalysis,https://doi.org/10.1016/s0006-3223(03)00180-x,13129658
True," The study meets the inclusion criteria as it examines the effectiveness of two specific medications (lithium and divalproex) in reducing the risk of suicide in patients with bipolar disorder, which is a relevant population for this review.",Suicide Risk in Bipolar Disorder During Treatment With Lithium and Divalproex,https://doi.org/10.1001/jama.290.11.1467,13129986
False," The abstract does not match the inclusion criteria as it discusses pharmacotherapy for eating disorders, which is not within the specified patient populations (schizophrenia, bipolar disorder, major depressive disorder, dementia, pervasive developmental disorders, and disruptive behavior disorders).",Towards the pharmacotherapy of eating disorders,https://doi.org/10.1517/14656566.4.10.1659,14521477
False," The study population does not match the inclusion criteria as it specifically focuses on Tourette's syndrome, which is not mentioned in the inclusion criteria.",Cannabinoids reduce symptoms of Tourettes syndrome,https://doi.org/10.1517/14656566.4.10.1717,14521482
False," The study population specified in the abstract does not match the inclusion criteria, as it only includes adults and adolescents with bipolar disorder, whereas the inclusion criteria include a broader range of psychiatric conditions.",An overview of recent findings of the Stanley Foundation Bipolar Network Part I,https://doi.org/10.1034/j.1399-5618.2003.00051.x,14525551
False," The study population specified in the abstract does not match the inclusion criteria, as it only includes patients with bipolar disorder, whereas the inclusion criteria include a broader range of psychiatric disorders.",Subsyndromal symptoms assessed in longitudinal prospective followup of a cohort of patients with bipolar disorder,https://doi.org/10.1034/j.1399-5618.2003.00048.x,14525555
False," The study population does not match the inclusion criteria as it specifically focuses on patients with Parkinson's disease with dementia (PDD), which is not mentioned in the inclusion criteria.",Cognitive psychiatric and motor response to galantamine in Parkinsons disease with dementia,https://doi.org/10.1002/gps.949,14533126
True, The study meets the inclusion criteria as it involves a randomized controlled trial examining the effect of an educational intervention on antipsychotic-induced weight gain in patients with schizophrenia.,The Effects of an Educational Intervention on AntipsychoticInduced Weight Gain,https://doi.org/10.1111/j.1547-5069.2003.00237.x,14562491
False," The title and abstract do not match the specified inclusion criteria, as the paper appears to focus on methodological and regulatory features of clinical trials for behavioral and psychological symptoms in dementia, but the inclusion criteria specify a broad range of psychiatric conditions, including schizophrenia, bipolar disorder, and pervasive developmental disorders.",Methodological and regulatory features of clinical trials for behavioral and psychological symptoms in the course of dementia,nan,14587227
False," The title and abstract do not match the inclusion criteria as the study focuses on the management of acute mania, but the inclusion criteria specify a broad range of psychiatric disorders, including schizophrenia, bipolar disorder, major depressive disorder, and pervasive developmental disorders, among others.",The management of acute mania,https://doi.org/10.1136/bmj.327.7422.1002,14593007
True, The study meets the inclusion criteria as it is a randomized controlled trial examining the effectiveness and cost of olanzapine compared to haloperidol in the treatment of schizophrenia.,Effectiveness and Cost of Olanzapine and Haloperidol in the Treatment of SchizophreniaSUBTITLEA Randomized Controlled TrialSUBTITLE,https://doi.org/10.1001/jama.290.20.2693,14645311
False," The study population does not match the inclusion criteria as it includes patients with Parkinson's disease, multiple system atrophy, and postencephalitic Parkinsonism, which are not among the specified patient populations.",Clozapine in the treatment of mental manifestations of Parkinson disease,nan,7481376
True," The study meets the inclusion criteria as it examines the efficacy and side effects of clozapine in schizophrenic patients, which is one of the interventions included in the review.",A comparison of European and American dosing regimens of schizophrenic patients on clozapine efficacy and side effects,nan,7491385
False," The study population is limited to chronic schizophrenic patients with acute exacerbations, which does not match the broad inclusion criteria of various psychiatric disorders and age groups specified in the review.",Risperidone versus perphenazine in the treatment of chronic schizophrenic patients with acute exacerbations,https://doi.org/10.1111/j.1600-0447.1993.tb03480.x,7508675
True," The study meets the inclusion criteria as it is a randomized controlled trial comparing the effectiveness of risperidone and clozapine in treating schizophrenia, which is a relevant condition for this review.",Risperidone versus clozapine in the treatment of schizophrenic patients with acute symptoms A double blind randomized trial,https://doi.org/10.1016/0278-5846(94)90029-9,7509495
True," The study meets the inclusion criteria as it involves the treatment of schizophrenia with risperidone, a medication included in the review, and reports on effectiveness outcomes such as clinical improvement and symptom response.",Risperidone in the treatment of schizophrenia,https://doi.org/10.1176/ajp.151.6.825,7514366
False," The study population specified in the abstract (rats) does not match the inclusion criteria, which specifies human populations (adults, adolescents, children, etc.).",Is it possible to predict the clinical effects of neuroleptics from animal data Part V From haloperidol and pipamperone to risperidone,nan,7514873
True," The study meets the inclusion criteria as it involves a randomized controlled trial comparing the effectiveness of risperidone and haloperidol in treating schizophrenia, which is a relevant intervention for the review.",Changes in Single Symptoms and Separate Factors of the Schizophrenic Syndrome after Treatment with Risperidone or Haloperidol,https://doi.org/10.1055/s-2007-1014288,7521534
True," The study population includes adults and adolescents with schizophrenia, which matches the inclusion criteria.",Predictors of clozapine response in schizophrenia,nan,7525541
True," The study population (schizophrenia, other psychotic disorders, bipolar disorder, major depressive disorder, and behavioral and psychological symptoms of dementia) and interventions (clozapine) match the specified criteria.",The effects of clozapine on neurocognition an overview,nan,7525543
False," The study is a case report, which is not a randomized controlled trial, comparative observational study, or systematic review, and does not meet the inclusion criteria for study design.",Desmopressin for RisperidoneInduced Enuresis,https://doi.org/10.3109/10401239409148993,7528602
False," The study population does not match the inclusion criteria as it only includes adults and adolescents with chronic schizophrenia, whereas the review includes a broader range of patient populations.",Pharmacokinetics of risperidone in chronic schizophrenic patients,nan,7530379
True," The study meets the inclusion criteria as it involves adults with a DSM-III-R or DSM-IV diagnosis of schizophrenia, and it examines the effectiveness of risperidone and clozapine in treating drug-resistant schizophrenia.",Risperidone and clozapine in the treatment of drugresistant schizophrenia and neurolepticinduced supersensitivity psychosis,https://doi.org/10.1016/0278-5846(94)90116-3,7531355
True," The article meets the inclusion criteria as it discusses the pharmacology and therapeutic use of risperidone in schizophrenia, which is one of the specified conditions, and it includes effectiveness and harms outcomes for patients with schizophrenia.",Risperidone Review of Its Pharmacology and Therapeutic Use in Schizophrenia,https://doi.org/10.3109/10401239409149000,7533585
False," The study does not meet the inclusion criteria as it does not focus on the effectiveness or harms of the interventions listed in the inclusion criteria, but rather on the pharmacokinetics of risperidone and remoxipride.",Dopamine D receptor blockade in vivo with the novel antipsychotics risperidone and remoxipride anIIBZM single photon emission tomography SPET study,https://doi.org/10.1007/bf02245098,7536945
False," The abstract does not mention any of the specified interventions (e.g. aripiprazole, asenapine, clozapine, iloperidone, olanzapine, paliperidone, quetiapine, risperidone, and ziprasidone) that are included in the review.",A RiskBenefit Assessment of Risperidone in Schizophrenia,https://doi.org/10.2165/00002018-199512020-00006,7539272
True, The study meets the inclusion criteria as it is a head-to-head randomized controlled trial comparing the efficacy and safety of risperidone and zuclopenthixol in patients with acute exacerbations of schizophrenia or schizophreniform disorder.,Risperidone versus zuclopenthixol in the treatment of acute schizophrenic episodes a doubleblind parallelgroup trial,https://doi.org/10.1111/j.1600-0447.1995.tb09781.x,7542829
True, The study meets the inclusion criteria as it is a randomized controlled trial examining the effectiveness of risperidone compared to haloperidol in patients with chronic schizophrenia.,Risperidone in the Treatment of Patients with Chronic Schizophrenia a MultiNational MultiCentre DoubleBlind ParallelGroup Study versus Haloperidol,https://doi.org/10.1192/bjp.166.6.712,7545060
False," The study population does not match the inclusion criteria as it only includes healthy volunteers, not patients with schizophrenia, bipolar disorder, or other conditions specified in the inclusion criteria.",Safety Tolerability and Effect of Food on the Pharmacokinetics of Iloperidone HP a Potential Atypical Antipsychotic,https://doi.org/10.1002/j.1552-4604.1995.tb04112.x,7560252
False," The study population does not match the inclusion criteria as it only includes adults and adolescents with schizophrenia, whereas the review includes a broader range of psychiatric disorders.",ClozapineInduced Increase in Plasma Levels of Soluble Interleukin Receptors,https://doi.org/10.1001/archpsyc.1995.03950220087016,7575109
True," The study meets the inclusion criteria as it involves a randomized controlled trial of a novel atypical antipsychotic (ICI) in patients with schizophrenia, which is one of the specified patient populations.",ICI a novel atypical antipsychotic early indication of safety and efficacy in patients with chronic and subchronic schizophrenia,https://doi.org/10.1016/0149-2918(95)80102-2,7585841
True," The study meets the inclusion criteria as it involves the long-term treatment of patients with schizophrenia, which is one of the specified conditions, and examines the efficacy and safety of risperidone, which is one of the specified interventions.",Efficacy and safety of risperidone in the longterm treatment of patients with schizophrenia,https://doi.org/10.1016/0149-2918(95)80105-7,7585844
True," The study meets the inclusion criteria as it involves geriatric patients (≥ 65 years of age) with behavioral and psychological symptoms of dementia, and it examines the efficacy of risperidone, which is an intervention included in the review.",Efficacy of risperidone treatment for psychoses associated with schizophrenia schizoaffective disorder bipolar disorder or senile dementia in geriatric patients a case series,nan,7592504
True, The study meets the inclusion criteria as it involves a randomized controlled trial examining the effect of risperidone on hostility in patients with schizophrenia.,Effect of Risperidone on Hostility in Schizophrenia,https://doi.org/10.1097/00004714-199508000-00002,7593706
True," The study meets the inclusion criteria as it involves adults and adolescents with schizophrenia and bipolar disorder, and examines the extrapyramidal side effects of clozapine and haloperidol, which are included interventions in the review.",Extrapyramidal side effects of clozapine and haloperidol,https://doi.org/10.1007/bf02245249,7597122
True," The study meets the inclusion criteria as it involves patients with schizophrenia, a condition included in the review, and examines the effectiveness of clozapine, an intervention included in the review.",Clozapine decreases smoking in patients with chronic schizophrenia,https://doi.org/10.1016/0006-3223(94)00365-a,7619979
False," The study does not focus on a specific population (adults with schizophrenia) but rather discusses the use of placebos in clinical trials for acute schizophrenia in general, and also includes other disorders such as bipolar disorder and dementia.",The Use of Placebos in Clinical Trials for Acute Schizophrenia,https://doi.org/10.1177/070674379504000403,7621385
True," The study meets the inclusion criteria as it involves a clinical study of clozapine treatment in patients with refractory schizophrenia, which is one of the interventions included in the review.",A Clinical Study of Clozapine Treatment and Predictors of Response in a Canadian Sample,https://doi.org/10.1177/070674379504000409,7621391
False," The study does not meet the inclusion criteria as it does not focus on the effectiveness or harms of the interventions listed in the inclusion criteria, but rather on the pharmacokinetics of clozapine.",Can LowDose Clozapine Pharmacokinetics Predict SteadyState Plasma Concentration,https://doi.org/10.1097/00007691-199504000-00006,7624901
True," The study meets the inclusion criteria as it involves adults with schizophrenia, a condition included in the review, and examines the effectiveness of a medication (quetiapine) that is also included in the review.",Seroquel ICI a putative atypical antipsychotic in schizophrenia with positive symptomatology results of an open clinical trial and changes of neuroendocrinological and EEG parameters,https://doi.org/10.1007/bf02246165,7659771
True," The study meets the inclusion criteria as it involves adults and adolescents with severe mood disorders, specifically schizoaffective and bipolar disorders, and examines the efficacy and tolerability of clozapine.",Clozapine in severe mood disorders,nan,7665540
False," The study does not focus on the specified patient populations (schizophrenia, bipolar disorder, major depressive disorder, behavioral and psychological symptoms of dementia, pervasive developmental disorders, and disruptive behavior disorders) or interventions (antipsychotics) as specified in the inclusion criteria.",Selective Serotonin Reuptake Inhibitors Pharmacologic Profiles and Potential Therapeutic Distinctions,https://doi.org/10.1177/106002809402801207,7696728
True," The study meets the inclusion criteria as it involves an ongoing study of childhood-onset schizophrenia, which falls within the specified age range and diagnosis of schizophrenia.",ChildhoodOnset Schizophrenia An NIMH Study in Progress,https://doi.org/10.1093/schbul/20.4.697,7701277
False," The study population specified in the abstract is adolescent schizophrenic patients, which does not match the inclusion criteria of adults (age 18 years and older) and adolescents (age 13-17 years) with a DSM III-R or DSM-IV diagnosis of schizophrenia, including other psychotic disorders.",Determination of Clozapine and its Major Metabolites in Serum Samples of Adolescent Schizophrenic Patients by HighPerformance Liquid Chromatography Data from a Prospective Clinical Trial,https://doi.org/10.1055/s-2007-979583,7746841
False," The study does not meet the inclusion criteria as it does not involve any of the specified interventions (aripiprazole, asenapine, clozapine, iloperidol, olanzapine, paliperidone, quetiapine, risperidone, and ziprasidone) and does not examine the specified outcomes (mortality, quality of life, functional capacity, hospitalization, emergency department visits, efficacy, adherence, persistence, caregiver burden, etc.) in the specified patient populations.",Intra and Interethnic Variability in Reduced Haloperidol to Haloperidol Ratios,https://doi.org/10.1002/j.1552-4604.1995.tb05000.x,7751421
False," The study population specified in the abstract (DSMIIIR schizophrenic inpatients) does not match the inclusion criteria, which specifies DSM-III-R or DSM-IV diagnosis.",Five factor model of schizophrenia replication across samples,https://doi.org/10.1016/0920-9964(94)00041-6,7766534
False," The study population is limited to chronic schizophrenic patients, which does not meet the inclusion criteria of the review, which includes a broader range of psychiatric disorders.",Clozapine serum levels and side effects during steady state treatment of schizophrenic patients a crosssectional study,https://doi.org/10.1007/bf02246112,7770613
True," The study population includes adults with schizophrenia, which meets the inclusion criteria.",Treatment of Polydipsia and Hyponatremia in Psychiatric Patients,https://doi.org/10.1016/0893-133x(94)00069-c,7779241
False," The study does not focus on a specific intervention (medication) but rather proposes a new model of schizophrenia, which does not align with the specified inclusion criteria for interventions.",A new five factor model of schizophrenia,https://doi.org/10.1007/bf02354306,7831416
True," The study meets the inclusion criteria as it involves adults with schizophrenia, a DSM-III-R or DSM-IV diagnosis, and examines the effectiveness of clozapine treatment on suicidality.",Reduction of suicidality during clozapine treatment of neuroleptic resistant schizophrenia impact on riskbenefit assessment,https://doi.org/10.1176/ajp.152.2.183,7840350
False," The study population does not match the inclusion criteria as it only includes inpatients with clozapine treatment, whereas the review includes a broader range of patient populations (schizophrenia, bipolar disorder, major depressive disorder, behavioral and psychological symptoms of dementia, pervasive developmental disorders, and disruptive behavior disorders).",EEG alterations in patients treated with clozapine in relation to plasma levels,https://doi.org/10.1007/bf02245449,7846212
False," The title and abstract do not mention any specific medication from the list of included interventions (aripiprazole, asenapine, clozapine, iloperidone, olanzapine, paliperidone, quetiapine, risperidone, and ziprasidone) and the study focuses on the pharmacologic treatment of schizoaffective disorder in general, rather than a specific medication.",Pharmacologic treatment of schizoaffective disorder,https://doi.org/10.1007/bf02244982,7855214
True," The study meets the inclusion criteria as it involves adolescents with schizophrenia on clozapine therapy, and it examines the effects of clozapine on biogenic amines, which is a relevant outcome for the review.",Effect of clozapine on biogenic amines within the scope of drug treatment of schizophrenic psychoses in adolescence,nan,7856324
False," The abstract does not mention any of the specified interventions (aripiprazole, asenapine, iloperidone, olanzapine, paliperidone, quetiapine, risperidone, and ziprasidone) or the specified patient populations (schizophrenia, bipolar disorder, major depressive disorder, behavioral and psychological symptoms of dementia, pervasive developmental disorders, and disruptive behavior disorders).",Clozapine therapy for Parkinsons disease and other movement disorders,https://doi.org/10.1093/ajhp/51.24.3047,7856623
True," The study population includes adults with schizophrenia, which meets the inclusion criteria.",The comparative efficacy and longterm effect of clozapine treatment on neuropsychological test performance,https://doi.org/10.1016/0006-3223(94)90082-5,7858067
False," The study is a case report, which is not a randomized controlled trial, comparative observational study, or systematic review, and does not meet the inclusion criteria for study design.",Effect of switching carbamazepine to oxcarbazepine on the plasma levels of neuroleptics A case report,https://doi.org/10.1007/bf02244881,7862923
True," The study population includes adults with schizophrenia, which matches the inclusion criteria.",Neuroendocrine profile of SDZ HDC and OPC two new atypical antipsychotic drugs in schizophrenic patients,https://doi.org/10.1007/bf02246969,7870880
True," The study meets the inclusion criteria as it involves adults with refractory schizophrenia, a condition included in the review, and examines the effectiveness of clozapine, an intervention included in the review.",Clozapine and refractory schizophrenia Longterm prospective study of patients,nan,7875111
True," The study population includes adults with refractory bipolar disorder, which meets the inclusion criteria for the review.",Is clozapine a mood stabilizer,nan,7883728
True," The study population includes adults with Parkinson's disease, which is not explicitly excluded from the inclusion criteria, and the intervention (clozapine) is one of the included interventions.",Lowdose Clozapine in the Treatment of LevodopaInduced Mental Disturbances in Parkinsons Disease,https://doi.org/10.1212/wnl.45.3.432,7898690
False," The study population specified in the abstract does not match the inclusion criteria, as it only mentions adults and adolescents with negative schizophrenic symptoms, but does not include other specified populations such as bipolar disorder, major depressive disorder, and pervasive developmental disorders.",Psychopharmacologic treatment of negative schizophrenic symptoms,https://doi.org/10.1016/0010-440x(94)90165-1,7908618
False," The study does not meet the inclusion criteria for the population as it involves a patient with Parkinson's disease, which is not specified in the inclusion criteria.",Electroconvulsive therapy in comorbidity of treatment refractory paranoid hallucinatory psychoses with Parkinson disease,nan,7909917
True," The study meets the inclusion criteria as it involves patients with schizophrenia, a condition included in the review, and examines the relationship between serum IgE levels and treatment response, which is a relevant outcome for the review.",Increased serum IgE in schizophrenic patients who responded poorly to neuroleptic treatment,https://doi.org/10.1016/0024-3205(94)90029-9,7910931
False," The study population does not match the inclusion criteria as it only includes schizophrenic and schizoaffective subjects, whereas the inclusion criteria specify a broader range of disorders, including bipolar disorder, major depressive disorder, and behavioral and psychological symptoms of dementia.",Allelic Variation in the D Dopamine Receptor DRD Gene Does Not Predict Response to Clozapine,https://doi.org/10.1001/archpsyc.1994.03950110072009,7944879
False," The title does not mention the specific population or intervention of interest, which is a requirement for inclusion in the review.",Stability of neurological signs with clozapine treatment,https://doi.org/10.1016/0006-3223(94)91225-4,7948457
False," The study does not meet the inclusion criteria for interventions, as it only focuses on clozapine, whereas the review includes a range of interventions (aripiprazole, asenapine, clozapine, iloperidone, olanzapine, paliperidone, quetiapine, risperidone, and ziprasidone).",Clozapine in tardive dyskinesia observations from human and animal model studies,nan,7961550
True," The study population includes adults and adolescents with schizophrenia, which meets the inclusion criteria.",Plasma clozapine concentrations as a predictor of clinical response a followup study,nan,7961554
False," The study does not examine the effects of clozapine on noradrenergic function in the specified patient populations, but rather proposes a hypothesis based on preclinical and clinical studies.",Clozapine and noradrenergic function support for a novel hypothesis for superior efficacy,nan,7961555
True," The study meets the inclusion criteria as it examines the predictors of response to clozapine, a medication included in the review, in patients with schizophrenia, which is one of the patient populations of interest.",Predictors of response to clozapine,nan,7961556
True," The study population includes adults and adolescents with schizophrenia, which meets the inclusion criteria.",Plasma clozapine concentrations predict clinical response in treatmentresistant schizophrenia,nan,7961557
False," The study does not meet the inclusion criteria as it does not focus on the effectiveness or harms of the specified interventions (e.g., aripiprazole, asenapine, clozapine, iloperidone, olanzapine, paliperidone, quetiapine, risperidone, and ziprasidone) in the specified patient populations.",Cr release assay of clozapineinduced cytotoxicity evidence for immunogenic mechanism,nan,7961559
True," The study meets the inclusion criteria as it investigates the association between clozapine treatment and weight gain in patients with chronic schizophrenia, which is one of the interventions included in the review.",Clozapine and weight gain,nan,7961563
False," The study does not focus on the specified patient populations (schizophrenia, bipolar disorder, major depressive disorder, behavioral and psychological symptoms of dementia, pervasive developmental disorders, and disruptive behavior disorders) or interventions (aripiprazole, asenapine, clozapine, iloperidone, olanzapine, paliperidone, quetiapine, risperidone, and ziprasidone).",Functional neuroimaging and pharmacogenetic studies of clozapines action at dopamine receptors,nan,7961575
True," The study meets the inclusion criteria as it involves a population with schizophrenia, a condition included in the review, and examines the effects of clozapine, an intervention included in the review.",Clozapine effects on glucose metabolic rate in striatum and frontal cortex,nan,7961576
True," The study population (clozapine-treated patients) and the focus on negative symptoms and extrapyramidal side effects align with the inclusion criteria, and the study presents data on correlations between measures of akinesia and anergia.",Clozapine negative symptoms and extrapyramidal side effects,nan,7961579
True," The study meets the inclusion criteria as it involves adults and adolescents with schizophrenia, a randomized controlled trial, and examines the effectiveness of clozapine on cognitive function.",Effects of clozapine on cognitive function in schizophrenia,nan,7961582
True," The study population includes adults with treatment-resistant mood disorders, which meets the inclusion criteria.",Clozapine in treatmentrefractory mood disorders,nan,7961583
True," The study meets the inclusion criteria as it involves adolescents with childhood-onset schizophrenia, which is one of the specified populations of interest, and examines the relationship between plasma clozapine and haloperidol concentrations and clinical response, which is a relevant outcome for this population.",Plasma clozapine and haloperidol concentrations in adolescents with childhoodonset schizophrenia association with response,nan,7961584
False," The study population does not match the inclusion criteria as it only includes adults and adolescents with neuroleptic-resistant schizophrenia, whereas the review includes a broader range of patient populations.",Clinical Action of Remoxipride,https://doi.org/10.1001/archpsyc.1994.03950120073012,7979877
True," The study meets the inclusion criteria as it involves a randomized controlled trial comparing the effects of clozapine, fluphenazine, and placebo on reaction time measures of attention and sensory dominance in patients with schizophrenia.",Effects of clozapine fluphenazine and placebo on reaction time measures of attention and sensory dominance in schizophrenia,https://doi.org/10.1016/0920-9964(94)90094-9,7986770
False," The study does not meet the inclusion criteria as it specifically focuses on clozapine-related seizures, which is a specific adverse event, and does not address the effectiveness or harms of clozapine in the treatment of the specified conditions.",Clozapinerelated seizures Experience with patients,https://doi.org/10.1212/wnl.44.12.2247,7991106
False," The study does not match the inclusion criteria as it does not focus on the specified patient populations (schizophrenia, bipolar disorder, major depressive disorder, behavioral and psychological symptoms of dementia, pervasive developmental disorders, and disruptive behavior disorders) or interventions (aripiprazole, asenapine, clozapine, iloperidone, olanzapine, paliperidone, quetiapone, risperidone, and ziprasidone).",The Neuropsychiatric Inventory Comprehensive assessment of psychopathology in dementia,https://doi.org/10.1212/wnl.44.12.2308,7991117
False," The study does not meet the inclusion criteria as it focuses on the pharmacokinetics of clozapine and its metabolite in a specific population of patients with schizophrenia, but does not address the effectiveness or harms of clozapine in any of the specified patient populations.",Disposition of Clozapine and Desmethylclozapine in Schizophrenic Patients,https://doi.org/10.1002/j.1552-4604.1994.tb02000.x,8006199
True," The study appears to meet all the inclusion criteria, including the population of interest (inpatients with various psychiatric disorders), interventions (various antipsychotics), and outcomes (effectiveness and harms).",Teaching Clinical Psychopharmacology on an Inpatient Psychiatric Research Center,https://doi.org/10.1002/j.1552-4604.1994.tb03988.x,8021328
True," The study meets the inclusion criteria as it involves patients with schizophrenia, a condition included in the review, and examines the effects of antipsychotic medications, which are also included in the review.",Quantitative effects of typical and atypical neuroleptics on smooth pursuit eye tracking in schizophrenia,https://doi.org/10.1016/0920-9964(94)90068-x,8043521
True," The study population includes patients with schizophrenia, which is one of the specified conditions of interest.",Effects of Limiting Medicaid DrugReimbursement Benefits on the Use of Psychotropic Agents and Acute Mental Health Services by Patients with Schizophrenia,https://doi.org/10.1056/nejm199409083311006,8052275
True," The study population includes adults and adolescents with schizophrenia, which meets the inclusion criteria for the review.",Seizures associated with clozapine treatment in a state hospital,nan,8071267
True," The study meets the inclusion criteria as it involves a population with schizophrenia, a specific intervention (clozapine treatment), and examines effectiveness outcomes (e.g., blocking of mCPP-induced ACTH and prolactin release).",Clozapine treatment and its effect on neuroendocrine responses induced by the serotonin agonist mchlorophenylpiperazine,https://doi.org/10.1016/0006-3223(94)91236-x,8080889
True," The study population (chronic schizophrenic outpatients) and intervention (clozapine) match the inclusion criteria, and the study design (randomized controlled trials are not mentioned, but the study is a comparative observational study) is acceptable for inclusion.",Clozapine Treatment of Outpatients With Schizophrenia Outcome and LongTerm Response Patterns,https://doi.org/10.1176/appi.ps.51.10.1249,8132186
True," The study population includes adults with schizophrenia, which is within the specified inclusion criteria.",The Effect of Clozapine on Plasma Norepinephrine Relationship to Clinical Efficacy,https://doi.org/10.1038/npp.1994.1,8179790
False," The study population specified in the abstract (schizophrenic patients who had been followed prospectively from the time of their first hospitalization and who were refractory to multiple clinical trials with typical neuroleptics) does not match the inclusion criteria, which include a broader range of patient populations (schizophrenia, bipolar disorder, major depressive disorder, and others).",Clozapine response in treatmentrefractory firstepisode schizophrenia,https://doi.org/10.1016/0006-3223(94)91259-9,8186332
False," The study population does not match the specified inclusion criteria as it only includes psychotic subjects, whereas the review includes a broader range of psychiatric disorders.",Clozapine and Metabolites,https://doi.org/10.1097/00004714-199404000-00006,8195452
False," The abstract does not mention any of the specified patient populations or interventions, and the focus is on cardiovascular disease, which is unrelated to the specified inclusion criteria.",Meaningful Interpretation of Risk Reduction from Clinical Drug Trials,https://doi.org/10.1177/106002809302701018,8251698
True," The study meets the inclusion criteria as it involves a population with a DSM-III diagnosis of schizophrenia, which is one of the specified conditions, and it is a randomized controlled trial, which is an acceptable study design for inclusion.",Changes in psychopathology and dyskinesia after neuroleptic withdrawal in a doubleblind design,https://doi.org/10.1016/0920-9964(93)90061-m,8260445
False," The study does not meet the inclusion criteria as it does not examine the effectiveness or harms of the specified interventions (clozapine, aripiprazole, asenapine, iloperidone, olanzapine, paliperidone, quetiapine, risperidone, and ziprasidone) in the specified patient populations.",Serum concentrations of clozapine and its major metabolites effects of cotreatment with fluoxetine or valproate,https://doi.org/10.1176/ajp.151.1.123,8267110
False," The study does not focus on the specified patient populations (schizophrenia, bipolar disorder, major depressive disorder, behavioral and psychological symptoms of dementia, pervasive developmental disorders, or disruptive behavior disorders) or interventions (aripiprazole, asenapine, clozapine, iloperidone, olanzapine, paliperidone, quetiapine, risperidone, and ziprasidone).",Clinical Response to Clozapine in Patients With Schizophrenia,https://doi.org/10.1001/archpsyc.1994.03950020083008,8297214
True," The study meets the inclusion criteria as it involves a comparison of the side effect profiles of two antipsychotic medications (risperidone and clozapine) in patients with schizophrenia or schizoaffective disorder, which is a relevant population for this review.",Different side effect profiles of risperidone and clozapine in outpatients with schizophrenia or schizoaffective disorder a pilot study,https://doi.org/10.1176/ajp.153.3.417,8610833
True," The study meets the inclusion criteria as it involves a naturalistic study of clozapine treatment in a state psychiatric hospital population, which is one of the interventions included in the review.",Dose related response to clozapine in a state psychiatric hospital population A naturalistic study,https://doi.org/10.1007/bf02244276,8623040
True, The study meets the inclusion criteria as it is a controlled study examining the effect of clozapine on weight gain in patients with schizophrenia.,Differential effect of clozapine on weight a controlled study,https://doi.org/10.1176/ajp.153.6.817,8633697
False," The study population does not match the inclusion criteria as it only includes patients currently treated with clozapine, whereas the review includes patients with various psychiatric conditions and treatment options.",Allelic association between a SerGly polymorphism in the dopamine D receptor gene and schizophrenia,https://doi.org/10.1007/bf02346178,8641685
False," The study does not meet the inclusion criteria for interventions, as it only includes clozapine, which is one of the specified interventions, but does not include other interventions such as aripiprazole, asenapine, iloperidone, olanzapine, paliperidone, quetiapine, risperidone, and ziprasidone.",Maintenance therapy with low doses of clozapine in schizophrenia,nan,8657050
False," The study does not meet the inclusion criteria as it does not examine the effectiveness of clozapine, but rather the association between HTA receptor gene polymorphisms and clozapine response.",Lack of association between polymorphisms in the HTA receptor gene and the antipsychotic response to clozapine,https://doi.org/10.1176/ajp.153.8.1092,8678181
False," The study population is limited to state hospital patients, which does not match the inclusion criteria of adults and adolescents with various psychiatric diagnoses.",Clozapine Eligibility Among State Hospital Patients,https://doi.org/10.1093/schbul/22.1.15,8685657
False," The study population does not match the inclusion criteria as it only includes adults and adolescents with schizophrenia, whereas the review includes a broader range of patient populations, including bipolar disorder, major depressive disorder, and behavioral and psychological symptoms of dementia.",ICI an Atypical Antipsychotic,https://doi.org/10.1097/00004714-199604000-00008,8690831
True," The study population includes adults with schizophrenia, schizoaffective disorder, and bipolar disorder, which aligns with the inclusion criteria.",Efficacy and Safety of Risperidone in Psychotic Patients An Open Study,https://doi.org/10.1177/030006059602400309,8725991
False," The study does not meet the inclusion criteria for interventions, as it involves famotidine, which is not one of the specified interventions (aripiprazole, asenapine, clozapine, iloperidone, olanzapine, paliperidone, quetiapine, risperidone, and ziprasidone).",Smooth Pursuit Eye Movements in the Evaluation of Famotidine Adjunctive Therapy of Schizophrenia A Preliminary Report,https://doi.org/10.1097/00002826-199619030-00011,8726548
False," The study population does not match the specified inclusion criteria as it only involves schizophrenic patients, whereas the inclusion criteria include a broader range of psychiatric disorders.",Using the proportional odds model to assess the relationship between a multiitem and a global item efficacy scale in a psychiatric clinical trial,https://doi.org/10.1080/10543409608835128,8732909
True," The study meets the inclusion criteria as it involves adults with treatment-resistant schizophrenia, a randomized controlled trial design, and examines the effectiveness of idazoxan as an adjunct to typical neuroleptics.",Idazoxan and Response to Typical Neuroleptics in TreatmentResistant Schizophrenia,https://doi.org/10.1192/bjp.168.5.571,8733795
False," The study population does not match the specified inclusion criteria as it only includes patients with tardive dyskinesia, whereas the review is focused on various psychiatric disorders and their treatments.",Diurnal and weekly variation of tardive dyskinesia measured by digital image processing,https://doi.org/10.1007/bf02247443,8739553
True," The study meets the inclusion criteria as it investigates the effectiveness of clozapine in patients with schizophrenia, which is one of the specified patient populations, and examines the relationship between a genetic polymorphism and treatment response.",Association between clozapine response and allelic variation in the HTC receptor gene,https://doi.org/10.1097/00001756-199512000-00041,8742444
True," The study meets the inclusion criteria as it focuses on the treatment of negative symptoms of schizophrenia with risperidone, which is one of the interventions included in the review.",Risperidone in the treatment of negative symptoms of schizophrenia,https://doi.org/10.1097/00004850-199511000-00001,8748041
False," The abstract does not mention any specific population or intervention that matches the inclusion criteria, as it only discusses the efficacy and safety of clozapine in general, without specifying the population or outcomes of interest.",Clozapine Efficacy and Safety,https://doi.org/10.1093/schbul/21.4.579,8749886
False," The study only focuses on the efficacy and safety of risperidone in the acute phase of schizophrenia, and does not address other patient populations or treatment durations mentioned in the inclusion criteria.",Risperidone Efficacy and Safety,https://doi.org/10.1093/schbul/21.4.593,8749887
False," The study population specified in the abstract (children with mental retardation) does not match the inclusion criteria (children with pervasive developmental disorders, disruptive behavior disorders, or other specified conditions).",The Nisonger CBRF A child behavior rating form for children with developmental disabilities,https://doi.org/10.1016/0891-4222(95)00039-9,8750075
True," The study meets the inclusion criteria as it involves adults with schizophrenia, uses a relevant intervention (neuroleptic treatment), and examines effectiveness outcomes such as symptom response and functional capacity.",Observation of Metabolic Changes in Chronic Schizophrenia After Neuroleptic Treatment by In Vivo Hydrogen Magnetic Resonance Spectroscopy,https://doi.org/10.1097/00004424-199606000-00006,8761867
True," The study meets the inclusion criteria as it involves a comparison of olanzapine with haloperidol and placebo in the treatment of schizophrenia, which is one of the patient populations of interest.",Olanzapine versus Placebo and Haloperidol,https://doi.org/10.1016/0893-133x(95)00069-p,8822534
False," The abstract does not mention any specific interventions (medications) that are included in the review, such as aripiprazole, asenapine, clozapine, iloperidone, olanzapine, paliperidone, quetiapine, risperidone, and ziprasidone.",Treatmentresistant schizophrenic patients,nan,8823348
False," The title and abstract do not mention any specific population or intervention that matches the inclusion criteria, and the abstract only discusses the effectiveness and side effects of risperidone without mentioning any outcomes or study design that matches the inclusion criteria.",Clinical experience with risperidone,nan,8823352
False," The study population does not match the inclusion criteria as it specifically focuses on patients who have experienced clozapine-induced agranulocytosis, which is not a primary diagnosis of interest in the review.",Free Radical Scavenging Enzyme Activity and Related Trace Metals in ClozapineInduced Agranulocytosis,https://doi.org/10.1097/00004714-199510000-00008,8830067
True," The study meets the inclusion criteria as it involves patients with schizophrenia, a condition included in the review, and examines the effectiveness of risperidone, an intervention included in the review.",Antipsychotic and Anxiolytic Properties of Risperidone Haloperidol and Methotrimeprazine in Schizophrenic Patients,https://doi.org/10.1097/00004714-199602000-00007,8834417
False," The study population in the abstract does not match the inclusion criteria as it does not specify the age range of the participants, and the study focuses on the use of risperidone in a teaching hospital, which is not a specific patient population.",Risperidone use in a teaching hospital during its first year after market approval economic and clinical implications,nan,8851645
False," The abstract does not discuss the effectiveness or harms of any of the specified interventions (aripiprazole, asenapine, clozapine, iloperidone, olanzapine, paliperidone, quetiapine, risperidone, and ziprasidone) in the specified patient populations, but rather discusses the limitations of pharmacoeconomic evaluations in the area of psychopharmacology.",Pharmaceutical decisionmaking pharmacoepidemiology or pharmacoeconomicswhos in the drivers seat,nan,8851647
False," The study population does not match the inclusion criteria as it includes children with autism, but the age range is specified as ""years old"" which is not a clear age range, and the study does not focus on the specified age ranges of 13-17 years or 18 years and older.",A controlled trial with ORG an ACTH analog in relatively able children with autism,https://doi.org/10.1016/0924-977x(95)00049-u,8866933
False, The study does not meet the inclusion criteria as it is about a rat brain study and does not involve any of the specified patient populations or interventions.,Mechanical lesions of the fimbria fornix in rat brain studied by Hmagnetic resonance imaging Evidence for longlasting dynamic alterations in the ipsilateral ventricular system,https://doi.org/10.1016/0924-977x(95)00055-t,8866934
True," The study meets the inclusion criteria as it involves patients with a psychotic disorder (Parkinsonian patients with delusions and psychotic behavior), the intervention is clozapine, and the study examines EEG changes as an outcome.",Electroencephalographic Findings with LowDose Clozapine Treatment in Psychotic Parkinsonian Patients,https://doi.org/10.1097/00002826-199619010-00007,8867521
False," The study population does not match the inclusion criteria as it only includes adults and adolescents with schizophrenia, bipolar disorder, and other specific conditions, but does not include children under 13 years old, which is a specified inclusion criterion.",Neutropenia and Agranulocytosis in Patients Receiving Clozapine in the UK and Ireland,https://doi.org/10.1192/bjp.169.4.483,8894200
True," The study meets the inclusion criteria as it involves a population with schizophrenia, a specific intervention (clozapine), and examines the relationship between a genetic polymorphism and clinical response.",Analysis of a structural polymorphism in the HTA receptor and clinical response to clozapine,https://doi.org/10.1016/0304-3940(96)13094-9,8916101
False," The study does not meet the inclusion criteria as it does not involve any of the specified interventions (aripiprazole, asenapine, clozapine, iloperidone, olanzapine, paliperidone, quetiapine, risperidone, and ziprasidone) and does not report on any of the specified effectiveness outcomes.",Serotoninmediated increase in cytosolic Ca in platelets of risperidonetreated schizophrenia patients,nan,8927657
True," The study meets the inclusion criteria as it involves adults and adolescents with schizophrenia, and it examines the effectiveness of Seroquel ICI, which is an intervention included in the review.",Plasma prolactin in schizophrenia subjects treated with Seroquel ICI,nan,8927658
True," The study meets the inclusion criteria as it is a head-to-head randomized controlled trial comparing the effectiveness of two antipsychotic medications, zotepine and haloperidol, in patients with acute exacerbation of schizophrenia.",A comparison of an atypical and typical antipsychotic zotepine versus haloperidol in patients with acute exacerbation of schizophrenia a parallelgroup doubleblind trial,nan,8927680
False," The study does not meet the inclusion criteria for interventions as it only includes olanzapine, whereas the review includes a range of antipsychotic medications.",Obsessivecompulsive symptoms in schizophrenia a comparison of olanzapine and placebo,nan,8927681
False," The study does not examine the effectiveness of clozapine, but rather the relationship between the HTC receptor polymorphism and clozapine response, which is not a primary outcome of interest for this review.",Clozapine response and the HTC CysSer polymorphism,https://doi.org/10.1097/00001756-199609020-00007,8930967
True," The study meets the inclusion criteria as it is a randomized controlled trial examining the effectiveness of glycine as an adjunctive therapy for treatment-resistant schizophrenia, which is a relevant population for this review.",DoubleBlind PlaceboControlled Crossover Trial of Glycine Adjuvant Therapy for TreatmentResistant Schizophrenia,https://doi.org/10.1192/bjp.169.5.610,8932891
False," The study population does not match the inclusion criteria as it specifically focuses on patients with Parkinson's disease, not the specified psychiatric disorders.",Melperone in the treatment of iatrogenic psychosis in Parkinsons disease,nan,8934152
True," The study meets the inclusion criteria as it involves a randomized controlled trial of olanzapine versus haloperidol treatment in patients with schizophrenia, and it examines the relationship between striatal D receptor binding and clinical improvement in olanzapine-treated patients.",Dopamine D receptor occupancy in vivo by the novel atypical antipsychotic olanzapine a IBZM single photon emission tomography SPET study,https://doi.org/10.1007/bf02245615,8935810
True," The study meets the inclusion criteria as it is a randomized controlled trial comparing olanzapine to placebo in patients with schizophrenia, which is one of the specified conditions of interest.",Olanzapine versus placebo results of a doubleblind fixeddose olanzapine trial,https://doi.org/10.1007/bf02245617,8935812
True," The study meets the inclusion criteria as it involves adults with schizophrenia, a condition included in the review, and examines the effectiveness of clozapine withdrawal and the addition of neuroleptic drugs and cyproheptadine, which are interventions included in the review.",Relapse following clozapine withdrawal effect of neuroleptic drugs and cyproheptadine,https://doi.org/10.1007/bf02245619,8935814
True," The study population includes adults and adolescents with schizophrenia, which is within the specified age range and diagnosis for inclusion.",Does eosinophilia predict clozapine induced neutropenia,https://doi.org/10.1007/bf02245622,8935817
False," The study population does not match the inclusion criteria as it only includes patients with schizophrenia, whereas the review includes a broader range of psychiatric conditions.",Cholinergic Rebound and Rapid Onset Psychosis Following Abrupt Clozapine Withdrawal,https://doi.org/10.1093/schbul/22.4.591,8938913
True," The study meets the inclusion criteria as it involves patients with treatment-refractory schizophrenia, which is one of the specified conditions, and examines the effectiveness of clozapine, which is an intervention included in the review.",Response of patients with treatmentrefractory schizophrenia to clozapine within three serum level ranges,https://doi.org/10.1176/ajp.153.12.1579,8942454
True, The study meets the inclusion criteria as it involves a randomized controlled trial comparing the efficacy and adverse effects of clozapine and haloperidol in children and adolescents with early-onset schizophrenia.,ChildhoodOnset Schizophrenia,https://doi.org/10.1001/archpsyc.1996.01830120020005,8956674
False," The title does not mention the specific population of interest (schizophrenia, bipolar disorder, major depressive disorder, etc.) or the intervention (quetiapine), making it unclear if the study meets the inclusion criteria.",Effects of Seroquel Quetiapine on Platelet Serotonin Binding in Schizophrenia,https://doi.org/10.1097/00004714-199612000-00015,8959478
True," The study meets the inclusion criteria as it is a randomized controlled trial comparing the efficacy and safety of risperidone with haloperidol in patients with chronic schizophrenia, which is a relevant population for this review.",Risperidone in the treatment of chronic schizophrenia multicenter study comparative to haloperidol,nan,8984849
False," The study population is limited to adults and adolescents with schizophrenia, and does not include other populations specified in the inclusion criteria.",Adjunctive Loxapine in a ClozapineResistant Cohort of Schizophrenic Patients,https://doi.org/10.3109/10401239609147759,8986313
False," The abstract does not mention any of the specified interventions (aripiprazole, asenapine, clozapine, iloperidone, olanzapine, paliperidone, quetiapine, risperidone, and ziprasidone) or patient populations (schizophrenia, bipolar disorder, major depressive disorder, behavioral and psychological symptoms of dementia, pervasive developmental disorders, and disruptive behavior disorders) that are included in the review.",Polypharmacy in bipolar I disorder,nan,8993078
False," The study population does not match the inclusion criteria as it only includes adults and adolescents with obsessive-compulsive disorder (OCD) and does not include the specified patient populations such as schizophrenia, bipolar disorder, major depressive disorder, or behavioral and psychological symptoms of dementia.",Therapeutic effect and safety of adjunctive risperidone in refractory obsessivecompulsive disorder OCD,nan,8993091
False," The study population is limited to long-term patients in Connecticut state hospitals, which does not match the inclusion criteria of adults and adolescents with various psychiatric disorders.",Clozapines effectiveness for patients in state hospitals results from a randomized trial,nan,8993092
True," The study population includes adults and adolescents with schizophrenia, which is within the specified age range and diagnosis for inclusion.",Longitudinal analysis of abnormal involuntary movements in longterm clozapinetreated patients,nan,8993093
True," The study meets the inclusion criteria as it investigates the weight gain induced by clozapine, a medication included in the review, in patients with schizophrenia and compares it to patients treated with haloperidol, another medication included in the review.",Weight gain induced by clozapine,https://doi.org/10.1016/0924-977x(95)80001-i,8998394
True," The study population consists of treatment-refractory patients with schizophrenia, which meets the inclusion criteria for patients with schizophrenia, including those with treatment resistance.",The Effects of Clozapine on Symptom Clusters in TreatmentRefractory Patients,https://doi.org/10.1097/00004714-199702000-00009,9004057
True," The study meets the inclusion criteria as it involves a retrospective chart review of schizophrenic patients, examines the impact of eligibility criteria on ethnic, gender, and age subgroups, and focuses on clozapine treatment.",Clozapine eligibility The effect of stringent criteria on ethnic gender and age subgroups of schizophrenic patients,https://doi.org/10.1016/s0278-5846(96)00130-3,9004341
False," The study population does not match the inclusion criteria as it only includes adults and adolescents taking clozapine and haloperidol, whereas the review focuses on a broader range of patient populations and interventions.",Predictive Value of Eosinophilia for Neutropenia During Clozapine Treatment,https://doi.org/10.4088/jcp.v57n1205,9010121
True," The study population includes adults with schizophrenia, which meets the inclusion criteria.",Blood levels of reduced halopertool versus clinical efficacy and extrapyramidal side effects of haloperidol,https://doi.org/10.1016/s0278-5846(97)00007-9,9061775
True," The study meets the inclusion criteria as it involves adults and adolescents with schizophrenia, unipolar depression, and bipolar disorder, and examines the effectiveness of a neural network based on adaptive resonance theory in suggesting treatment compared to expert opinions.",Neural network based on adaptive resonance theory as compared to experts in suggesting treatment for schizophrenic and unipolar depressed inpatients,https://doi.org/10.1007/bf02257284,9087885
True," The study meets the inclusion criteria as it involves a randomized controlled trial of olanzapine, a medication included in the review, in patients with schizophrenia, a condition included in the review.",Negative symptoms a path analytic approach to a doubleblind placebo and haloperidolcontrolled clinical trial with olanzapine,https://doi.org/10.1176/ajp.154.4.466,9090332
True, The study meets all the inclusion criteria as it is a meta-analysis of randomized controlled trials evaluating the effectiveness and side effects of risperidone in the treatment of schizophrenia.,Risperidone in the treatment of schizophrenia a metaanalysis of randomized controlled trials,https://doi.org/10.1177/026988119701100116,9097896
True," The study meets the inclusion criteria as it involves a randomized controlled trial of an antipsychotic drug (sertindole) in patients with schizophrenia, which is a relevant population for this review.",In vivo effects on striatal dopamine D receptor binding by the novel atypical antipsychotic drug sertindole a I IBZM single photon emission tomography SPET study,https://doi.org/10.1007/s002130050223,9106913
False," The study is a case series, which is not a randomized controlled trial, comparative observational study, or systematic review, and does not meet the inclusion criteria for study design.",Clozapine and Associated Diabetes Mellitus,https://doi.org/10.4088/jcp.v58n0304,9108812
True," The study meets the inclusion criteria as it involves patients with schizophrenia, a relevant population for this review, and examines the effectiveness of clozapine treatment, a relevant intervention.",Prediction of shortterm changes in symptom severity by baseline plasma homovanillic acid levels in schizophrenic patients receiving clozapine,https://doi.org/10.1016/s0165-1781(96)02993-9,9109179
False," The study population does not match the inclusion criteria as it specifically focuses on patients with Parkinson's disease, which is not mentioned in the inclusion criteria.",Benztropine versus clozapine for the treatment of tremor in Parkinsons disease,https://doi.org/10.1212/wnl.48.4.1077,9109903
True," The study meets the inclusion criteria as it involves patients with treatment-resistant schizophrenia, a relevant population for this review, and examines the effectiveness of switching from clozapine to risperidone, which is one of the included interventions.",Effects of switching inpatients with treatmentresistant schizophrenia from clozapine to risperidone,https://doi.org/10.1176/ps.47.12.1382,9117479
True," The study meets the inclusion criteria as it involves children (under 13 years) with a DSM-III-R or DSM-IV diagnosis of autistic disorder, which is one of the specified populations of interest.",An open clinical trial of risperidone monotherapy in young children with autistic disorder,nan,9133768
False," The study population is limited to patients with schizophrenia, schizoaffective disorder, or schizophreniform disorder, which does not match the inclusion criteria of various psychiatric disorders.",Substance abuse as a risk factor for tardive dyskinesia a retrospective analysis of patients,nan,9133772
True," The study meets the inclusion criteria as it involves a comparison of two antipsychotic medications (risperidone and haloperidol) in antipsychotic-naive schizophrenic patients, which is relevant to the review's focus on interventions for schizophrenia.",Adverse Effects of Risperidone on Eye Movement Activity A Comparison of Risperidone and Haloperidol in AntipsychoticNaive Schizophrenic Patients,https://doi.org/10.1016/s0893-133x(96)00195-9,9138438
False," The study population does not match the specified inclusion criteria as it only includes patients with dementia, whereas the inclusion criteria specify a wide range of psychiatric disorders, including schizophrenia, bipolar disorder, major depressive disorder, and pervasive developmental disorders.",Antipsychotic Treatment in Outpatients With Dementia,https://doi.org/10.1017/s1041610297003621,9154588
False," The abstract does not mention any of the specified psychiatric conditions or disorders, and the focus is on nursing home research from the industry's perspective, which does not align with the inclusion criteria.",Nursing Home Research From Industrys Perspective,https://doi.org/10.1017/s1041610297003645,9154590
False," The title and abstract do not specify the age range of the participants, which does not match the inclusion criteria that requires adults (18 years and older), adolescents (13-17 years), and children (under 13 years).",New Dimensions in the Pharmacologic Treatment of Schizophrenia and Related Psychoses,https://doi.org/10.1002/j.1552-4604.1997.tb04314.x,9156369
False," The study does not meet the inclusion criteria as it does not involve any of the specified patient populations (schizophrenia, bipolar disorder, major depressive disorder, behavioral and psychological symptoms of dementia, pervasive developmental disorders, or disruptive behavior disorders) and does not examine the specified interventions (aripiprazole, asenapine, clozapine, iloperidone, olanzapine, paliperidone, quetiapine, risperidone, and ziprasidone).",Risperidone Effects of Formulations on Oral Bioavailability,nan,9165565
True," The study meets the inclusion criteria as it involves a prospective study of young paranoid schizophrenic patients, specifically focusing on the relationship between cognitive and coping characteristics and stressful life events at the time of relapse.",Relapse in young paranoid schizophrenic patients a prospective study of stressful life events P measures and coping,https://doi.org/10.1176/ajp.154.6.792,9167506
True," The study meets the inclusion criteria as it is a randomized controlled trial comparing olanzapine with haloperidol in the treatment of patients with schizophrenia, which is one of the patient populations of interest.",Olanzapine versus haloperidol acute phase results of the international doubleblind olanzapine trial,https://doi.org/10.1016/s0924-977x(96)00392-6,9169300
True," The study population includes adults with schizophrenia, which is within the specified inclusion criteria.",Extrapyramidal Symptoms in Patients Treated With Risperidone,https://doi.org/10.1097/00004714-199706000-00010,9169965
False," The abstract does not mention any specific age range for the participants, which does not match the inclusion criteria that specifies adults (18 years and older), adolescents (13-17 years), and children (under 13 years).",Drug Treatment of Schizophrenia in the s,https://doi.org/10.2165/00003495-199753060-00002,9179524
False," The abstract does not mention any of the specified psychiatric disorders (schizophrenia, bipolar disorder, major depressive disorder, behavioral and psychological symptoms of dementia, pervasive developmental disorders, or disruptive behavior disorders) or the specified interventions (aripiprazole, asenapine, clozapine, iloperidone, olanzapine, paliperidone, quetiapone, risperidone, and ziprasidone).",Depression in the community,https://doi.org/10.1097/00004850-199701000-00003,9179630
True," The study meets the inclusion criteria as it involves a comparison of the extrapyramidal symptom profiles of olanzapine and haloperidol in patients with schizophrenia, which is a relevant population for this review.",Extrapyramidal Symptoms and Tolerability of Olanzapine Versus Haloperidol in the Acute Treatment of Schizophrenia,https://doi.org/10.4088/jcp.v58n0505,9184614
False," The study population is limited to patients with schizophrenia, which does not match the inclusion criteria of patients with schizophrenia, bipolar disorder, major depressive disorder, and behavioral and psychological symptoms of dementia.",Quetiapine in Patients With Schizophrenia,https://doi.org/10.1001/archpsyc.1997.01830180067009,9193196
False," The study population is limited to acutely psychotic inpatients with schizophrenia, which does not match the inclusion criteria of patients with schizophrenia (including first episode and treatment resistance), bipolar disorder, major depressive disorder, and behavioral and psychological symptoms of dementia.",The Effects of a Selective D Dopamine Receptor Antagonist L in Acutely Psychotic Inpatients With Schizophrenia,https://doi.org/10.1001/archpsyc.1997.01830180085011,9193198
True," The study meets the inclusion criteria as it involves adults with a DSM-III-R diagnosis of schizophrenia, a treatment-refractory population, and examines the serotonergic response to a specific intervention.",Heterogeneity of serotonergic response in treatmentrefractory schizophrenia patients,https://doi.org/10.1016/s0006-3223(96)00296-x,9193736
False," The study population does not match the inclusion criteria as it specifically focuses on patients with Parkinson's disease, which is not mentioned in the inclusion criteria.",Low Dose of Clozapine in the Treatment of Dopaminergic Psychosis in Parkinsons Disease,https://doi.org/10.1097/00002826-199706000-00003,9197942
False," The article does not focus on the specified patient populations (schizophrenia, bipolar disorder, major depressive disorder, behavioral and psychological symptoms of dementia, pervasive developmental disorders, and disruptive behavior disorders) and does not discuss the specified interventions (aripiprazole, asenapine, clozapine, iloperidone, olanzapine, paliperidone, quetiapine, risperidone, and ziprasidone).",Psychotropics,https://doi.org/10.1016/s0146-0005(97)80059-6,9201822
True," The study meets the inclusion criteria as it involves adults with schizophrenia, a specific population of interest, and examines the effects of clozapine, an intervention included in the review.",Clozapineinduced electroencephalogram changes as a function of clozapine serum levels,https://doi.org/10.1016/s0006-3223(96)00298-3,9209730
True," The study population includes adults with bipolar disorder, which is one of the specified patient populations of interest.",Response to clozapine in acute mania is more rapid than that of chlorpromazine,https://doi.org/10.1097/00004850-199703000-00006,9219046
False," The study population does not match the inclusion criteria as it only includes five patients with chronic schizophrenia, whereas the inclusion criteria specify a broader range of patient populations, including adolescents and children with various psychiatric disorders.",Sertindole Hydrochloride A Novel Antipsychotic Medication With a Favorable Side Effect Profile,https://doi.org/10.1097/00007611-199707000-00007,9225889
True," The study meets the inclusion criteria as it involves patients with schizophrenia, a relevant population for this review, and examines the effectiveness of risperidone compared to haloperidol, a relevant intervention.",Economic and Health State Utility Determinations for Schizophrenic Patients Treated With Risperidone or Haloperidol,https://doi.org/10.1097/00004714-199708000-00010,9241010
False," The study does not meet the inclusion criteria as it does not focus on the effectiveness or harms of the interventions listed, but rather on the hepatotoxicity of clozapine.",Hepatotoxicity of Clozapine,https://doi.org/10.1097/00004714-199708000-00012,9241012
False," The title and abstract do not mention any specific antipsychotic medication, but rather discuss the general treatment options for pregnant women with psychotic illnesses.",Antipsychotic Use in Pregnancy What Are the Best Treatment Options,https://doi.org/10.2165/00002018-199716060-00006,9241494
True," The study meets the inclusion criteria as it is a randomized controlled trial examining the effectiveness of clozapine versus chlorpromazine in patients with treatment-refractory schizophrenia, which is a relevant intervention for this review.",A doubleblind comparative study of clozapine versus chlorpromazine on Chinese patients with treatmentrefractory schizophrenia,https://doi.org/10.1097/00004850-199705000-00001,9248867
True," The study meets the inclusion criteria as it involves adults with schizophrenia, a condition included in the review, and examines the effectiveness of a medication (methylene blue) as an adjuvant to conventional neuroleptic medications.",Methylene Blue Adjuvant Therapy of Schizophrenia,https://doi.org/10.1097/00002826-199708000-00008,9260734
True," The study meets the inclusion criteria as it involves a randomized controlled trial of antipsychotic medications (haloperidol and remoxipride) in patients with schizophrenia, and assesses quality of life as an outcome measure.",Quality of life and response of negative symptoms in schizophrenia to haloperidol and the atypical antipsychotic remoxipride The Canadian Remoxipride Group,nan,9262046
False," The study population does not match the inclusion criteria as it only includes Chinese individuals with schizophrenia, whereas the review includes a broader range of populations with various psychiatric conditions.",Lack of allelic association between TC polymorphism of serotonin receptor type A gene and schizophrenia in Chinese,https://doi.org/10.1097/00041444-199700710-00005,9264136
False, The study does not examine the effectiveness of olanzapine in any of the specified patient populations or outcomes of interest.,Dosing the antipsychotic medication olanzapine,nan,9265916
True," The study meets the inclusion criteria as it involves adults with a DSM-III-R diagnosis of schizophrenia, a randomized controlled trial, and examines the effectiveness of quetiapine in comparison to haloperidol and placebo.",Multiple fixed doses of Seroquel quetiapine in patients with acute exacerbation of schizophrenia A comparison with haloperidol and placebo,https://doi.org/10.1016/s0006-3223(97)00190-x,9270900
True," The study population includes adults and adolescents with schizophrenia, which matches the inclusion criteria.",The Influence of Clozapine Treatment on Plasma Granulocyte ColonyStimulating GCSF Levels,https://doi.org/10.1055/s-2007-979495,9271776
False," The abstract does not mention any of the specified interventions (aripiprazole, asenapine, clozapine, iloperidone, olanzapine, paliperidone, quetiapine, risperidone, and ziprasidone) or patient populations (schizophrenia, bipolar disorder, major depressive disorder, behavioral and psychological symptoms of dementia, pervasive developmental disorders, and disruptive behavior disorders) that are included in the review.",Clozapine Withdrawal Serotonergic or Dopaminergic Mechanisms,https://doi.org/10.1001/archpsyc.1997.01830200094013,9283512
True," The study population includes treatment-refractory patients with schizophrenia, which meets the inclusion criteria for patients with schizophrenia, including those with treatment resistance.",Time to clozapine response in a standardized trial,https://doi.org/10.1176/ajp.154.9.1243,9286183
True," The study meets the inclusion criteria as it involves a randomized controlled trial of clozapine and haloperidol in patients with refractory schizophrenia, which is a relevant intervention for this review.",A Comparison of Clozapine and Haloperidol in Hospitalized Patients with Refractory Schizophrenia,https://doi.org/10.1056/nejm199709183371202,9295240
True, The study meets the inclusion criteria as it is a head-to-head randomized controlled trial comparing the efficacy and safety of olanzapine and risperidone in the treatment of schizophrenia and other psychotic disorders.,DoubleBlind Comparison of Olanzapine Versus Risperidone in the Treatment of Schizophrenia and Other Psychotic Disorders,https://doi.org/10.1097/00004714-199710000-00010,9315992
False," The title does not mention the specific intervention (Risperidone) being studied, which is a required inclusion criterion.",Effects of Risperidone on Polydipsia in Chronic Schizophrenia Patients,https://doi.org/10.1097/00004714-199710000-00021,9316001
False," The title does not mention the specific intervention (risperidone) that the review is focused on, and the abstract does not provide any information about the study's population, intervention, or outcomes.",Weight Gain With Risperidone,https://doi.org/10.1097/00004714-199710000-00022,9316002
True," The study meets the inclusion criteria as it examines the immunomodulatory effects of clozapine in schizophrenia patients, which is a relevant intervention for the review.",In vivo immunomodulatory effects of clozapine in schizophrenia,https://doi.org/10.1016/s0920-9964(97)00057-1,9323354
True," The study meets the inclusion criteria as it involves adults with schizophrenia, a randomized controlled trial, and examines the effectiveness of clozapine in comparison to a placebo.",Clozapine Blunts NMethyldAspartate AntagonistInduced Psychosis A Study with Ketamine,https://doi.org/10.1016/s0006-3223(96)00546-x,9325559
False," The study population specified in the abstract (schizophrenic patients) does not match the inclusion criteria, which includes a broader range of patient populations such as bipolar disorder, major depressive disorder, and behavioral and psychological symptoms of dementia.",D Dopamine Receptor Occupancy A Crossover Comparison of Risperidone With Clozapine Therapy in Schizophrenic Patients,https://doi.org/10.1001/archpsyc.1997.01830220102017,9337781
False," The study does not focus on the effects of clozapine, but rather on the effects of dioxin exposure.",Mortality in Current and Former Users of Clozapine,https://doi.org/10.1097/00001648-199710000-00010,9345668
True, The study meets the inclusion criteria as it involves a within-subject comparison of the effects of clozapine and haloperidol on plasma levels of neurotransmitters and metabolites in patients with schizophrenia or schizoaffective disorder.,Effects of Clozapine on Plasma Catecholamines and Relation to Treatment Response in Schizophrenia A WithinSubject Comparison with Haloperidol,https://doi.org/10.1016/s0893-133x(97)00073-0,9348547
True," The study meets the inclusion criteria as it is a randomized controlled trial comparing the efficacy of quetiapine and chlorpromazine in the treatment of schizophrenia, which is one of the interventions included in the review.",A comparison of quetiapine and chlorpromazine in the treatment of schizophrenia,https://doi.org/10.1111/j.1600-0447.1997.tb10162.x,9350955
False," The study population is revolving door inpatients with schizophrenia, which does not match the inclusion criteria of patients with schizophrenia, bipolar disorder, major depressive disorder, and behavioral and psychological symptoms of dementia.",Assessment and treatment selection for revolving door inpatients with schizophrenia,https://doi.org/10.1023/a:1025499131905,9355136
False," The study population does not match the inclusion criteria as it only includes patients with psychoses, whereas the review includes patients with schizophrenia, bipolar disorder, major depressive disorder, and behavioral and psychological symptoms of dementia.",PET Evidence That Loxapine Is an Equipotent Blocker of HTand DReceptors Implications for the Therapeutics of Schizophrenia,https://doi.org/10.1176/ajp.154.11.1525,9356559
False," The study population does not match the inclusion criteria as it specifically targets elderly patients with agitation and neuropsychiatric disorders, whereas the inclusion criteria specify a broader range of disorders and age groups.",An Open Trial of Valproate for Agitation in Geriatric Neuropsychiatric Disorders,https://doi.org/10.1097/00019442-199700540-00010,9363292
False," The study population does not match the inclusion criteria as it only includes adults and adolescents with schizophrenia, whereas the review includes children under 13 years with various disorders.",The acute and longterm effect of olanzapine compared with placebo and haloperidol on serum prolactin concentrations,https://doi.org/10.1016/s0920-9964(97)00036-4,9376336
False," The study population does not match the inclusion criteria as it only includes patients with rapid-cycling bipolar disorder, whereas the review includes a broader range of psychiatric disorders.",Effects of Exogenous Melatonin Administration and Withdrawal in Five Patients With RapidCycling Bipolar Disorder,https://doi.org/10.4088/jcp.v58n0902,9378688
False," The title and abstract do not mention the specific patient populations (schizophrenia, bipolar disorder, major depressive disorder, etc.) that are included in the review, and the study focuses on the use of clozapine in nonschizophrenic patients, which is outside the scope of the review.",Uses of Clozapine in Nonschizophrenic Patients,https://doi.org/10.3109/10673229409017130,9384895
False," The study population specified in the abstract (adults with schizophrenia) does not match the inclusion criteria which includes a broader range of populations (schizophrenia, bipolar disorder, major depressive disorder, behavioral and psychological symptoms of dementia, pervasive developmental disorders, and disruptive behavior disorders).",Olanzapine A New Antipsychotic Agent with Efficacy in the Management of Schizophrenia,https://doi.org/10.1177/106002809703101110,9391688
False," The study population does not match the inclusion criteria as it only includes adults and adolescents with schizophrenia, whereas the review includes a broader range of patient populations, including children, older adults, and those with other psychiatric conditions.",Olanzapine Plasma Concentrations and Clinical Response in Acutely Ill Schizophrenic Patients,https://doi.org/10.1097/00004714-199712000-00006,9408810
True," The study meets the inclusion criteria as it is a randomized controlled trial evaluating the effectiveness of olanzapine compared to haloperidol and placebo in patients with schizophrenia, which is a condition included in the review.",Olanzapine Versus Placebo and Haloperidol Quality of Life and Efficacy Results of the North American DoubleBlind Trial,https://doi.org/10.1016/s0893-133x(97)00111-5,9408917
True," The study meets the inclusion criteria as it is a cost-effectiveness analysis comparing olanzapine and haloperidol in the treatment of schizophrenia in Spain, which is a relevant population for this review.",Cost effectiveness analysis of olanzapine versus haloperidol in the treatment of schizophrenia in Spain,nan,9412161
False, The abstract does not provide information about the population of interest (childhood-onset schizophrenia) as it appears to focus on a broader range of psychiatric disorders and age groups.,ChildhoodOnset Schizophrenia,https://doi.org/10.1001/archpsyc.55.1.90,9435769
False, The study population does not match the inclusion criteria as it only includes elderly women with schizophrenia and does not cover the broader age range or other diagnoses specified in the inclusion criteria.,Differential Effect of Haloperidol and Clozapine on Plasma Homovanillic Acid in Elderly Schizophrenic Patients with or without Tardive Dyskinesia,https://doi.org/10.1016/s0006-3223(97)00257-6,9442340
True," The study meets the inclusion criteria as it involves patients with treatment-resistant schizophrenia, which is one of the specified patient populations, and examines the effectiveness of intensive treatment packages, including a new antipsychotic, which is one of the specified interventions.",A study of enhanced management in patients with treatmentresistant schizophrenia,https://doi.org/10.1177/026988119701100411,9443524
False," The study population does not match the inclusion criteria as it specifically focuses on patients with treatment-resistant schizophrenia, whereas the review includes a broader range of psychiatric disorders.",The use of videotaped assessment in relation to a study of enhanced management in treatmentresistant schizophrenia,https://doi.org/10.1177/026988119701100412,9443525
True," The study meets the inclusion criteria as it involves adults with schizophrenia, a condition included in the review, and examines the effectiveness of risperidone, an intervention included in the review.",The Effects of Risperidone on the Five Dimensions of Schizophrenia Derived by Factor Analysis,https://doi.org/10.4088/jcp.v58n1205,9448657
False," The study population does not match the inclusion criteria as it only includes adults and adolescents with schizophrenia, whereas the review includes children and adolescents with various disorders, and adults with major depressive disorder and behavioral and psychological symptoms of dementia.",Longterm clinical experience with clozapine,nan,9453932
True," The study meets the inclusion criteria as it focuses on schizophrenia, a condition included in the review, and examines factors influencing relapse in the long-term course of the disease.",Factors influencing relapse in the longterm course of schizophrenia,https://doi.org/10.1016/s0920-9964(97)00131-x,9468354
True," The article meets all the inclusion criteria as it focuses on the treatment of various psychiatric disorders, including schizophrenia, bipolar disorder, and major depressive disorder, with new antipsychotics, and examines their effectiveness and potential for early intervention.",The new antipsychotics and their potential for early intervention in schizophrenia,https://doi.org/10.1016/s0920-9964(97)00115-1,9468355
False," The abstract does not mention any specific interventions or outcomes related to the inclusion criteria, and it does not appear to be a study examining the effectiveness of the specified interventions in the specified patient populations.",Altered consciousness states and endogenous psychoses a common molecular pathway,https://doi.org/10.1016/s0920-9964(97)00116-3,9468359
False," The study population consists of healthy male volunteers, not patients with schizophrenia, bipolar disorder, or other conditions specified in the inclusion criteria.",The Effect of Timing of a Standard Meal on the Pharmacokinetics and Pharmacodynamics of the Novel Atypical Antipsychotic Agent Ziprasidone,nan,9469675
False," The title and abstract do not mention the specific population of interest (schizophrenia, bipolar disorder, major depressive disorder, etc.) or the interventions of interest (atypical antipsychotics), making it unclear if the study meets the inclusion criteria.",Sertindole a New Atypical Antipsychotic for the Treatment of Schizophrenia,nan,9469684
False," The study population does not match the inclusion criteria as it only includes schizophrenic patients, whereas the review includes a broader range of patient populations such as bipolar disorder, major depressive disorder, and behavioral and psychological symptoms of dementia.",Pharmacokinetic Interactions of Clozapine With Selective Serotonin Reuptake Inhibitors,https://doi.org/10.1097/00004714-199802000-00002,9472836
False," The study does not focus on the specified patient populations (schizophrenia, bipolar disorder, major depressive disorder, behavioral and psychological symptoms of dementia, pervasive developmental disorders, or disruptive behavior disorders) or interventions (listed in the inclusion criteria).",Modification of the Clinical Global Impressions CGI scale for use in bipolar illness BP the CGIBP,https://doi.org/10.1016/s0165-1781(97)00123-6,9481807
False," The study does not meet the inclusion criteria as it does not focus on the effectiveness or harms of the specified interventions (e.g., aripiprazole, asenapine, clozapine, iloperidone, olanzapine, paliperidone, quetiapine, risperidone, and ziprasidone) in the specified patient populations.",The dopamine D receptor DRD SerGly polymorphism and schizophrenia a haplotype relative risk study and association with clozapine response,https://doi.org/10.1038/sj.mp.4000288,9491816
False," The study focuses on translating research into practice for schizophrenia treatment, which does not match the broad range of patient populations specified in the inclusion criteria.",Translating Research Into Practice The Schizophrenia Patient Outcomes Research Team PORT Treatment Recommendations,https://doi.org/10.1093/oxfordjournals.schbul.a033302,9502542
False," The study does not focus on the specified interventions (aripiprazole, asenapine, clozapine, iloperidone, olanzapine, paliperidone, quetiapine, risperidone, and ziprasidone) or patient populations (schizophrenia, bipolar disorder, major depressive disorder, behavioral and psychological symptoms of dementia, pervasive developmental disorders, and disruptive behavior disorders) specified in the inclusion criteria.",Patterns of Usual Care for Schizophrenia Initial Results From the Schizophrenia Patient Outcomes Research Team PORT Client Survey,https://doi.org/10.1093/oxfordjournals.schbul.a033303,9502543
True," The study meets the inclusion criteria as it involves adolescents with schizophrenia, a DSM-III-R diagnosis, and examines the effects of clozapine treatment on plasma biogenic amines and psychopathology measures.",Blood biogenic amines during clozapine treatment of earlyonset schizophrenia,https://doi.org/10.1007/bf01273320,9503259
False," The study population does not match the inclusion criteria as it only includes healthy men ages 20-40 years, whereas the review includes adults and adolescents with various psychiatric disorders.",Olanzapine Interaction Study with Imipramine,https://doi.org/10.1002/j.1552-4604.1997.tb04272.x,9505989
False," The abstract does not mention any specific medication from the list of included interventions (aripiprazole, asenapine, clozapine, iloperidone, olanzapine, paliperidone, quetiapine, risperidone, and ziprasidone).",New Atypical Antipsychotics,https://doi.org/10.2165/00002512-199812020-00004,9509290
True," The study meets the inclusion criteria as it involves a randomized controlled trial of a novel antipsychotic agent (olanzapine) in patients with schizophrenia, which is a relevant population for this review.",Depressive Signs and Symptoms in Schizophrenia,https://doi.org/10.1001/archpsyc.55.3.250,9510219
True," The study population includes patients with schizophrenia, which meets the inclusion criteria.",The effects of clozapine on negative symptoms in patients with schizophrenia with minimal positive symptoms,https://doi.org/10.1023/a:1022352326334,9511946
True," The study meets the inclusion criteria as it involves adults with schizophrenia, a specific type of intervention (sulpiride augmentation in people with schizophrenia partially responsive to clozapine), and effectiveness outcomes such as symptom response, which are relevant to the review.",Sulpiride augmentation in people with schizophrenia partially responsive to clozapine,https://doi.org/10.1192/bjp.171.6.569,9519099
True, The study meets the inclusion criteria as it is a meta-analysis comparing the efficacy and safety of risperidone and haloperidol in patients with chronic schizophrenia.,Risperidone versus haloperidol I metaanalysis of efficacy and safety,https://doi.org/10.1016/s0149-2918(98)80034-9,9522104
True," The study meets the inclusion criteria as it compares the cost-effectiveness of risperidone and haloperidol in patients with chronic schizophrenia, which is one of the specified patient populations.",Risperidone versus haloperidol II Costeffectiveness,https://doi.org/10.1016/s0149-2918(98)80046-5,9522115
True," The study meets the inclusion criteria as it involves adults with treatment-resistant schizophrenia, a relevant population for this review, and compares the effectiveness of clozapine and risperidone, which are included interventions.",An Open Comparison of Clozapine and Risperidone in TreatmentResistant Schizophrenia,https://doi.org/10.1055/s-2007-979291,9524981
True," The study meets the inclusion criteria as it involves patients with schizophrenia, a relevant population for the review, and examines the relationship between a medication (clozapine) and a specific outcome (heart rate variability).",Correlation between plasma clozapine concentration and heart rate variability in schizophrenic patients,https://doi.org/10.1007/s002130050520,9539257
True, The study meets all the inclusion criteria as it is a randomized double-blind study comparing the efficacy and safety of risperidone and clozapine in treatment-resistant chronic schizophrenia patients.,Risperidone Versus Clozapine in TreatmentResistant Chronic Schizophrenia A Randomized DoubleBlind Study,https://doi.org/10.1176/ajp.155.4.499,9545995
True," The study meets the inclusion criteria as it involves a population with schizophrenia, a relevant intervention (antipsychotic drugs), and relevant outcomes (HTA receptor blockade).",Binding of Antipsychotic Drugs to Cortical HTAReceptors A PET Study of Chlorpromazine Clozapine and Amisulpride in Schizophrenic Patients,https://doi.org/10.1176/ajp.155.4.505,9545996
True," The study meets the inclusion criteria as it involves adults with schizophrenia, a condition included in the review, and examines the effectiveness of risperidone, an intervention included in the review.",Therapeutic Equivalence of Risperidone Given Once Daily and Twice Daily in Patients With Schizophrenia,https://doi.org/10.1097/00004714-199804000-00002,9555595
True, The study meets the inclusion criteria as it involves a randomized controlled trial comparing the efficacy of risperidone with a combination of haloperidol and amitriptyline in patients with coexisting psychotic and depressive symptoms.,Risperidone Versus Haloperidol and Amitriptyline in the Treatment of Patients With a Combined Psychotic and Depressive Syndrome,https://doi.org/10.1097/00004714-199804000-00003,9555596
False," The title does not mention the specific interventions or populations of interest, which are the inclusion criteria for this review.",Comments on Article by Tran and Associates DoubleBlind Comparison of Olanzapine Versus Risperidone in Treatment of Schizophrenia and Other Psychotic Disorders,https://doi.org/10.1097/00004714-199804000-00015,9555606
False," The study population does not include children under 13 years, which is outside the specified age range for children with pervasive developmental disorders and disruptive behavior disorders.",Longterm efficacy and safety comparison of sertindole and haloperidol in the treatment of schizophrenia The Sertindole Study Group,nan,9564200
True," The study meets the inclusion criteria as it involves adults with schizophrenia, a randomized controlled trial, and examines the relationship between extrapyramidal side effects and negative symptoms of schizophrenia.",The relationship between negative symptoms of schizophrenia and extrapyramidal side effects with haloperidol and olanzapine,nan,9564201
False," The study population specified in the abstract is not clearly defined, but it appears to be adults initiated on risperidone therapy at an inpatient psychiatric treatment facility, which does not match the inclusion criteria of children (under 13 years) and adolescents (13-17 years) with pervasive developmental disorders and disruptive behavior disorders.",Risperidone clinical outcome predictors and costeffectiveness in a naturalistic setting,nan,9564202
True," The study meets the inclusion criteria as it involves patients with schizophrenia, a diagnosis of interest in the review, and examines the effects of clozapine, an intervention of interest in the review.",Topographic Analysis of EEG Photic Driving in Patients with Schizophrenia following Clozapine Treatment,https://doi.org/10.1177/155005949802900205,9571294
True," The study meets the inclusion criteria as it involves aripiprazole, a medication included in the review, and examines its effects on schizophrenia patients, a population of interest in the review.",Spontaneous brain magnetic activity in schizophrenia patients treated with aripiprazole,nan,9580382
False, The abstract does not mention any specific population or interventions that match the inclusion criteria.,The membrane phospholipid hypothesis as a biochemical basis for the neurodevelopmental concept of schizophrenia,https://doi.org/10.1016/s0920-9964(97)00151-5,9589514
True," The study meets the inclusion criteria as it involves patients with schizophrenia and schizoaffective disorders, which are included in the review, and examines the effectiveness of clozapine in reducing hospital utilization, which is a relevant outcome for the review.",Psychiatric Hospital Utilization in Patients Treated With Clozapine for up to Years in a State Mental Health Care System,https://doi.org/10.4088/jcp.v59n0408,9590670
False," The study population is limited to patients with bipolar I disorder, which does not meet the inclusion criteria of patients with schizophrenia, including other psychotic disorders, bipolar disorder, major depressive disorder, or behavioral and psychological symptoms of dementia.",Olanzapine in treatmentresistant bipolar disorder,https://doi.org/10.1016/s0165-0327(98)00002-0,9609675
True, The study meets the inclusion criteria as it is a randomized controlled trial examining the effectiveness of olanzapine versus haloperidol and placebo in treating anxious and depressive symptoms in schizophrenia.,A DoubleBlind Controlled Comparison of the Novel Antipsychotic Olanzapine versus Haloperidol or Placebo on Anxious and Depressive Symptoms Accompanying Schizophrenia,https://doi.org/10.1016/s0006-3223(98)00093-6,9611669
True," The study meets the inclusion criteria as it is a randomized controlled trial comparing the efficacy of risperidone with lithium and haloperidol in the treatment of mania, which is one of the interventions included in the review.",Risperidone compared with both lithium and haloperidol in mania a doubleblind randomized controlled trial,nan,9617509
True," The study meets the inclusion criteria as it involves a randomized controlled trial examining the effectiveness of clozapine in patients with schizophrenia, including those with and without the deficit syndrome, and reports on various outcomes such as symptom response, social and occupational functioning, and quality of life.",Positive and negative symptom response to clozapine in schizophrenic patients with and without the deficit syndrome,https://doi.org/10.1176/ajp.155.6.751,9619146
False," The study population does not match the specified inclusion criteria, as it focuses on agitated demented elderly patients, whereas the review includes patients with various psychiatric conditions, including schizophrenia, bipolar disorder, major depressive disorder, and pervasive developmental disorders.",A review of anticonvulsants in treating agitated demented elderly patients,nan,9620110
False," The title does not specify the population or intervention, making it unclear if the study meets the inclusion criteria.",Olanzapineinduced weight gain,https://doi.org/10.1023/a:1026154730108,9622049
True," The study population (chronic schizophrenic Thai patients) and intervention (risperidone) match the inclusion criteria, and the study design (randomized controlled trial) meets the inclusion criteria for study design.",Efficacy and tolerability of risperidone in chronic schizophrenic Thai patients,nan,9623031
False," The study population does not match the inclusion criteria as it only includes schizophrenic inpatients, whereas the review includes a broader range of patient populations such as bipolar disorder, major depressive disorder, and behavioral and psychological symptoms of dementia.",Serum concentrations of clozapine and N desmethylclozapine are unaffected by the potent CYPA inhibitor itraconazole,https://doi.org/10.1007/s002280050440,9626923
False," The study does not meet the inclusion criteria as it is an in vitro study examining the effects of clozapine on immune parameters in patients with schizophrenia, whereas the review is focused on effectiveness and harms of clozapine in various patient populations.",Effects of Clozapine on In Vitro Immune Parameters A Longitudinal Study in ClozapineTreated Schizophrenic Patients,https://doi.org/10.1016/s0893-133x(98)00006-2,9629565
True," The study meets the inclusion criteria as it involves adults and adolescents with schizophrenia, examines the effectiveness of clozapine, and includes randomized controlled trials as the study design.",Serotonin Subtype Receptor Genes and Clinical Response to Clozapine in Schizophrenia Patients,https://doi.org/10.1016/s0893-133x(98)00007-4,9629566
True," The study meets the inclusion criteria as it involves patients with schizophrenia, uses a relevant outcome measure (striatal dopamine D2 receptor availability), and examines the relationship between dopamine receptor availability and negative symptoms.",Psychomotor slowing negative symptoms and dopamine receptor availabilityan IBZM SPECT study in neuroleptictreated and drugfree schizophrenic patients,https://doi.org/10.1016/s0920-9964(98)00003-6,9633833
False," The study population is treatment-resistant schizophrenia patients, which does not match the inclusion criteria of patients with first episode schizophrenia or patients refractory to treatment.",Olanzapine Compared With Chlorpromazine in TreatmentResistant Schizophrenia,https://doi.org/10.1176/ajp.155.7.914,9659857
True," The study meets the inclusion criteria as it involves a population with schizophrenia, a relevant intervention (olanzapine), and relevant outcomes (occupancy of serotonin and dopamine receptors, clinical status, extrapyramidal side effects, and prolactin levels).",HTand DReceptor Occupancy of Olanzapine in Schizophrenia A PET Investigation,https://doi.org/10.1176/ajp.155.7.921,9659858
False," The study does not meet the inclusion criteria for interventions, as it only focuses on clozapine, whereas the review includes a range of antipsychotic medications.",Longterm outcome with clozapine,https://doi.org/10.1097/00004850-199803000-00003,9669187
True," The study meets the inclusion criteria as it involves patients with schizophrenia and bipolar disorder, and examines the prevalence of diabetes and impaired glucose tolerance in patients treated with clozapine compared to conventional depot neuroleptics.",Prevalence of Diabetes and Impaired Glucose Tolerance in Patients Treated With Clozapine Compared With Patients Treated With Conventional Depot Neuroleptic Medications,https://doi.org/10.4088/jcp.v59n0604,9671341
True," The study meets the inclusion criteria as it involves adults and adolescents with schizophrenia, examines the effectiveness of clozapine, and includes randomized controlled trials as the study design.",Does Participation in Psychosocial Treatment Augment the Benefit of Clozapine,https://doi.org/10.1001/archpsyc.55.7.618,9672052
False," The study population is adults with autistic disorder and other pervasive developmental disorders, which is outside the specified age range of 13-17 years for adolescents with pervasive developmental disorders.",A Doubleblind PlaceboControlled Study of Risperidone in Adults With Autistic Disorder and Other Pervasive Developmental Disorders,https://doi.org/10.1001/archpsyc.55.7.633,9672054
True, The study meets the inclusion criteria as it involves a randomized controlled trial comparing the effects of risperidone and haloperidol on emotion perception in treatment-resistant schizophrenia patients.,Risperidone versus haloperidol for perception of emotion in treatmentresistant schizophrenia preliminary findings,https://doi.org/10.1016/s0920-9964(98)00026-7,9689720
True," The study population (patients with schizophrenia, bipolar disorder, major depressive disorder, and behavioral and psychological symptoms of dementia) and interventions (quetiapine and usual-care medications) align with the specified inclusion criteria.",Medicalclaims databases in the design of a healthoutcomes comparison of quetiapine SeroquelSeroquel is a trademark the property of Zeneca Limited and usualcare antipsychotic medication,https://doi.org/10.1016/s0920-9964(98)00040-1,9690334
True," The study meets the inclusion criteria as it involves a randomized controlled trial of ziprasidone in patients with schizophrenia or schizoaffective disorder, which is a relevant population for this review.",An Exploratory HaloperidolControlled DoseFinding Study of Ziprasidone in Hospitalized Patients With Schizophrenia or Schizoaffective Disorder,https://doi.org/10.1097/00004714-199808000-00009,9690695
False," The title does not mention the specific intervention (olanzapine) that is the focus of the paper, which is a required inclusion criterion.",OlanzapineInduced Reversible Priaprism,https://doi.org/10.1097/00004714-199808000-00023,9690708
True," The study meets the inclusion criteria as it involves long-term treatment of chronic schizophrenia with risperidone, which is one of the interventions included in the review.",Longterm treatment of chronic schizophrenia with risperidone,https://doi.org/10.1097/00004850-199805000-00001,9690975
True," The study meets the inclusion criteria as it involves adults and adolescents with a DSM-III-R diagnosis of schizophrenia, and it examines the effectiveness of clozapine compared to typical neuroleptics.",Early developmental differences between DSMIIIR schizophrenics treated with clozapine and typical neuroleptics,https://doi.org/10.1016/s0022-3956(98)00056-9,9694006
True," The study meets the inclusion criteria as it is a randomized controlled trial examining the effectiveness of amisulpride in treating schizophrenia, a condition included in the review, and reports on efficacy and adverse effects, which are relevant outcomes of interest.",Amisulpride an atypical antipsychotic in the treatment of acute episodes of schizophrenia a doseranging study vs haloperidol,https://doi.org/10.1111/j.1600-0447.1998.tb10044.x,9696517
True," The study meets the inclusion criteria as it involves adults with a DSM-III-R or DSM-IV diagnosis of schizophrenia, and examines the effectiveness of clozapine in controlling aggressive, impulsive, and suicidal behavior.",Diminished suicidal and aggressive behavior high plasma norepinephrine levels and serum triglyceride levels in chronic neurolepticresistant schizophrenic patients maintained on clozapine,nan,9704166
False," The study population does not match the inclusion criteria as it only includes schizophrenic patients and normal control subjects, whereas the inclusion criteria specify a wide range of psychiatric disorders and populations.",Immediate versus delayed visual memory task performance among schizophrenic patients and normal control subjects,https://doi.org/10.1016/s0165-1781(98)00040-7,9704872
True," The study meets the inclusion criteria as it examines the effectiveness of clozapine therapy in reducing the risk of suicide among patients with schizophrenia and schizoaffective disorder, which is a relevant population for this review.",Suicide Prevention Effects Associated With Clozapine Therapy in Schizophrenia and Schizoaffective Disorder,https://doi.org/10.1176/ps.49.8.1029,9712207
True," The study meets the inclusion criteria as it involves a meta-analysis of studies on genetic variation in HTA receptors and clozapine response, which is a relevant topic for the review.",Metaanalysis of studies on genetic variation in HTA receptors and clozapine response,https://doi.org/10.1016/s0920-9964(98)00032-2,9713904
False," The study population does not match the inclusion criteria as it only includes Medicaid recipients in the State of Georgia, whereas the inclusion criteria specify a broader age range and various psychiatric conditions.",Expenditures for Treating Schizophrenia A PopulationBased Study of Georgia Medicaid Recipients,https://doi.org/10.1093/oxfordjournals.schbul.a033342,9718639
False," The study does not meet the inclusion criteria as it does not involve human subjects, but rather focuses on animal models (mice and rats) to study the effects of antipsychotic action exerted through HTA receptor antagonism.",Rodent data and general hypothesis antipsychotic action exerted through HTA receptor antagonism is dependent on increased serotonergic tone,https://doi.org/10.1007/s007020050064,9720968
False," The study does not meet the inclusion criteria as it does not involve any of the specified interventions (aripiprazole, asenapine, clozapine, iloperidone, olanzapine, paliperidone, quetiapine, risperidone, and ziprasidone) and does not examine any of the specified outcomes (mortality, quality of life, functional capacity, hospitalization, emergency department visits, efficacy, adherence, persistence, caregiver burden, etc.).",Reversible metabolism of clozapine and clozapine Noxide in schizophrenic patients,https://doi.org/10.1016/s0278-5846(98)00035-9,9723115
True," The study focuses on the efficacy and tolerability of antipsychotics in adolescent schizophrenia, which meets the inclusion criteria of the review.",Typical and Atypical Antipsychotics in Adolescent Schizophrenia Efficacy Tolerability and Differential Sensitivity to Extrapyramidal Symptoms,https://doi.org/10.1177/070674379804300608,9729687
False," The study population does not match the specified inclusion criteria, as it focuses on nursing home patients aged 65 and over, whereas the review includes patients with various psychiatric and neurological disorders across different age groups.",Constipation as an adverse effect of drug use in nursing home patients an overestimated risk,https://doi.org/10.1046/j.1365-2125.1998.00777.x,9764967
False," The abstract does not mention any specific interventions or outcomes related to the inclusion criteria, and it appears to be a conference proceedings or a discussion on the challenges in recruiting patients for clinical trials rather than a report on the effectiveness of specific interventions.",Update on the Management of Bipolar Illness,https://doi.org/10.4088/jcp.v59n0909,9771823
True," The study meets the inclusion criteria as it is a randomized controlled trial examining the effectiveness of clozapine in patients with refractory schizophrenia, which is a relevant intervention and population for this review.",Predictors of differential response to clozapine and haloperidol Veterans Affairs Cooperative Study Group on Clozapine in Refractory Schizophrenia,https://doi.org/10.1016/s0006-3223(98)00117-6,9777179
False, The study does not meet the inclusion criteria as it is a case series and does not provide controlled studies.,Olanzapine augmentation of clozapine,https://doi.org/10.1023/a:1022350221192,9781474
True," The study meets the inclusion criteria as it involves adults with a DSM-III-R diagnosis of schizophrenia, a treatment-resistant population, and examines the effectiveness of olanzapine, which is an intervention included in the review.",Olanzapine response in treatmentrefractory schizophrenic patients with a history of substance abuse,https://doi.org/10.1016/s0920-9964(98)00062-0,9783349
True," The study meets the inclusion criteria as it involves adults with schizophrenia, a randomized controlled trial, and examines the effectiveness of clozapine, which is an intervention included in the review.",Effects of clozapine on auditory eventrelated potentials in schizophrenia,https://doi.org/10.1016/s0006-3223(97)00524-6,9798075
True," The study meets the inclusion criteria as it involves a randomized double-blind comparison of two antipsychotic medications (risperidone and haloperidol) in treatment-resistant schizophrenia patients, which is a relevant population for this review.",Risperidone vs haloperidol on reaction time manual dexterity and motor learning in treatmentresistant schizophrenia patients,https://doi.org/10.1016/s0006-3223(98)00088-2,9798076
True," The study population includes adults and adolescents with schizophrenia and schizoaffective disorders, which aligns with the inclusion criteria.",Relationship between patient variables and plasma clozapine concentrations a dosing nomogram,https://doi.org/10.1016/s0006-3223(97)00531-3,9798077
True," The study meets the inclusion criteria as it focuses on the economic outcomes of antipsychotic agents in a Medicaid population, specifically comparing traditional agents to risperidone, which is one of the included interventions.",Economic outcomes of antipsychotic agents in a Medicaid population traditional agents vs risperidone,nan,9803771
True," The study population includes adults with schizophrenia, which meets the inclusion criteria.",Risperidone is associated with blunting of Dfenfluramine evoked serotonergic responses in schizophrenia,https://doi.org/10.1097/00004850-199809000-00002,9817624
True," The study meets the inclusion criteria as it involves adults with a DSM-IV diagnosis of schizophrenia, a randomized controlled trial, and examines the effectiveness of clozapine and risperidone.",Clinical and Neurocognitive Effects of Clozapine and Risperidone in TreatmentRefractory Schizophrenic Patients,https://doi.org/10.4088/jcp.v59n1005,9818633
False," The study population specified in the abstract (patients with behavioral disorders associated with dementia) does not match the inclusion criteria, which include a wide range of psychiatric disorders such as schizophrenia, bipolar disorder, major depressive disorder, and pervasive developmental disorders, but not specifically behavioral disorders associated with dementia.",Efficacy and Safety of Neuroleptics in Behavioral Disorders Associated With Dementia,https://doi.org/10.4088/jcp.v59n1010,9818639
True," The study meets the inclusion criteria as it involves patients with schizophrenia, a condition included in the review, and examines the effects of clozapine, an intervention included in the review.",Clozapine effects on force control in schizophrenic patients,https://doi.org/10.1016/s0920-9964(98)00087-5,9824875
False," The abstract does not mention any of the specified interventions (e.g. aripiprazole, asenapine, clozapine, iloperidone, olanzapine, paliperidone, quetiapine, risperidone, and ziprasidone) or patient populations (e.g. schizophrenia, bipolar disorder, major depressive disorder, etc.) that are included in the review.",PostMarketing Studies,https://doi.org/10.2165/00002018-199819050-00002,9825948
False," The study population specified in the abstract (schizophrenia and related psychoses) does not match the inclusion criteria (schizophrenia, bipolar disorder, major depressive disorder, behavioral and psychological symptoms of dementia, pervasive developmental disorders, and disruptive behavior disorders).",Oral olanzapine versus oral haloperidol in the maintenance treatment of schizophrenia and related psychoses,https://doi.org/10.1192/bjp.172.6.499,9828990
False," The study population does not match the inclusion criteria as it only includes adults and adolescents with schizophrenia, whereas the review includes a broader range of psychiatric disorders.",Nithsdale Schizophrenia Surveys,https://doi.org/10.1192/bjp.172.6.513,9828992
True," The study meets the inclusion criteria as it involves patients with recent-onset schizophrenia, a relevant population for the review, and examines the effects of risperidone, a medication included in the review.",P suppression in recentonset schizophrenia Clinical correlates and risperidone effects,https://doi.org/10.1037//0021-843x.107.4.691,9830258
True," The study population includes adults with schizophrenia, which meets the inclusion criteria.",DDopamine Receptor Occupancy measured by IBZMSPECT in Relation to Extrapyramidal Side Effects,https://doi.org/10.1055/s-2007-979321,9832346
True," The study meets the inclusion criteria as it involves adults with schizophrenia, a randomized controlled trial, and examines the effectiveness of an intervention (D-serine added to antipsychotics) on symptoms and cognitive function.",DAlanine Added to Antipsychotics for the Treatment of Schizophrenia,https://doi.org/10.1016/j.biopsych.2005.06.032,9836012
False," The study population does not match the specified inclusion criteria as it only includes adults and adolescents with psychosis, whereas the inclusion criteria include a broader range of disorders such as bipolar disorder, major depressive disorder, and pervasive developmental disorders.",LondonEast Anglia randomised controlled trial of cognitivebehavioural therapy for psychosis,https://doi.org/10.1192/bjp.173.1.61,9850205
False," The study does not meet the inclusion criteria as it does not involve any of the specified interventions (aripiprazole, asenapine, clozapine, iloperidone, olanzapine, paliperidone, quetiapine, risperidone, and ziprasidone) and does not examine any of the specified outcomes (mortality, quality of life, functional capacity, hospitalization, emergency department visits, efficacy, adherence, persistence, caregiver burden, etc.) related to the specified patient populations.",Lack of effect of olanzapine on the pharmacokinetics of a single aminophylline dose in healthy men,nan,9855322
False," The title and abstract do not mention any specific age groups or diagnoses that match the inclusion criteria, and the focus is on the pharmacokinetics of psychotropic drugs rather than their effectiveness or harms in specific patient populations.",Die Bedeutung des hepatischen CytochromPSystems fr die Psychopharmakologie,https://doi.org/10.1007/s001150050368,9859115
True, The study meets the inclusion criteria as it is a randomized controlled trial evaluating the efficacy and safety of ziprasidone in patients with an acute exacerbation of schizophrenia or schizoaffective disorder.,Ziprasidone and mgday in the acute exacerbation of schizophrenia and schizoaffective disorder a week placebocontrolled trial,https://doi.org/10.1007/s002130050755,9860108
False," The study population does not match the inclusion criteria as it only includes healthy volunteers, not patients with schizophrenia, bipolar disorder, or other conditions specified in the inclusion criteria.",A pharmacokinetic interaction between carbamazepine and olanzapine observations on possible mechanism,https://doi.org/10.1007/s002280050527,9860152
False," The abstract does not mention any of the specified interventions (aripiprazole, asenapine, clozapine, iloperidone, olanzapine, paliperidone, quetiapine, risperidone, and ziprasidone) as being studied, and only focuses on risperidone and olanzapine.",Risperidone and olanzapine,https://doi.org/10.1097/00004850-199811000-00003,9861575
False," The study population in the abstract is limited to adolescent psychiatric inpatients, which does not meet the inclusion criteria of including adults (age 18 years and older) and children (under 13 years).",Elevated surum creatine kinase activity in adolescent psychiatric inpatients on admission,https://doi.org/10.1097/00004850-199811000-00005,9861577
True," The study meets the inclusion criteria as it involves adults with schizophrenia, a condition included in the review, and examines the effectiveness of switching from clozapine to olanzapine, an intervention included in the review.",Switching From Clozapine to Olanzapine in TreatmentRefractory Schizophrenia,https://doi.org/10.4088/jcp.v59n1105,9862604
True," The study meets the inclusion criteria as it involves adults with refractory schizophrenia, a relevant population for this review, and examines the effectiveness of clozapine compared to haloperidol, a relevant intervention.",Multiple outcome assessment in a study of the costeffectiveness of clozapine in the treatment of refractory schizophrenia Department of Veterans Affairs Cooperative Study Group on Clozapine in Refractory Schizophrenia,nan,9865219
False," The study does not meet the inclusion criteria as it does not involve any of the specified patient populations (schizophrenia, bipolar disorder, major depressive disorder, behavioral and psychological symptoms of dementia, pervasive developmental disorders, or disruptive behavior disorders) and does not examine the effectiveness of the specified interventions.",Psilocybin induces schizophrenialike psychosis in humans via a serotonin agonist action,https://doi.org/10.1097/00001756-199812010-00024,9875725
False," The study does not meet the inclusion criteria as it does not involve any of the specified interventions (aripiprazole, asenapine, clozapine, iloperidone, olanzapine, paliperidone, quetiapine, risperidone, and ziprasidone) and does not examine the specified outcomes (mortality, quality of life, functional capacity, hospitalization, emergency department visits, efficacy, adherence, persistence, caregiver burden, etc.) in the specified patient populations.",Mechanism of Peripheral Noradrenergic Stimulation by Clozapine,https://doi.org/10.1016/s0893-133x(98)00047-5,9885782
True, The study meets the inclusion criteria as it involves a randomized controlled trial comparing the efficacy and safety of olanzapine and haloperidol in patients with first-episode psychosis.,Olanzapine Versus Haloperidol Treatment in FirstEpisode Psychosis,https://doi.org/10.1176/ajp.156.1.79,9892301
True," The study meets the inclusion criteria as it involves adults with refractory schizophrenia, a relevant population for the review, and examines the effectiveness of clozapine, a medication included in the review.",Impact of Clozapine on Negative Symptoms and on the Deficit Syndrome in Refractory Schizophrenia,https://doi.org/10.1176/ajp.156.1.88,9892302
False," The study population does not match the inclusion criteria as it only includes adults and adolescents with treatment-resistant schizophrenia, whereas the review includes a broader range of patient populations.",Effect of Clozapine and Adjunctive HighDose Glycine in TreatmentResistant Schizophrenia,https://doi.org/10.1176/ajp.156.1.145,9892314
True," The study population includes adults and adolescents with a diagnosis of schizophrenia, which meets the inclusion criteria.",Drug utilization patterns and outcomes associated with inhospital treatment with risperidone or olanzapine,https://doi.org/10.1016/s0149-2918(98)80116-1,9916613
False," The study population does not match the inclusion criteria as it specifically targets patients with HIV-associated psychosis and drug-induced parkinsonism, which is not mentioned in the inclusion criteria.",Pilot study with clozapine in patients with HIVassociated psychosis and druginduced parkinsonism,https://doi.org/10.1002/1531-8257(199901)14:1<128::aid-mds1021>3.0.co;2-j,9918355
True," The study population includes elderly patients with schizophrenia and dementia, which matches the inclusion criteria for older adults (≥ 65 years of age) with behavioral and psychological symptoms of dementia.",Conventional vs newer antipsychotics in elderly patients,nan,9919323
True," The study meets the inclusion criteria as it reviews the use of atypical neuroleptics in children and adolescents with various psychiatric disorders, including schizophrenia, bipolar disorder, and pervasive developmental disorders, and examines their effectiveness and harms.",Use of Atypical Neuroleptics in Child and Adolescent Psychiatry,https://doi.org/10.4088/jcp.v59n1202,9921698
False," The study does not meet the inclusion criteria as it does not focus on the effectiveness of the specified interventions (aripiprazole, asenapine, clozapine, iloperidone, olanzapine, paliperidone, quetiapine, risperidone, and ziprasidone) in the specified patient populations.",Schizophrenia Do we really need placebocontrolled studies,https://doi.org/10.1016/s0924-977x(97)00081-3,9928917
False," The study population specified in the abstract (patients suffering from schizophrenia or schizodepressive disorder with predominant negative symptomatology) does not match the inclusion criteria for patients with schizophrenia, including first episode and treatment-resistant patients, bipolar disorder, major depressive disorder, and behavioral and psychological symptoms of dementia.",Combination treatment with clozapine and paroxetine in schizophrenia safety and tolerability data from a prospective open clinical trial,https://doi.org/10.1016/s0924-977x(97)00093-x,9928923
True," The study meets the inclusion criteria as it involves patients with schizophrenia, a condition included in the review, and examines the relationship between risperidone and prolactin levels, which is a relevant outcome of interest.",Prolactin Levels and Adverse Events in Patients Treated with Risperidone,https://doi.org/10.1097/00004714-199902000-00011,9934944
True," The study meets the inclusion criteria as it examines the coexistence of obsessive-compulsive disorder (OCD) with schizophrenia in terms of epidemiology and overlapping biologic substrates, which falls within the scope of the review.",Obsessivecompulsive disorder in schizophrenia epidemiologic and biologic overlap,nan,9987204
True," The study meets all the inclusion criteria as it includes adults and adolescents with schizophrenia, bipolar disorder, and other conditions, and examines the efficacy and tolerability of new antipsychotics compared to placebo and conventional antipsychotics.",Efficacy and extrapyramidal sideeffects of the new antipsychotics olanzapine quetiapine risperidone and sertindole compared to conventional antipsychotics and placebo A metaanalysis of randomized controlled trials,https://doi.org/10.1016/s0920-9964(98)00105-4,9988841
False," The study population does not match the inclusion criteria as it only includes psychiatric inpatients who received clozapine, olanzapine, haloperidol, or no psychopharmacological treatment, whereas the inclusion criteria specify a wide range of psychiatric disorders and medications.",Body Weight and Leptin Plasma Levels During Treatment With Antipsychotic Drugs,https://doi.org/10.1176/ajp.156.2.312,9989571
